[
  {
    "id": 10,
    "user_query": "You MUST give a detailed answer to the following question: Name synonym of Acrokeratosis paraneoplastica.",
    "llama-7b_response": "Acrokeratosis paraneoplastica is a rare skin condition that is characterized by the development of thick, rough, and scaly patches of skin on the fingers, toes, and soles of the feet. These patches are caused by the body's immune system reacting to a cancerous tumor in the body.\n\nThere are several synonyms for acrokeratosis paraneoplastica, including:\n\n1. Acrokeratotic paraneoplastic pemphigus\n2. Acrokeratotic paraneoplastic pemphigoid\n3. Acrokeratotic paraneoplastic dermatitis\n4. Acrokeratotic paraneoplastic eczema\n5. Acrokeratotic paraneoplastic psoriasis\n6. Acrokeratotic paraneoplastic lichen planus\n7. Acrokeratotic paraneoplastic scleroderma\n8. Acrokeratotic paraneoplastic discoid lupus erythematosus\n9. Acrokeratotic paraneoplastic lupus erythematosus\n10. Acrokeratotic paraneoplastic dermatomyositis.",
    "llama-7b_fact_raw": "1. Acrokeratosis paraneoplastica is characterized by the development of thick, rough, and scaly patches of skin.\n2. The patches associated with acrokeratosis paraneoplastica appear on the fingers, toes, and soles of the feet.\n3. Acrokeratosis paraneoplastica is a rare skin condition.\n4. The condition is caused by the body's immune system reacting to a cancerous tumor.\n5. \"Acrokeratotic paraneoplastic pemphigus\" is a synonym for acrokeratosis paraneoplastica.",
    "llama-7b_fact": [
      "Acrokeratosis paraneoplastica is characterized by the development of thick, rough, and scaly patches of skin.",
      "The patches associated with acrokeratosis paraneoplastica appear on the fingers, toes, and soles of the feet.",
      "Acrokeratosis paraneoplastica is a rare skin condition.",
      "The condition is caused by the body's immune system reacting to a cancerous tumor.",
      "\"Acrokeratotic paraneoplastic pemphigus\" is a synonym for acrokeratosis paraneoplastica."
    ]
  },
  {
    "id": 47,
    "user_query": "You MUST give a detailed answer to the following question: Is Weaver syndrome similar to Sotos?",
    "llama-7b_response": "Weaver syndrome and Sotos syndrome are both genetic disorders that affect growth and development, but they are distinct conditions with different genetic causes and clinical features.\n\nWeaver syndrome, also known as Simpson-Golabi-Behmel syndrome (SGBS), is caused by mutations in the GH1 gene on chromosome 17q21. This gene encodes for the growth hormone receptor, which plays a crucial role in regulating growth and development. Individuals with Weaver syndrome have characteristic physical features such as macrocephaly (large head), hypotonia (low muscle tone), and distinctive facial features such as a broad forehead, low-set and malformed ears, and a single crease in the palm of the hand. Intellectual disability and delayed puberty are also common in this condition.\n\nSotos syndrome, on the other hand, is caused by mutations in the NSD1 gene on chromosome 5q31. This gene encodes for a transcription factor that plays a crucial role in regulating gene expression during embryonic development. Individuals with Sotos syndrome have characteristic physical features such as a large head, wide-set eyes, and a distinctive facial structure with a broad forehead, full cheeks, and a flat nasal bridge. Intellectual disability and rapid growth during childhood are also common in this condition.\n\nWhile both Weaver syndrome and Sotos syndrome are genetic disorders that affect growth and development, they differ in their genetic causes and clinical features. Weaver syndrome is caused by mutations in the GH1 gene, while Sotos syndrome is caused by mutations in the NSD1 gene. Additionally, individuals with Weaver syndrome have characteristic physical features such as macrocephaly, hypotonia, and distinctive facial features, while individuals with Sotos syndrome have characteristic physical features such as a large head, wide-set eyes, and a distinctive facial structure. It is important for healthcare professionals to accurately diagnose these conditions in order to provide appropriate management and support to affected individuals and their families.",
    "llama-7b_fact_raw": "1. Weaver syndrome and Sotos syndrome are both genetic disorders that impact growth and development.\n2. Weaver syndrome is caused by mutations in the GH1 gene located on chromosome 17q21.\n3. Sotos syndrome is caused by mutations in the NSD1 gene located on chromosome 5q31.\n4. Individuals with Weaver syndrome typically have features such as macrocephaly, hypotonia, and distinctive facial characteristics.\n5. Characteristics of individuals with Sotos syndrome include a large head, wide-set eyes, and a distinctive facial structure.",
    "llama-7b_fact": [
      "Weaver syndrome and Sotos syndrome are both genetic disorders that impact growth and development.",
      "Weaver syndrome is caused by mutations in the GH1 gene located on chromosome 17q21.",
      "Sotos syndrome is caused by mutations in the NSD1 gene located on chromosome 5q31.",
      "Individuals with Weaver syndrome typically have features such as macrocephaly, hypotonia, and distinctive facial characteristics.",
      "Characteristics of individuals with Sotos syndrome include a large head, wide-set eyes, and a distinctive facial structure."
    ]
  },
  {
    "id": 81,
    "user_query": "You MUST give a detailed answer to the following question: List the releases of JASPAR database",
    "llama-7b_response": "The JASPAR database is a widely used database of protein-coding transcription factor binding profiles. Here are the releases of the JASPAR database, along with their corresponding years:\n\n1. JASPAR 2004 Release: This was the first release of the JASPAR database, which was published in 2004. It contained binding profiles for 18 transcription factors.\n2. JASPAR 2007 Release: This release of the JASPAR database was published in 2007 and contained binding profiles for 35 transcription factors.\n3. JASPAR 2010 Release: This release of the JASPAR database was published in 2010 and contained binding profiles for 45 transcription factors.\n4. JASPAR 2012 Release: This release of the JASPAR database was published in 2012 and contained binding profiles for 55 transcription factors.\n5. JASPAR 2014 Release: This release of the JASPAR database was published in 2014 and contained binding profiles for 65 transcription factors.\n6. JASPAR 2016 Release: This release of the JASPAR database was published in 2016 and contained binding profiles for 75 transcription factors.\n7. JASPAR 2018 Release: This release of the JASPAR database was published in 2018 and contained binding profiles for 85 transcription factors.\n8. JASPAR 2020 Release: This release of the JASPAR database was published in 2020 and contained binding profiles for 95 transcription factors.",
    "llama-7b_fact_raw": "1. The JASPAR 2004 Release was published in 2004 with binding profiles for 18 transcription factors.\n2. The JASPAR 2007 Release was published in 2007 with binding profiles for 35 transcription factors.\n3. The JASPAR 2010 Release was published in 2010 with binding profiles for 45 transcription factors.\n4. The JASPAR 2012 Release was published in 2012 with binding profiles for 55 transcription factors.\n5. The JASPAR 2014 Release was published in 2014 with binding profiles for 65 transcription factors.",
    "llama-7b_fact": [
      "The JASPAR 2004 Release was published in 2004 with binding profiles for 18 transcription factors.",
      "The JASPAR 2007 Release was published in 2007 with binding profiles for 35 transcription factors.",
      "The JASPAR 2010 Release was published in 2010 with binding profiles for 45 transcription factors.",
      "The JASPAR 2012 Release was published in 2012 with binding profiles for 55 transcription factors.",
      "The JASPAR 2014 Release was published in 2014 with binding profiles for 65 transcription factors."
    ]
  },
  {
    "id": 99,
    "user_query": "You MUST give a detailed answer to the following question: What is the function of the viral KP4 protein?",
    "llama-7b_response": "The KP4 protein is a viral protein that is encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV), which is a member of the herpesvirus family. The KP4 protein is also known as ORF73, and it is one of the largest and most complex viral proteins produced by KSHV.\n\nThe function of the KP4 protein is not fully understood, but it is believed to play a crucial role in the life cycle of the virus. The KP4 protein is synthesized as a precursor protein that is cleaved into two smaller proteins, K1 and K2, which are then transported to the cell membrane.\n\nOne of the functions of the KP4 protein is to help the virus evade the host immune system. Studies have shown that the KP4 protein can interact with immune cells, such as macrophages and dendritic cells, and prevent them from recognizing and attacking the virus. This helps the virus to establish a persistent infection in the host.\n\nIn addition to its role in immune evasion, the KP4 protein may also play a role in the replication of the virus. Studies have shown that the KP4 protein is localized to the nucleus of infected cells and may be involved in the transcription of viral genes.\n\nOverall, the function of the KP4 protein is complex and not fully understood, but it is clear that it plays an important role in the life cycle of the Kaposi's sarcoma-associated herpesvirus. Further research is needed to fully understand the role of the KP4 protein in the virus's replication and pathogenesis.",
    "llama-7b_fact_raw": "1. The KP4 protein is encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV).\n2. KP4 is also known as ORF73.\n3. KP4 is involved in the viral life cycle and evasion of the host immune system.\n4. The KP4 protein interacts with immune cells such as macrophages and dendritic cells to prevent virus recognition and attack.\n5. The KP4 protein is found in the nucleus of infected cells and may be involved in the transcription of viral genes.",
    "llama-7b_fact": [
      "The KP4 protein is encoded by the Kaposi's sarcoma-associated herpesvirus (KSHV).",
      "KP4 is also known as ORF73.",
      "KP4 is involved in the viral life cycle and evasion of the host immune system.",
      "The KP4 protein interacts with immune cells such as macrophages and dendritic cells to prevent virus recognition and attack.",
      "The KP4 protein is found in the nucleus of infected cells and may be involved in the transcription of viral genes."
    ]
  },
  {
    "id": 124,
    "user_query": "You MUST give a detailed answer to the following question: Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-7b_response": "Yes, 3,5-diiodo-L-thyronine (DITPA) is a thyroid hormone analog that has been utilized in both experimental and clinical studies. DITPA is structurally similar to triiodothyronine (T3), one of the two primary hormones produced by the thyroid gland. However, DITPA has an iodine atom replaced by an iodine analog, which results in increased potency and stability compared to T3.\n\nDITPA has been studied for its potential to treat a variety of thyroid-related conditions, including hypothyroidism, hyperthyroidism, and thyroid cancer. In animal studies, DITPA has been shown to improve thyroid hormone levels, increase metabolism, and reduce weight gain. Additionally, DITPA has been used in clinical trials to treat patients with hypothyroidism and hyperthyroidism, with some evidence suggesting that it may be more effective than traditional thyroid hormone replacement therapy.\n\nHowever, more research is needed to fully understand the safety and efficacy of DITPA in humans, and its use is currently limited to experimental and clinical studies.",
    "llama-7b_fact_raw": "1. 3,5-diiodo-L-thyronine (DITPA) is a thyroid hormone analog.\n2. DITPA has been utilized in both experimental and clinical studies.\n3. DITPA is structurally similar to triiodothyronine (T3), which is a primary hormone produced by the thyroid gland.\n4. In animal studies, DITPA has been shown to improve thyroid hormone levels and increase metabolism.\n5. DITPA has been used in clinical trials to treat patients with hypothyroidism and hyperthyroidism.",
    "llama-7b_fact": [
      "3,5-diiodo-L-thyronine (DITPA) is a thyroid hormone analog.",
      "DITPA has been utilized in both experimental and clinical studies.",
      "DITPA is structurally similar to triiodothyronine (T3), which is a primary hormone produced by the thyroid gland.",
      "In animal studies, DITPA has been shown to improve thyroid hormone levels and increase metabolism.",
      "DITPA has been used in clinical trials to treat patients with hypothyroidism and hyperthyroidism."
    ]
  },
  {
    "id": 144,
    "user_query": "You MUST give a detailed answer to the following question: What is the COUGER tool?",
    "llama-7b_response": "The COUGER tool is a software tool developed by the National Institute of Standards and Technology (NIST) that is used to generate cryptographic key pairs and other cryptographic operations. COUGER stands for \"Cryptographic Operations Using Generated Keys.\"\n\nThe COUGER tool is designed to be a flexible and extensible tool that can be used to perform a wide range of cryptographic operations, including key generation, encryption, decryption, signature generation, and signature verification. It can be used to generate key pairs using a variety of cryptographic algorithms, including RSA, ElGamal, Diffie-Hellman, and more.\n\nOne of the key features of the COUGER tool is its ability to generate large key sizes, making it suitable for use in high-security applications. It can also generate key pairs with different levels of security, allowing users to choose the level of security that is appropriate for their needs.\n\nIn addition to key generation, the COUGER tool can also be used to perform other cryptographic operations, such as encryption and decryption of data, generation of digital signatures, and verification of digital signatures. It can also be used to generate random numbers, which are often used in cryptographic operations.\n\nOverall, the COUGER tool is a powerful and flexible tool that can be used to perform a wide range of cryptographic operations, making it a valuable tool for anyone working with cryptography.",
    "llama-7b_fact_raw": "1. The COUGER tool is developed by the National Institute of Standards and Technology (NIST).\n2. COUGER is used to generate cryptographic key pairs and perform other cryptographic operations.\n3. The acronym COUGER stands for \"Cryptographic Operations Using Generated Keys.\"\n4. COUGER can generate key pairs using cryptographic algorithms like RSA, ElGamal, and Diffie-Hellman.\n5. The COUGER tool is capable of generating large key sizes for high-security applications.",
    "llama-7b_fact": [
      "The COUGER tool is developed by the National Institute of Standards and Technology (NIST).",
      "COUGER is used to generate cryptographic key pairs and perform other cryptographic operations.",
      "The acronym COUGER stands for \"Cryptographic Operations Using Generated Keys.\"",
      "COUGER can generate key pairs using cryptographic algorithms like RSA, ElGamal, and Diffie-Hellman.",
      "The COUGER tool is capable of generating large key sizes for high-security applications."
    ]
  },
  {
    "id": 145,
    "user_query": "You MUST give a detailed answer to the following question: Are there drugs for Tick-borne Encephalitis?",
    "llama-7b_response": "Tick-borne encephalitis (TBE) is a viral infection that is transmitted to humans through the bite of an infected tick. There are several different viruses that can cause TBE, including the European tick-borne encephalitis virus (TBEV), the Far Eastern tick-borne encephalitis virus (FEV), and the Siberian tick-borne encephalitis virus (Siberian TBEV).\n\nTreatment for TBE typically involves supportive care to manage symptoms such as fever, headache, and muscle weakness. There is no specific antiviral treatment for TBE, and antibiotics are not effective against viral infections.\n\nIn some cases, hospitalization may be necessary to manage complications such as seizures, coma, or respiratory failure.\n\nThere are no specific drugs that have been proven to be effective in preventing or treating TBE. However, there are vaccines available that can provide protection against TBEV and FEV. These vaccines are generally recommended for people who are at high risk of exposure to TBE, such as travelers to endemic areas, outdoor workers, and people who live in rural or forested areas.",
    "llama-7b_fact_raw": "1. Tick-borne encephalitis (TBE) is transmitted to humans through the bite of an infected tick.\n2. The European tick-borne encephalitis virus (TBEV), the Far Eastern tick-borne encephalitis virus (FEV), and the Siberian tick-borne encephalitis virus (Siberian TBEV) are different viruses that can cause TBE.\n3. There is no specific antiviral treatment available for TBE.\n4. Antibiotics are ineffective against the viral infection of TBE.\n5. Vaccines are available that can provide protection against TBEV and FEV.",
    "llama-7b_fact": [
      "Tick-borne encephalitis (TBE) is transmitted to humans through the bite of an infected tick.",
      "The European tick-borne encephalitis virus (TBEV), the Far Eastern tick-borne encephalitis virus (FEV), and the Siberian tick-borne encephalitis virus (Siberian TBEV) are different viruses that can cause TBE.",
      "There is no specific antiviral treatment available for TBE.",
      "Antibiotics are ineffective against the viral infection of TBE.",
      "Vaccines are available that can provide protection against TBEV and FEV."
    ]
  },
  {
    "id": 151,
    "user_query": "You MUST give a detailed answer to the following question: Which genome browser database for DNA shape annotations is available?",
    "llama-7b_response": "There are several genome browser databases for DNA shape annotations that are available. Some of the most popular ones include:\n\n1. UCSC Genome Browser: This is a free, online genome browser that provides access to a wide range of genomic data, including DNA shape annotations. The browser allows users to visualize and analyze genomic data using a variety of tools and resources.\n2. Ensembl Genome Browser: This is another free, online genome browser that provides access to a wide range of genomic data, including DNA shape annotations. The browser allows users to visualize and analyze genomic data using a variety of tools and resources.\n3. Integrative Genomics Viewer (IGV): This is a free, open-source genome browser that provides access to a wide range of genomic data, including DNA shape annotations. The browser allows users to visualize and analyze genomic data using a variety of tools and resources.\n4. Genome Analysis Toolkit (GATK): This is a free, open-source software suite that provides tools for analyzing and interpreting genomic data, including DNA shape annotations. The suite includes tools for aligning genomic data, calling variants, and analyzing population genetics data.\n\nOverall, these genome browser databases provide a wealth of information and resources for studying DNA shape annotations and other aspects of genomic data.",
    "llama-7b_fact_raw": "1. The UCSC Genome Browser is an online platform that offers access to genomic data, including DNA shape annotations.\n2. Ensembl Genome Browser is another online genome browser that provides DNA shape annotations as part of its genomic data offerings.\n3. Integrative Genomics Viewer (IGV) is a free, open-source genome browser that includes DNA shape annotations in its data resources.\n4. Genome Analysis Toolkit (GATK) is an open-source software suite that offers tools for the analysis of genomic data, including DNA shape annotations.",
    "llama-7b_fact": [
      "The UCSC Genome Browser is an online platform that offers access to genomic data, including DNA shape annotations.",
      "Ensembl Genome Browser is another online genome browser that provides DNA shape annotations as part of its genomic data offerings.",
      "Integrative Genomics Viewer (IGV) is a free, open-source genome browser that includes DNA shape annotations in its data resources.",
      "Genome Analysis Toolkit (GATK) is an open-source software suite that offers tools for the analysis of genomic data, including DNA shape annotations."
    ]
  },
  {
    "id": 174,
    "user_query": "You MUST give a detailed answer to the following question: Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-7b_response": "The EZH2 gene encodes for an enzyme called enhancer of zeste homolog 2, which is involved in the regulation of gene expression. Mutations in the EZH2 gene have been associated with several syndromes, including:\n\n1. Wolf-Hirschhorn syndrome: This is a genetic disorder that is caused by a deletion on chromosome 4, which includes the EZH2 gene. The syndrome is characterized by intellectual disability, developmental delays, and abnormal facial features.\n2. DICER1 syndrome: This is a rare genetic disorder that is caused by mutations in the DICER1 gene, which is located on chromosome 7. DICER1 syndrome is characterized by a wide range of symptoms, including hearing loss, developmental delays, and abnormal facial features.\n3. Beckwith-Wiedemann syndrome: This is a genetic disorder that is caused by mutations in the IGF2 gene, which is located on chromosome 11. Beckwith-Wiedemann syndrome is characterized by macroglossia (enlarged tongue), macrocephaly (large head), and an increased risk of developing tumors, including Wilms' tumor and hepatoblastoma.\n4. PTEN hamartoma tumor syndrome: This is a genetic disorder that is caused by mutations in the PTEN gene, which is located on chromosome 10. PTEN hamartoma tumor syndrome is characterized by the development of benign tumors in various parts of the body, including the brain, kidneys, and skin. The syndrome is also associated with intellectual disability, developmental delays, and abnormal facial features.\n\nIn summary, mutations in the EZH2 gene have been associated with several syndromes, including Wolf-Hirschhorn syndrome, DICER1 syndrome, Beckwith-Wiedemann syndrome, and PTEN hamartoma tumor syndrome. These syndromes are characterized by a wide range of symptoms and are caused by mutations in different genes.",
    "llama-7b_fact_raw": "1. Wolf-Hirschhorn syndrome is associated with a deletion on chromosome 4, which includes the EZH2 gene.\n2. Mutations in the EZH2 gene are associated with several syndromes.\n3. Beckwith-Wiedemann syndrome is characterized by an enlarged tongue, large head, and an increased risk of developing tumors.\n4. The EZH2 gene is involved in the regulation of gene expression.\n5. PTEN hamartoma tumor syndrome is caused by mutations in the PTEN gene and is characterized by the development of benign tumors in various parts of the body.",
    "llama-7b_fact": [
      "Wolf-Hirschhorn syndrome is associated with a deletion on chromosome 4, which includes the EZH2 gene.",
      "Mutations in the EZH2 gene are associated with several syndromes.",
      "Beckwith-Wiedemann syndrome is characterized by an enlarged tongue, large head, and an increased risk of developing tumors.",
      "The EZH2 gene is involved in the regulation of gene expression.",
      "PTEN hamartoma tumor syndrome is caused by mutations in the PTEN gene and is characterized by the development of benign tumors in various parts of the body."
    ]
  },
  {
    "id": 193,
    "user_query": "You MUST give a detailed answer to the following question: List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-7b_response": "There are several human proteins that are known to undergo a dimer-to-tetramer transition. These proteins are characterized by having multiple copies of the same protein molecule come together to form a larger, more complex structure. Some examples of proteins that undergo this transition include:\n\n1. Hemoglobin: Hemoglobin is a protein found in red blood cells that carries oxygen throughout the body. It is a tetramer made up of two alpha and two beta subunits.\n2. Myoglobin: Myoglobin is a protein found in muscle cells that helps to store and transport oxygen. It is a dimer made up of two alpha subunits.\n3. Cytochrome C: Cytochrome C is a protein found in the mitochondria of cells that plays a role in cellular respiration. It is a tetramer made up of two alpha and two beta subunits.\n4. Ferritin: Ferritin is a protein found in cells that helps to store iron. It is a tetramer made up of four identical subunits.\n5. Ceruloplasmin: Ceruloplasmin is a protein found in the blood that helps to transport iron throughout the body. It is a tetramer made up of two alpha and two beta subunits.\n\nThese are just a few examples of human proteins that undergo a dimer-to-tetramer transition. The dimer-to-tetramer transition is a common structural feature of many proteins and plays an important role in their function.",
    "llama-7b_fact_raw": "1. Hemoglobin in red blood cells is a protein that undergoes a dimer-to-tetramer transition and is composed of two alpha and two beta subunits.\n2. Myoglobin in muscle cells is known to be a dimer consisting of two alpha subunits.\n3. Cytochrome C, which aids cellular respiration in mitochondria, is described as a tetramer with two alpha and two beta subunits.\n4. Ferritin, involved in iron storage within cells, forms a tetramer composed of four identical subunits.\n5. Ceruloplasmin, a blood protein involved in iron transport, undergoes a transition to a tetramer, made up of two alpha and two beta subunits.",
    "llama-7b_fact": [
      "Hemoglobin in red blood cells is a protein that undergoes a dimer-to-tetramer transition and is composed of two alpha and two beta subunits.",
      "Myoglobin in muscle cells is known to be a dimer consisting of two alpha subunits.",
      "Cytochrome C, which aids cellular respiration in mitochondria, is described as a tetramer with two alpha and two beta subunits.",
      "Ferritin, involved in iron storage within cells, forms a tetramer composed of four identical subunits.",
      "Ceruloplasmin, a blood protein involved in iron transport, undergoes a transition to a tetramer, made up of two alpha and two beta subunits."
    ]
  },
  {
    "id": 210,
    "user_query": "You MUST give a detailed answer to the following question: Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-7b_response": "Phospholamban (PLN) is a protein that plays a crucial role in the regulation of cardiovascular function. It has been found to interact with a number of other proteins, including the anti-apoptotic protein Bcl-xL.\n\nBcl-xL is a member of the Bcl-2 family of proteins, which are involved in the regulation of programmed cell death (apoptosis). Bcl-xL is an anti-apoptotic protein, which means that it helps to prevent cells from undergoing programmed cell death. It does this by binding to and inhibiting the activity of pro-apoptotic proteins, such as Bax and Bak.\n\nStudies have shown that PLN and Bcl-xL interact with each other and that this interaction is important for the regulation of cardiovascular function. For example, it has been shown that the interaction between PLN and Bcl-xL is important for the maintenance of cardiac contractility and for the prevention of cardiac remodeling following myocardial infarction.\n\nIn summary, the anti-apoptotic protein Bcl-xL has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein that helps to prevent cells from undergoing programmed cell death. The interaction between PLN and Bcl-xL is important for the regulation of cardiovascular function.",
    "llama-7b_fact_raw": "1. Phospholamban (PLN) is a protein that regulates cardiovascular function.\n2. Bcl-xL is an anti-apoptotic protein that interacts with PLN.\n3. Bcl-xL is a member of the Bcl-2 family of proteins, which are involved in the regulation of apoptosis.\n4. Bcl-xL prevents cell death by inhibiting the activity of pro-apoptotic proteins such as Bax and Bak.\n5. The interaction between PLN and Bcl-xL is significant for maintaining cardiac contractility and preventing cardiac remodeling after a myocardial infarction.",
    "llama-7b_fact": [
      "Phospholamban (PLN) is a protein that regulates cardiovascular function.",
      "Bcl-xL is an anti-apoptotic protein that interacts with PLN.",
      "Bcl-xL is a member of the Bcl-2 family of proteins, which are involved in the regulation of apoptosis.",
      "Bcl-xL prevents cell death by inhibiting the activity of pro-apoptotic proteins such as Bax and Bak.",
      "The interaction between PLN and Bcl-xL is significant for maintaining cardiac contractility and preventing cardiac remodeling after a myocardial infarction."
    ]
  },
  {
    "id": 218,
    "user_query": "You MUST give a detailed answer to the following question: Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-7b_response": "Yes, vitamin D has been shown to reduce the incidence of falls in older people in clinical trials. Several studies have found that vitamin D supplementation can reduce the risk of falls in older adults, particularly those who are deficient in vitamin D.\n\nFor example, a meta-analysis of 25 randomized controlled trials found that vitamin D supplementation significantly reduced the risk of falls in older adults by 19%. Another study found that vitamin D supplementation reduced the risk of falls by 22% in older adults who were deficient in vitamin D.\n\nThese findings suggest that maintaining adequate levels of vitamin D through diet or supplementation may be an important strategy for preventing falls in older adults. However, it is worth noting that more research is needed to fully understand the relationship between vitamin D and falls in older adults, and the optimal dosage and form of vitamin D supplementation for fall prevention.",
    "llama-7b_fact_raw": "1. Vitamin D supplementation has been associated with a reduction in the incidence of falls in older adults, according to several studies.\n2. A meta-analysis of 25 randomized controlled trials indicated that vitamin D supplementation led to a significant 19% reduction in the risk of falls among older adults.\n3. Vitamin D supplementation was found to reduce the risk of falls by 22% in older adults who were deficient in the vitamin, as per one study.\n4. Adequate levels of vitamin D may be an important preventive measure against falls in the older population.\n5. Further research is needed to fully understand how vitamin D relates to fall prevention in older adults and to determine the optimal dosage and form for supplementation.",
    "llama-7b_fact": [
      "Vitamin D supplementation has been associated with a reduction in the incidence of falls in older adults, according to several studies.",
      "A meta-analysis of 25 randomized controlled trials indicated that vitamin D supplementation led to a significant 19% reduction in the risk of falls among older adults.",
      "Vitamin D supplementation was found to reduce the risk of falls by 22% in older adults who were deficient in the vitamin, as per one study.",
      "Adequate levels of vitamin D may be an important preventive measure against falls in the older population.",
      "Further research is needed to fully understand how vitamin D relates to fall prevention in older adults and to determine the optimal dosage and form for supplementation."
    ]
  },
  {
    "id": 222,
    "user_query": "You MUST give a detailed answer to the following question: Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-7b_response": "There is some evidence to suggest that Jarid2 and miR-155 may be associated in the regulation of Th17 cells.\n\nmiR-155 is a microRNA that has been implicated in the regulation of Th17 cell differentiation and function. It has been shown to negatively regulate the expression of genes involved in Th17 cell differentiation, including the transcription factor RORgt, which is a key regulator of Th17 cell differentiation. miR-155 has also been shown to negatively regulate the expression of genes involved in the production of IL-17, a key cytokine produced by Th17 cells.\n\nJarid2, on the other hand, is a non-coding RNA that has been shown to play a role in the regulation of gene expression at the level of transcription. It has been shown to negatively regulate the expression of genes involved in Th17 cell differentiation and function, including the transcription factor RORgt. Jarid2 has also been shown to negatively regulate the expression of genes involved in the production of IL-17 in Th17 cells.\n\nWhile there is some evidence to suggest that Jarid2 and miR-155 may be associated in the regulation of Th17 cells, the exact mechanism by which they interact is not fully understood. It is possible that Jarid2 and miR-155 may work together to negatively regulate the expression of genes involved in Th17 cell differentiation and function. Alternatively, they may act independently of each other to regulate gene expression in Th17 cells. Further research is needed to fully understand the relationship between Jarid2 and miR-155 in the regulation of Th17 cells.",
    "llama-7b_fact_raw": "1. miR-155 negatively regulates the expression of genes important for Th17 cell differentiation.\n2. The transcription factor RORgt, crucial for Th17 cell differentiation, is negatively regulated by miR-155.\n3. miR-155 negatively affects the expression of genes involved in the production of IL-17 by Th17 cells.\n4. Jarid2 negatively regulates the expression of genes linked to Th17 cell differentiation and function.\n5. Both miR-155 and Jarid2 negatively impact the expression of the transcription factor RORgt and genes related to IL-17 production in Th17 cells.",
    "llama-7b_fact": [
      "miR-155 negatively regulates the expression of genes important for Th17 cell differentiation.",
      "The transcription factor RORgt, crucial for Th17 cell differentiation, is negatively regulated by miR-155.",
      "miR-155 negatively affects the expression of genes involved in the production of IL-17 by Th17 cells.",
      "Jarid2 negatively regulates the expression of genes linked to Th17 cell differentiation and function.",
      "Both miR-155 and Jarid2 negatively impact the expression of the transcription factor RORgt and genes related to IL-17 production in Th17 cells."
    ]
  },
  {
    "id": 224,
    "user_query": "You MUST give a detailed answer to the following question: How many genes does the human hoxD cluster contain?",
    "llama-7b_response": "The human HOXD cluster contains 11 genes.",
    "llama-7b_fact_raw": "1. The human HOXD cluster is composed of 11 genes.",
    "llama-7b_fact": [
      "The human HOXD cluster is composed of 11 genes."
    ]
  },
  {
    "id": 268,
    "user_query": "You MUST give a detailed answer to the following question: List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-7b_response": "Casein Kinase 1 (CK1) is an enzyme that catalyzes the transfer of the phosphate group from ATP to a target protein, resulting in phosphorylation. There are several different consensus motifs for CK1 phosphorylation sites, which are based on the amino acid sequence of the target protein and the specific residues that are most likely to be phosphorylated by CK1. Here are a few examples of CK1 phosphorylation consensus motifs:\n\n1. S/T-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-",
    "llama-7b_fact_raw": "1. Casein Kinase 1 (CK1) catalyzes the transfer of a phosphate group from ATP to a target protein.\n2. Phosphorylation by CK1 involves specific consensus motifs based on the amino acid sequence of the target protein.\n3. The consensus motif for CK1 typically starts with a serine (S) or threonine (T).\n4. The consensus motif mentioned for CK1 includes a sequence with numerous unspecified amino acids, represented by the letter 'x'.\n5. The sequence provided in the answer for the consensus motif contains at least fifty unspecified amino acids following an initial serine (S) or threonine (T).",
    "llama-7b_fact": [
      "Casein Kinase 1 (CK1) catalyzes the transfer of a phosphate group from ATP to a target protein.",
      "Phosphorylation by CK1 involves specific consensus motifs based on the amino acid sequence of the target protein.",
      "The consensus motif for CK1 typically starts with a serine (S) or threonine (T).",
      "The consensus motif mentioned for CK1 includes a sequence with numerous unspecified amino acids, represented by the letter 'x'.",
      "The sequence provided in the answer for the consensus motif contains at least fifty unspecified amino acids following an initial serine (S) or threonine (T)."
    ]
  },
  {
    "id": 305,
    "user_query": "You MUST give a detailed answer to the following question: Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-7b_response": "The ASPH (aspartate beta-hydroxylase) gene encodes for the enzyme aspartate beta-hydroxylase, which is involved in the metabolism of aspartate and other amino acids. The gene is located on the long (q) arm of chromosome 12 at position 12q24.3.\n\nThere are several different transcript variants of the ASPH gene, which can result from alternative splicing of the gene's pre-mRNA. These transcript variants can encode different isoforms of the aspartate beta-hydroxylase enzyme, which may have different functions or substrate specificities.\n\nSome of the different isoforms of aspartate beta-hydroxylase encoded by the ASPH gene include:\n\n1. Aspartate beta-hydroxylase 1 (ASPH1): This isoform is primarily expressed in the liver and kidneys, and is involved in the metabolism of aspartate and other amino acids.\n2. Aspartate beta-hydroxylase 2 (ASPH2): This isoform is primarily expressed in the brain and testes, and is involved in the metabolism of aspartate and other amino acids.\n3. Aspartate beta-hydroxylase 3 (ASPH3): This isoform is primarily expressed in the brain and testes, and is involved in the metabolism of aspartate and other amino acids.\n4. Aspartate beta-hydroxylase 4 (ASPH4): This isoform is primarily expressed in the brain and testes, and is involved in the metabolism of aspartate and other amino acids.\n5. Aspartate beta-hydroxylase 5 (ASPH5): This isoform is primarily expressed in the brain and testes, and is involved in the metabolism of aspartate and other amino acids.\n6. Aspartate beta-hydroxylase 6 (ASPH6): This isoform is primarily expressed in the brain and testes, and is involved in the metabolism of aspartate and other amino acids.\n7. Aspartate beta-h",
    "llama-7b_fact_raw": "1. The ASPH gene encodes for the enzyme aspartate beta-hydroxylase.\n2. The ASPH gene is located on the long (q) arm of chromosome 12 at position 12q24.3.\n3. Alternative splicing of the ASPH gene's pre-mRNA results in different transcript variants.\n4. These transcript variants can encode different isoforms of the aspartate beta-hydroxylase enzyme.\n5. Isoforms such as ASPH1, ASPH2, and ASPH3 are involved in the metabolism of aspartate and other amino acids and have varying expressions in different organs like the liver, kidneys, brain, and testes.",
    "llama-7b_fact": [
      "The ASPH gene encodes for the enzyme aspartate beta-hydroxylase.",
      "The ASPH gene is located on the long (q) arm of chromosome 12 at position 12q24.3.",
      "Alternative splicing of the ASPH gene's pre-mRNA results in different transcript variants.",
      "These transcript variants can encode different isoforms of the aspartate beta-hydroxylase enzyme.",
      "Isoforms such as ASPH1, ASPH2, and ASPH3 are involved in the metabolism of aspartate and other amino acids and have varying expressions in different organs like the liver, kidneys, brain, and testes."
    ]
  },
  {
    "id": 330,
    "user_query": "You MUST give a detailed answer to the following question: When was empagliflozin FDA approved?",
    "llama-7b_response": "Empagliflozin, also known by the brand name Jardiance, was approved by the U.S. Food and Drug Administration (FDA) on August 27, 2014, for the treatment of adults with type 2 diabetes. Empagliflozin is a medication that is used in combination with diet and exercise to improve glycemic control in patients with type 2 diabetes. It works by helping the body to excrete excess glucose through the urine. Empagliflozin is not recommended for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.",
    "llama-7b_fact_raw": "1. Empagliflozin was approved by the U.S. Food and Drug Administration (FDA) on August 27, 2014.\n2. The approval was specific to the treatment of adults with type 2 diabetes.\n3. Empagliflozin is used in combination with diet and exercise to improve glycemic control.\n4. The medication works by helping the body excrete excess glucose through the urine.\n5. Empagliflozin is not recommended for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.",
    "llama-7b_fact": [
      "Empagliflozin was approved by the U.S. Food and Drug Administration (FDA) on August 27, 2014.",
      "The approval was specific to the treatment of adults with type 2 diabetes.",
      "Empagliflozin is used in combination with diet and exercise to improve glycemic control.",
      "The medication works by helping the body excrete excess glucose through the urine.",
      "Empagliflozin is not recommended for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis."
    ]
  },
  {
    "id": 350,
    "user_query": "You MUST give a detailed answer to the following question: What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-7b_response": "Lon1 is a protein that plays an important role in the regulation of protein homeostasis in various organisms, including plants. In the plant Arabidopsis, loss of the Lon1 protein has been shown to result in various changes in the plant's growth and development.\n\nOne of the most notable effects of Lon1 loss in Arabidopsis is an increase in the accumulation of misfolded and damaged proteins in the endoplasmic reticulum (ER) of the plant cells. This accumulation of misfolded proteins can lead to the formation of protein aggregates, which can disrupt the normal functioning of the ER and cause cellular stress. As a result, the plant cells may undergo programmed cell death, leading to the death of the plant tissue.\n\nAnother effect of Lon1 loss in Arabidopsis is an alteration in the expression of various genes involved in the plant's response to stress. For example, Lon1 loss has been shown to increase the expression of genes involved in the plant's defense response, such as those encoding for reactive oxygen species (ROS) scavenging enzymes and antioxidant proteins. This increase in defense gene expression may help the plant to cope with the increased cellular stress caused by the accumulation of misfolded proteins.\n\nAdditionally, Lon1 loss in Arabidopsis has been shown to affect the plant's growth and development. For example, Lon1 loss has been shown to result in reduced plant height, reduced leaf size, and delayed flowering. These effects may be due to the altered expression of genes involved in plant growth and development, as well as the increased cellular stress caused by the accumulation of misfolded proteins.\n\nOverall, the loss of the protein Lon1 in the plant Arabidopsis results in changes in the plant's growth and development, as well as an increase in the accumulation of misfolded proteins in the ER and an alteration in the expression of genes involved in the plant's response to stress.",
    "llama-7b_fact_raw": "1. Lon1 is a protein that regulates protein homeostasis in various organisms, including the plant Arabidopsis.\n2. Loss of the Lon1 protein in Arabidopsis leads to increased accumulation of misfolded and damaged proteins in the endoplasmic reticulum.\n3. Accumulation of misfolded proteins in Arabidopsis due to Lon1 loss can lead to protein aggregates and cellular stress, resulting in programmed cell death.\n4. Arabidopsis plants without Lon1 protein show increased expression of genes involved in defense response, such as those for ROS scavenging enzymes and antioxidant proteins.\n5. Arabidopsis plants deficient in Lon1 protein exhibit reduced plant height, reduced leaf size, and delayed flowering.",
    "llama-7b_fact": [
      "Lon1 is a protein that regulates protein homeostasis in various organisms, including the plant Arabidopsis.",
      "Loss of the Lon1 protein in Arabidopsis leads to increased accumulation of misfolded and damaged proteins in the endoplasmic reticulum.",
      "Accumulation of misfolded proteins in Arabidopsis due to Lon1 loss can lead to protein aggregates and cellular stress, resulting in programmed cell death.",
      "Arabidopsis plants without Lon1 protein show increased expression of genes involved in defense response, such as those for ROS scavenging enzymes and antioxidant proteins.",
      "Arabidopsis plants deficient in Lon1 protein exhibit reduced plant height, reduced leaf size, and delayed flowering."
    ]
  },
  {
    "id": 409,
    "user_query": "You MUST give a detailed answer to the following question: Does a linker histone exist in the yeast genome?",
    "llama-7b_response": "Yes, a linker histone exists in the yeast genome. Linker histones are a type of histone protein that helps to package DNA into nucleosomes, which are the basic units of chromatin. In yeast, there are three types of linker histones: H1a, H1b, and H1c. These histones are involved in the regulation of gene expression and play a role in the formation of higher-order chromatin structures.",
    "llama-7b_fact_raw": "1. Linker histones are present in the yeast genome.\n2. Linker histones help package DNA into nucleosomes, which are the basic units of chromatin.\n3. In yeast, the types of linker histones include H1a, H1b, and H1c.\n4. Linker histones in yeast are involved in the regulation of gene expression.\n5. Linker histones play a role in the formation of higher-order chromatin structures.",
    "llama-7b_fact": [
      "Linker histones are present in the yeast genome.",
      "Linker histones help package DNA into nucleosomes, which are the basic units of chromatin.",
      "In yeast, the types of linker histones include H1a, H1b, and H1c.",
      "Linker histones in yeast are involved in the regulation of gene expression.",
      "Linker histones play a role in the formation of higher-order chromatin structures."
    ]
  },
  {
    "id": 418,
    "user_query": "You MUST give a detailed answer to the following question: Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-7b_response": "There is limited evidence to support the claim that tomato juice can lower cholesterol levels. While tomatoes are a rich source of lycopene, a phytochemical that has been shown to have potential cholesterol-lowering properties, the amount of lycopene found in tomato juice is not sufficient to have a significant impact on cholesterol levels.\n\nA study published in the Journal of the American College of Nutrition in 2009 found that consuming tomato juice daily for four weeks did not significantly reduce cholesterol levels in healthy adults. The study suggested that other factors, such as the type and amount of fat in the diet, may play a more significant role in regulating cholesterol levels than the lycopene content of tomato products.\n\nAnother study published in the Journal of Nutrition in 2012 found that supplementing with lycopene did not significantly reduce cholesterol levels in overweight or obese adults.\n\nWhile tomato juice may have other health benefits, such as its high vitamin C and potassium content, there is currently insufficient evidence to support the claim that it can lower cholesterol levels. It is always best to consult with a healthcare professional before making dietary changes to manage cholesterol levels.",
    "llama-7b_fact_raw": "1. Tomatoes are rich in lycopene, which has potential cholesterol-lowering properties.\n2. A study published in 2009 by the Journal of the American College of Nutrition did not find a significant reduction in cholesterol levels after daily consumption of tomato juice for four weeks in healthy adults.\n3. The 2009 study concluded that the type and amount of fat in the diet may be more influential in regulating cholesterol levels than the lycopene content in tomato products.\n4. A 2012 study published in the Journal of Nutrition found that lycopene supplementation did not significantly reduce cholesterol levels in overweight or obese adults.\n5. Tomato juice is high in vitamin C and potassium.",
    "llama-7b_fact": [
      "Tomatoes are rich in lycopene, which has potential cholesterol-lowering properties.",
      "A study published in 2009 by the Journal of the American College of Nutrition did not find a significant reduction in cholesterol levels after daily consumption of tomato juice for four weeks in healthy adults.",
      "The 2009 study concluded that the type and amount of fat in the diet may be more influential in regulating cholesterol levels than the lycopene content in tomato products.",
      "A 2012 study published in the Journal of Nutrition found that lycopene supplementation did not significantly reduce cholesterol levels in overweight or obese adults.",
      "Tomato juice is high in vitamin C and potassium."
    ]
  },
  {
    "id": 472,
    "user_query": "You MUST give a detailed answer to the following question: How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-7b_response": "Hsp70 and Hsp110 are two types of heat shock proteins (HSPs) that play important roles in protecting cells from stress and maintaining cellular homeostasis. One of the functions of Hsp70 and Hsp110 is to regulate the stability of messenger RNA (mRNA).\n\nmRNA stability refers to the length of time that an mRNA molecule remains intact and functional within a cell. In general, mRNAs have a relatively short half-life, which means that they are degraded quickly by enzymes such as ribonuclease (RNase).\n\nHsp70 and Hsp110 can affect mRNA stability in several ways:\n\n1. Chaperone activity: Hsp70 and Hsp110 can bind to and stabilize mRNAs by acting as chaperones. They help to protect mRNAs from degradation by RNase and other enzymes, allowing them to remain intact and functional for longer periods of time.\n2. mRNA translation: Hsp70 and Hsp110 can also affect mRNA stability by regulating the translation of mRNAs. For example, they can bind to and inhibit the activity of eukaryotic initiation factor 4E (eIF4E), which is an important regulator of mRNA translation. By inhibiting eIF4E, Hsp70 and Hsp110 can reduce the rate of mRNA translation and prolong the half-life of mRNAs.\n3. mRNA decay: Hsp70 and Hsp110 can also participate in the process of mRNA decay, which is the breakdown of mRNAs by enzymes such as RNase. By binding to and inhibiting the activity of these enzymes, Hsp70 and Hsp110 can slow down the rate of mRNA decay and extend the half-life of mRNAs.\n\nIn summary, Hsp70 and Hsp110 can affect mRNA stability by acting as chaperones, regulating mRNA translation, and participating in the process of mRNA decay. These functions help to protect mRNAs from degradation",
    "llama-7b_fact_raw": "1. Hsp70 and Hsp110 are types of heat shock proteins that help in protecting cells from stress and in maintaining cellular homeostasis.\n2. Hsp70 and Hsp110 can regulate the stability of messenger RNA (mRNA) in cells.\n3. Hsp70 and Hsp110 can act as chaperones to bind and stabilize mRNAs, protecting them from degradation by enzymes like ribonuclease (RNase).\n4. These proteins can affect mRNA stability by regulating the translation of mRNAs, including inhibiting the activity of eukaryotic initiation factor 4E (eIF4E).\n5. Hsp70 and Hsp110 can participate in the process of mRNA decay by inhibiting the activity of enzymes involved in mRNA breakdown, which can slow down mRNA decay rates and extend mRNA half-life.",
    "llama-7b_fact": [
      "Hsp70 and Hsp110 are types of heat shock proteins that help in protecting cells from stress and in maintaining cellular homeostasis.",
      "Hsp70 and Hsp110 can regulate the stability of messenger RNA (mRNA) in cells.",
      "Hsp70 and Hsp110 can act as chaperones to bind and stabilize mRNAs, protecting them from degradation by enzymes like ribonuclease (RNase).",
      "These proteins can affect mRNA stability by regulating the translation of mRNAs, including inhibiting the activity of eukaryotic initiation factor 4E (eIF4E).",
      "Hsp70 and Hsp110 can participate in the process of mRNA decay by inhibiting the activity of enzymes involved in mRNA breakdown, which can slow down mRNA decay rates and extend mRNA half-life."
    ]
  },
  {
    "id": 481,
    "user_query": "You MUST give a detailed answer to the following question: Which deiodinases are present in skeletal  muscle?",
    "llama-7b_response": "Deiodinases are enzymes that convert one type of thyroid hormone into another. There are three main types of deiodinases: type 1 (D1), type 2 (D2), and type 3 (D3).\n\nSkeletal muscle contains all three types of deiodinases. D1 is the most abundant type of deiodinase in skeletal muscle and is responsible for converting T4 to the active form of thyroid hormone, T3. D2 is also present in skeletal muscle and is responsible for converting T4 to the less active form of thyroid hormone, T2. D3 is the least abundant type of deiodinase in skeletal muscle and is responsible for converting T3 to the inactive form of thyroid hormone, rT3.\n\nIt is worth noting that the activity of these deiodinases can be regulated by a variety of factors, including thyroid hormone levels, nutrition, and exercise. For example, exercise can increase the activity of D1 and D2 in skeletal muscle, leading to an increase in T3 levels and improved muscle function.",
    "llama-7b_fact_raw": "1. There are three main types of deiodinases: type 1 (D1), type 2 (D2), and type 3 (D3).\n2. Skeletal muscle contains all three types of deiodinases: D1, D2, and D3.\n3. D1 is the most abundant type of deiodinase in skeletal muscle and converts T4 to T3, the active form of thyroid hormone.\n4. D2 is responsible for converting T4 to T2, which is a less active form of thyroid hormone, in skeletal muscle.\n5. D3 is the least abundant type of deiodinase in skeletal muscle and converts T3 to rT3, an inactive form of thyroid hormone.",
    "llama-7b_fact": [
      "There are three main types of deiodinases: type 1 (D1), type 2 (D2), and type 3 (D3).",
      "Skeletal muscle contains all three types of deiodinases: D1, D2, and D3.",
      "D1 is the most abundant type of deiodinase in skeletal muscle and converts T4 to T3, the active form of thyroid hormone.",
      "D2 is responsible for converting T4 to T2, which is a less active form of thyroid hormone, in skeletal muscle.",
      "D3 is the least abundant type of deiodinase in skeletal muscle and converts T3 to rT3, an inactive form of thyroid hormone."
    ]
  },
  {
    "id": 534,
    "user_query": "You MUST give a detailed answer to the following question: List inflammatory caspase proteins?",
    "llama-7b_response": "",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 579,
    "user_query": "You MUST give a detailed answer to the following question: Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-7b_response": "Yes, there is a link between the Aurora B kinase and the Polycomb protein Ring1B.\n\nAurora B is a serine/threonine kinase that plays a crucial role in the regulation of mitosis, the process of cell division. It is involved in the formation of mitotic spindles and the separation of chromosomes during cell division. Ring1B is a member of the Polycomb family of proteins, which are involved in the regulation of gene expression.\n\nStudies have shown that Aurora B and Ring1B interact with each other and that this interaction is important for the regulation of mitosis. Specifically, Aurora B phosphorylates Ring1B at multiple sites, which leads to the degradation of Ring1B and the repression of target genes. Conversely, the degradation of Ring1B leads to the activation of target genes, including those involved in the regulation of mitosis.\n\nFurthermore, studies have shown that the interaction between Aurora B and Ring1B is important for the regulation of cell proliferation and the development of cancer. For example, overexpression of Aurora B and Ring1B has been observed in various types of cancer, and these proteins have been implicated in the development of resistance to chemotherapy in cancer cells.\n\nIn summary, there is a clear link between Aurora B and Ring1B, and this link is important for the regulation of mitosis and the control of gene expression. Dysregulation of this interaction has been implicated in the development of cancer and other diseases.",
    "llama-7b_fact_raw": "1. Aurora B kinase is a serine/threonine kinase involved in mitosis regulation.\n2. Ring1B is a member of the Polycomb family of proteins, which regulate gene expression.\n3. Aurora B kinase phosphorylates Ring1B at multiple sites, influencing Ring1B's degradation and gene repression.\n4. An interaction between Aurora B kinase and Ring1B influences cell proliferation and cancer development.\n5. Overexpression of Aurora B kinase and Ring1B has been linked to various types of cancer and chemotherapy resistance.",
    "llama-7b_fact": [
      "Aurora B kinase is a serine/threonine kinase involved in mitosis regulation.",
      "Ring1B is a member of the Polycomb family of proteins, which regulate gene expression.",
      "Aurora B kinase phosphorylates Ring1B at multiple sites, influencing Ring1B's degradation and gene repression.",
      "An interaction between Aurora B kinase and Ring1B influences cell proliferation and cancer development.",
      "Overexpression of Aurora B kinase and Ring1B has been linked to various types of cancer and chemotherapy resistance."
    ]
  },
  {
    "id": 597,
    "user_query": "You MUST give a detailed answer to the following question: What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-7b_response": "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates include:\n\n1. GT-AG motif at the donor splice site: This is the canonical splice site motif and is recognized by the spliceosome.\n2. AT-AC motif at the acceptor splice site: This motif is also recognized by the spliceosome and plays a role in regulating alternative splicing.\n3. GU-AG motif at the donor splice site: This motif is found in some species, including humans, and is recognized by the spliceosome.\n4. UG-AG motif at the acceptor splice site: This motif is found in some species, including humans, and is recognized by the spliceosome.\n5. CU-AG motif at the acceptor splice site: This motif is found in some species, including humans, and is recognized by the spliceosome.\n6. GU-UA motif at the donor splice site: This motif is found in some species, including humans, and is recognized by the spliceosome.\n7. UG-UA motif at the acceptor splice site: This motif is found in some species, including humans, and is recognized by the spliceosome.\n8. CU-UA motif at the acceptor splice site: This motif is found in some species, including humans, and is recognized by the spliceosome.\n\nThese non-canonical motifs can affect splicing efficiency and may play a role in regulating alternative splicing events.",
    "llama-7b_fact_raw": "1. The GT-AG motif at the donor splice site is the canonical splice site motif recognized by the spliceosome.\n2. The AT-AC motif at the acceptor splice site is recognized by the spliceosome and is involved in alternative splicing regulation.\n3. The GU-AG motif at the donor splice site is recognized by the spliceosome and found in species including humans.\n4. The UG-AG motif at the acceptor splice site is recognized by the spliceosome and found in species including humans.\n5. Non-canonical motifs such as CU-AG, GU-UA, UG-UA, and CU-UA at splice sites are found in some species including humans and are recognized by the spliceosome.",
    "llama-7b_fact": [
      "The GT-AG motif at the donor splice site is the canonical splice site motif recognized by the spliceosome.",
      "The AT-AC motif at the acceptor splice site is recognized by the spliceosome and is involved in alternative splicing regulation.",
      "The GU-AG motif at the donor splice site is recognized by the spliceosome and found in species including humans.",
      "The UG-AG motif at the acceptor splice site is recognized by the spliceosome and found in species including humans.",
      "Non-canonical motifs such as CU-AG, GU-UA, UG-UA, and CU-UA at splice sites are found in some species including humans and are recognized by the spliceosome."
    ]
  },
  {
    "id": 629,
    "user_query": "You MUST give a detailed answer to the following question: Which event results in the acetylation of S6K1?",
    "llama-7b_response": "The acetylation of S6K1 (S6 kinase 1) is a post-translational modification that is regulated by a variety of signaling pathways. One event that can result in the acetylation of S6K1 is the activation of the mammalian target of rapamycin (mTOR) pathway.\n\nThe mTOR pathway is a key regulator of cell growth and metabolism, and it is activated in response to a variety of stimuli, including growth factors, nutrients, and energy. When the mTOR pathway is activated, it leads to the phosphorylation and activation of S6K1, which in turn stimulates the translation of a number of key cellular proteins, including ribosomal proteins.\n\nThe acetylation of S6K1 is thought to play a role in the regulation of its activity and stability. Acetylation of S6K1 can inhibit its activity by preventing its association with ribosomes, and it can also promote its degradation by the proteasome.\n\nTherefore, the activation of the mTOR pathway, which leads to the phosphorylation and activation of S6K1, is one event that can result in the acetylation of S6K1.",
    "llama-7b_fact_raw": "1. The acetylation of S6K1 is a post-translational modification.\n2. The mammalian target of rapamycin (mTOR) pathway activation can result in the acetylation of S6K1.\n3. The mTOR pathway is activated by stimuli such as growth factors, nutrients, and energy.\n4. Activation of the mTOR pathway leads to the phosphorylation and activation of S6K1.\n5. Acetylation of S6K1 can inhibit its activity and promote its degradation by the proteasome.",
    "llama-7b_fact": [
      "The acetylation of S6K1 is a post-translational modification.",
      "The mammalian target of rapamycin (mTOR) pathway activation can result in the acetylation of S6K1.",
      "The mTOR pathway is activated by stimuli such as growth factors, nutrients, and energy.",
      "Activation of the mTOR pathway leads to the phosphorylation and activation of S6K1.",
      "Acetylation of S6K1 can inhibit its activity and promote its degradation by the proteasome."
    ]
  },
  {
    "id": 632,
    "user_query": "You MUST give a detailed answer to the following question: What is the cause of episodic ataxia type 6?",
    "llama-7b_response": "Episodic ataxia type 6 is a rare genetic disorder that is caused by mutations in the CACNA1A gene. This gene provides instructions for making a protein called the alpha-1A subunit of the voltage-gated calcium channel, which is responsible for regulating the flow of calcium ions into nerve cells.\n\nThe CACNA1A gene is located on the long (q) arm of chromosome 12. Mutations in this gene can lead to changes in the function of the alpha-1A subunit of the voltage-gated calcium channel, which can disrupt the normal communication between nerve cells in the brain and the rest of the body.\n\nEpisodic ataxia type 6 is characterized by recurrent episodes of ataxia, which is a lack of coordination in the muscles, especially in the arms and legs. These episodes can be triggered by a variety of stimuli, such as stress, exercise, or exposure to heat or cold. Other symptoms of episodic ataxia type 6 may include dizziness, vertigo, nausea, and vomiting.\n\nThe severity of the symptoms can vary greatly from person to person, and some individuals may only experience a few episodes in their lifetime, while others may have frequent and severe episodes. There is currently no cure for episodic ataxia type 6, but medications can be used to manage the symptoms and prevent episodes from occurring.",
    "llama-7b_fact_raw": "1. Episodic ataxia type 6 is a rare genetic disorder caused by mutations in the CACNA1A gene.\n2. The CACNA1A gene is responsible for making a protein that forms part of a voltage-gated calcium channel.\n3. This gene is located on the long (q) arm of chromosome 12.\n4. Mutations in the CACNA1A gene affect the flow of calcium ions into nerve cells, disrupting normal communication between nerve cells in the brain and the rest of the body.\n5. Symptoms of episodic ataxia type 6 include recurrent episodes of ataxia, dizziness, vertigo, nausea, and vomiting.",
    "llama-7b_fact": [
      "Episodic ataxia type 6 is a rare genetic disorder caused by mutations in the CACNA1A gene.",
      "The CACNA1A gene is responsible for making a protein that forms part of a voltage-gated calcium channel.",
      "This gene is located on the long (q) arm of chromosome 12.",
      "Mutations in the CACNA1A gene affect the flow of calcium ions into nerve cells, disrupting normal communication between nerve cells in the brain and the rest of the body.",
      "Symptoms of episodic ataxia type 6 include recurrent episodes of ataxia, dizziness, vertigo, nausea, and vomiting."
    ]
  },
  {
    "id": 646,
    "user_query": "You MUST give a detailed answer to the following question: Are chromomethylases present in animal genomes?",
    "llama-7b_response": "Yes, chromomethylases are present in animal genomes. Chromomethylases are enzymes that add methyl groups to DNA, and they play a role in regulating gene expression. They are found in many organisms, including animals. In animals, chromomethylases are typically found in the nucleus of cells and are involved in a variety of processes, including DNA replication, transcription, and repair. Some examples of animals that have been shown to have chromomethylases include humans, mice, and fruit flies.",
    "llama-7b_fact_raw": "1. Chromomethylases are present in animal genomes.\n2. Chromomethylases are enzymes that add methyl groups to DNA.\n3. These enzymes play a role in regulating gene expression.\n4. In animals, chromomethylases are generally located in the cell nucleus.\n5. Humans, mice, and fruit flies are examples of animals that possess chromomethylases.",
    "llama-7b_fact": [
      "Chromomethylases are present in animal genomes.",
      "Chromomethylases are enzymes that add methyl groups to DNA.",
      "These enzymes play a role in regulating gene expression.",
      "In animals, chromomethylases are generally located in the cell nucleus.",
      "Humans, mice, and fruit flies are examples of animals that possess chromomethylases."
    ]
  },
  {
    "id": 650,
    "user_query": "You MUST give a detailed answer to the following question: List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-7b_response": "There are several packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis. Some of the most commonly used packages are:\n\n1. Chipster: This package provides tools for the analysis of ChIP-chip and ChIP-seq data. It includes functions for mapping reads to the reference genome, detecting peaks, and visualizing the distribution of peaks across the genome.\n2. Bedtools: This package provides tools for working with bed files, which are used to store genomic data. It includes functions for sorting, filtering, and aligning bed files, as well as functions for visualizing the distribution of peaks across the genome.\n3. GenomicRanges: This package provides tools for working with genomic ranges, which are used to store genomic data. It includes functions for sorting, filtering, and aligning genomic ranges, as well as functions for visualizing the distribution of peaks across the genome.\n4. TopHat: This package provides tools for aligning RNA-seq data to a reference genome. It includes functions for detecting transcription start sites, splice junctions, and transcription factor binding sites.\n5. Cistrome: This package provides tools for the analysis of ChIP-seq data from chromatin immunoprecipitation experiments. It includes functions for mapping reads to the reference genome, detecting peaks, and visualizing the distribution of peaks across the genome.\n6. HOMER: This package provides tools for the analysis of ChIP-chip and ChIP-seq data. It includes functions for mapping reads to the reference genome, detecting peaks, and visualizing the distribution of peaks across the genome. It also includes functions for modeling the binding sites of transcription factors and for predicting the binding sites of unknown transcription factors.\n7. RegulatoryGenomics: This package provides tools for the analysis of ChIP-chip and ChIP-seq data. It includes functions for mapping reads to the reference genome, detecting peaks, and visualizing the distribution of peaks across the genome. It also includes functions for modeling the binding sites of transcription factors and for predicting the binding sites of unknown transcription factors.\n\nThese are just a few of the many packages available in R/Bioconductor for",
    "llama-7b_fact_raw": "1. Chipster is a package in R/Bioconductor designed for the analysis of ChIP-chip and ChIP-seq data.\n2. Bedtools is an R/Bioconductor package that includes tools for working with bed files for genomic data storage.\n3. GenomicRanges is a package in R/Bioconductor which provides tools for sorting, filtering, and aligning genomic ranges.\n4. The TopHat package in R/Bioconductor provides tools for aligning RNA-seq data to a reference genome with transcription factor binding sites detection capabilities.\n5. Cistrome is an R/Bioconductor package tailored for ChIP-seq data analysis from chromatin immunoprecipitation experiments.",
    "llama-7b_fact": [
      "Chipster is a package in R/Bioconductor designed for the analysis of ChIP-chip and ChIP-seq data.",
      "Bedtools is an R/Bioconductor package that includes tools for working with bed files for genomic data storage.",
      "GenomicRanges is a package in R/Bioconductor which provides tools for sorting, filtering, and aligning genomic ranges.",
      "The TopHat package in R/Bioconductor provides tools for aligning RNA-seq data to a reference genome with transcription factor binding sites detection capabilities.",
      "Cistrome is an R/Bioconductor package tailored for ChIP-seq data analysis from chromatin immunoprecipitation experiments."
    ]
  },
  {
    "id": 721,
    "user_query": "You MUST give a detailed answer to the following question: List clinical trials for prevention of sarcopenia",
    "llama-7b_response": "Sure, here are some clinical trials for the prevention of sarcopenia:\n\n1. Sarcopenia Prevention with Resistance Training and Nutritional Supplementation (SPRINT): This is a randomized, double-blind, placebo-controlled trial that aims to determine the effectiveness of resistance training and nutritional supplementation in preventing sarcopenia in older adults.\n2. Sarcopenia: Prevention and Treatment (SPARC): This is a multicenter, randomized, double-blind, placebo-controlled trial that aims to evaluate the effectiveness of resistance training and nutritional supplementation in preventing and treating sarcopenia in older adults.\n3. Sarcopenia: Prevention and Treatment with Resistance Training and Nutritional Supplementation (SPARTAN): This is a randomized, double-blind, placebo-controlled trial that aims to determine the effectiveness of resistance training and nutritional supplementation in preventing and treating sarcopenia in older adults.\n4. Sarcopenia Prevention and Treatment Trial (SPATT): This is a randomized, double-blind, placebo-controlled trial that aims to evaluate the effectiveness of resistance training and nutritional supplementation in preventing and treating sarcopenia in older adults.\n5. Sarcopenia Prevention and Treatment with Resistance Training and Nutritional Supplementation (SPARTS): This is a randomized, double-blind, placebo-controlled trial that aims to determine the effectiveness of resistance training and nutritional supplementation in preventing and treating sarcopenia in older adults.\n\nThese are just a few examples of clinical trials that are currently being conducted or have been conducted in the past to study the prevention of sarcopenia.",
    "llama-7b_fact_raw": "1. The Sarcopenia Prevention with Resistance Training and Nutritional Supplementation (SPRINT) trial is a randomized, double-blind, placebo-controlled clinical trial.\n2. The Sarcopenia: Prevention and Treatment (SPARC) trial is evaluating resistance training and nutritional supplementation in a multicenter study.\n3. The Sarcopenia: Prevention and Treatment with Resistance Training and Nutritional Supplementation (SPARTAN) trial is designed to determine the effectiveness of resistance training and nutritional supplements in the prevention and treatment of sarcopenia.\n4. The Sarcopenia Prevention and Treatment Trial (SPATT) conducts evaluations on the effectiveness of resistance training and nutritional supplementation in both preventing and treating sarcopenia.\n5. The Sarcopenia Prevention and Treatment with Resistance Training and Nutritional Supplementation (SPARTS) trial aims to determine the effectiveness of these interventions specifically for sarcopenia prevention and treatment.",
    "llama-7b_fact": [
      "The Sarcopenia Prevention with Resistance Training and Nutritional Supplementation (SPRINT) trial is a randomized, double-blind, placebo-controlled clinical trial.",
      "The Sarcopenia: Prevention and Treatment (SPARC) trial is evaluating resistance training and nutritional supplementation in a multicenter study.",
      "The Sarcopenia: Prevention and Treatment with Resistance Training and Nutritional Supplementation (SPARTAN) trial is designed to determine the effectiveness of resistance training and nutritional supplements in the prevention and treatment of sarcopenia.",
      "The Sarcopenia Prevention and Treatment Trial (SPATT) conducts evaluations on the effectiveness of resistance training and nutritional supplementation in both preventing and treating sarcopenia.",
      "The Sarcopenia Prevention and Treatment with Resistance Training and Nutritional Supplementation (SPARTS) trial aims to determine the effectiveness of these interventions specifically for sarcopenia prevention and treatment."
    ]
  },
  {
    "id": 722,
    "user_query": "You MUST give a detailed answer to the following question: Which is the database of molecular recognition features in membrane proteins?",
    "llama-7b_response": "There are several databases that contain information on molecular recognition features in membrane proteins, including:\n\n1. The Protein Data Bank (PDB): The PDB is a public database of three-dimensional structural data for proteins, nucleic acids, and complex assemblies. It contains a large number of structures of membrane proteins, including those with molecular recognition features.\n2. The Database of Membrane Proteins (DMP): The DMP is a comprehensive database of three-dimensional structures of membrane proteins. It contains structures of a wide range of membrane proteins, including those with molecular recognition features.\n3. The Membrane Protein Data Bank (MPDB): The MPDB is a subset of the PDB that contains only structures of membrane proteins. It contains a large number of structures of membrane proteins with molecular recognition features.\n4. The Membrane Protein Structure and Function Resource (MPSF): The MPSF is a database that provides information on the structure, function, and evolution of membrane proteins. It contains a large number of structures of membrane proteins with molecular recognition features.\n\nOverall, these databases provide a wealth of information on the structure and function of membrane proteins, including those with molecular recognition features.",
    "llama-7b_fact_raw": "1. The Protein Data Bank (PDB) is a public database that includes three-dimensional structural data for proteins, nucleic acids, and complex assemblies.\n2. The Database of Membrane Proteins (DMP) is a comprehensive database specifically for three-dimensional structures of membrane proteins.\n3. The Membrane Protein Data Bank (MPDB) is a subset of the PDB dedicated to membrane proteins only.\n4. The Membrane Protein Structure and Function Resource (MPSF) provides information on the structure, function, and evolution of membrane proteins.\n5. All four databases mentionedPDB, DMP, MPDB, and MPSFcontain structures of membrane proteins with molecular recognition features.",
    "llama-7b_fact": [
      "The Protein Data Bank (PDB) is a public database that includes three-dimensional structural data for proteins, nucleic acids, and complex assemblies.",
      "The Database of Membrane Proteins (DMP) is a comprehensive database specifically for three-dimensional structures of membrane proteins.",
      "The Membrane Protein Data Bank (MPDB) is a subset of the PDB dedicated to membrane proteins only.",
      "The Membrane Protein Structure and Function Resource (MPSF) provides information on the structure, function, and evolution of membrane proteins.",
      "All four databases mentionedPDB, DMP, MPDB, and MPSFcontain structures of membrane proteins with molecular recognition features."
    ]
  },
  {
    "id": 745,
    "user_query": "You MUST give a detailed answer to the following question: Is rivaroxaban metabolized in kidneys?",
    "llama-7b_response": "Yes, rivaroxaban is metabolized in the kidneys. Rivaroxaban is a direct factor Xa inhibitor that is primarily metabolized by the liver through glucuronidation and sulfation. However, the kidneys also play a role in the metabolism of rivaroxaban by eliminating unchanged drug and its metabolites in the urine.\n\nThe metabolism of rivaroxaban is primarily mediated by the cytochrome P450 (CYP) enzymes CYP3A4 and CYP2C9. These enzymes are primarily located in the liver, but they can also be expressed in other organs, including the kidneys. Therefore, the kidneys can contribute to the metabolism of rivaroxaban by expressing these enzymes and metabolizing the drug.\n\nIn addition, the kidneys play a role in the elimination of rivaroxaban and its metabolites. Unchanged rivaroxaban and its metabolites are excreted in the urine, and the kidneys are responsible for filtering and eliminating the drug and its metabolites from the body.\n\nTherefore, while the liver is the primary site of metabolism for rivaroxaban, the kidneys also play a role in its metabolism and elimination from the body.",
    "llama-7b_fact_raw": "1. Rivaroxaban is a direct factor Xa inhibitor.\n2. The primary metabolism of rivaroxaban occurs in the liver through processes such as glucuronidation and sulfation.\n3. The kidneys eliminate unchanged rivaroxaban and its metabolites in the urine.\n4. The cytochrome P450 (CYP) enzymes CYP3A4 and CYP2C9, which are mainly located in the liver, mediate the metabolism of rivaroxaban and can also be expressed in the kidneys.\n5. The kidneys filter and eliminate rivaroxaban and its metabolites from the body.",
    "llama-7b_fact": [
      "Rivaroxaban is a direct factor Xa inhibitor.",
      "The primary metabolism of rivaroxaban occurs in the liver through processes such as glucuronidation and sulfation.",
      "The kidneys eliminate unchanged rivaroxaban and its metabolites in the urine.",
      "The cytochrome P450 (CYP) enzymes CYP3A4 and CYP2C9, which are mainly located in the liver, mediate the metabolism of rivaroxaban and can also be expressed in the kidneys.",
      "The kidneys filter and eliminate rivaroxaban and its metabolites from the body."
    ]
  },
  {
    "id": 763,
    "user_query": "You MUST give a detailed answer to the following question: Which genes are regulated by TRalpha2  in the heart?",
    "llama-7b_response": "TRalpha2, also known as thyroid hormone receptor alpha 2, is a nuclear receptor that plays a crucial role in regulating the expression of genes involved in various physiological processes, including metabolism, development, and growth. In the heart, TRalpha2 has been shown to play a role in the regulation of cardiac function and development.\n\nStudies have identified several genes that are regulated by TRalpha2 in the heart. For example, TRalpha2 has been shown to regulate the expression of genes involved in the development and maturation of cardiac muscle cells, including genes that encode proteins involved in the formation of cardiac muscle fibers, the regulation of heart rate, and the maintenance of cardiac contractility.\n\nAdditionally, TRalpha2 has been shown to regulate the expression of genes involved in the response to stress and injury in the heart. For example, TRalpha2 has been shown to regulate the expression of genes involved in the production of antioxidant enzymes, such as superoxide dismutase and catalase, which help to protect the heart against oxidative stress and injury.\n\nOverall, TRalpha2 plays an important role in regulating the expression of genes involved in the development, maturation, and maintenance of cardiac function, as well as the response to stress and injury in the heart.",
    "llama-7b_fact_raw": "1. TRalpha2 is a nuclear receptor involved in regulating gene expression relating to metabolism, development, and growth.\n2. In the heart, TRalpha2 regulates genes involved in the development and maturation of cardiac muscle cells.\n3. TRalpha2 influences genes that are responsible for the formation of cardiac muscle fibers.\n4. TRalpha2 affects the regulation of heart rate and maintenance of cardiac contractility.\n5. TRalpha2 is involved in regulating the expression of genes that produce antioxidant enzymes like superoxide dismutase and catalase in the heart.",
    "llama-7b_fact": [
      "TRalpha2 is a nuclear receptor involved in regulating gene expression relating to metabolism, development, and growth.",
      "In the heart, TRalpha2 regulates genes involved in the development and maturation of cardiac muscle cells.",
      "TRalpha2 influences genes that are responsible for the formation of cardiac muscle fibers.",
      "TRalpha2 affects the regulation of heart rate and maintenance of cardiac contractility.",
      "TRalpha2 is involved in regulating the expression of genes that produce antioxidant enzymes like superoxide dismutase and catalase in the heart."
    ]
  },
  {
    "id": 786,
    "user_query": "You MUST give a detailed answer to the following question: List available biomedical question answering systems.",
    "llama-7b_response": "There are several biomedical question answering systems available, including:\n\n1. Clinical Question Answering (CRAQ) system: This system is designed to answer clinical questions posed in natural language. It uses a combination of natural language processing and machine learning techniques to extract relevant information from unstructured text.\n2. Biocreative 2 system: This system is designed to answer biomedical questions posed in natural language. It uses a combination of natural language processing and machine learning techniques to extract relevant information from unstructured text.\n3. Biomedical Question Answering (Bio-QA) system: This system is designed to answer biomedical questions posed in natural language. It uses a combination of natural language processing and machine learning techniques to extract relevant information from unstructured text.\n4. Biomedical Text Analysis and Knowledge Extraction (BTAKE) system: This system is designed to extract biomedical knowledge from unstructured text. It uses a combination of natural language processing and machine learning techniques to extract relevant information from unstructured text.\n5. Biomedical Text Mining (BTM) system: This system is designed to extract biomedical knowledge from unstructured text. It uses a combination of natural language processing and machine learning techniques to extract relevant information from unstructured text.\n6. Biomedical Question Answering (Bio-QA) system: This system is designed to answer biomedical questions posed in natural language. It uses a combination of natural language processing and machine learning techniques to extract relevant information from unstructured text.\n7. Biomedical Question Answering (Bio-QA) system: This system is designed to answer biomedical questions posed in natural language. It uses a combination of natural language processing and machine learning techniques to extract relevant information from unstructured text.\n8. Biomedical Question Answering (Bio-QA) system: This system is designed to answer biomedical questions posed in natural language. It uses a combination of natural language processing and machine learning techniques to extract relevant information from unstructured text.\n9. Biomedical Question Answering (Bio-QA) system: This system is designed to answer biomedical questions posed in natural language. It uses a combination of natural language processing and machine learning techniques to extract relevant information from unstructured text.\n10.",
    "llama-7b_fact_raw": "1. The Clinical Question Answering (CRAQ) system is designed to answer clinical questions using natural language processing and machine learning techniques.\n2. The Biocreative 2 system is tailored for answering biomedical questions with a combination of natural language processing and machine learning.\n3. The Biomedical Question Answering (Bio-QA) system aims at providing answers to biomedical inquiries through the use of natural language processing and machine learning.\n4. The Biomedical Text Analysis and Knowledge Extraction (BTAKE) system extracts biomedical knowledge using natural language processing and machine learning methodologies.\n5. The Biomedical Text Mining (BTM) system is developed to extract biomedical knowledge from unstructured text employing natural language processing and machine learning.",
    "llama-7b_fact": [
      "The Clinical Question Answering (CRAQ) system is designed to answer clinical questions using natural language processing and machine learning techniques.",
      "The Biocreative 2 system is tailored for answering biomedical questions with a combination of natural language processing and machine learning.",
      "The Biomedical Question Answering (Bio-QA) system aims at providing answers to biomedical inquiries through the use of natural language processing and machine learning.",
      "The Biomedical Text Analysis and Knowledge Extraction (BTAKE) system extracts biomedical knowledge using natural language processing and machine learning methodologies.",
      "The Biomedical Text Mining (BTM) system is developed to extract biomedical knowledge from unstructured text employing natural language processing and machine learning."
    ]
  },
  {
    "id": 794,
    "user_query": "You MUST give a detailed answer to the following question: Which trancription factor activates the betalain pathway?",
    "llama-7b_response": "The betalain pathway is activated by the transcription factor MYB.\n\nMYB is a transcription factor that belongs to the MYB family of proteins. It is a DNA-binding protein that plays a crucial role in the regulation of gene expression by binding to specific DNA sequences known as MYB boxes.\n\nIn the case of the betalain pathway, MYB binds to specific MYB boxes located in the promoter region of genes involved in the biosynthesis of betalain pigments. Once bound to these MYB boxes, MYB activates the transcription of these genes, leading to the production of enzymes involved in the biosynthesis of betalain pigments.\n\nThe activation of the betalain pathway by MYB is a complex process that involves multiple steps. First, MYB binds to specific DNA sequences known as MYB boxes, which are located in the promoter region of genes involved in betalain biosynthesis. Once bound to these MYB boxes, MYB recruits other transcription factors and co-factors, which help to activate the transcription of these genes.\n\nIn addition to activating the transcription of genes involved in betalain biosynthesis, MYB also plays a role in the regulation of gene expression at the post-transcriptional level. It has been shown to interact with microRNAs, which are small non-coding RNAs that play a role in the regulation of gene expression at the post-transcriptional level.\n\nIn summary, the transcription factor MYB plays a crucial role in the activation of the betalain pathway by binding to specific DNA sequences known as MYB boxes located in the promoter region of genes involved in betalain biosynthesis. It activates the transcription of these genes and also plays a role in the regulation of gene expression at the post-transcriptional level.",
    "llama-7b_fact_raw": "1. The transcription factor MYB activates the betalain pathway.\n2. MYB belongs to the MYB family of DNA-binding proteins.\n3. The MYB protein binds to specific DNA sequences called MYB boxes in the promoter region of genes.\n4. The binding of MYB to MYB boxes leads to the transcription of genes involved in the biosynthesis of betalain pigments.\n5. MYB also interacts with microRNAs, which regulate gene expression at the post-transcriptional level.",
    "llama-7b_fact": [
      "The transcription factor MYB activates the betalain pathway.",
      "MYB belongs to the MYB family of DNA-binding proteins.",
      "The MYB protein binds to specific DNA sequences called MYB boxes in the promoter region of genes.",
      "The binding of MYB to MYB boxes leads to the transcription of genes involved in the biosynthesis of betalain pigments.",
      "MYB also interacts with microRNAs, which regulate gene expression at the post-transcriptional level."
    ]
  },
  {
    "id": 883,
    "user_query": "You MUST give a detailed answer to the following question: Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-7b_response": "There are several technologies that are commonly used for the enrichment of phosphorylated peptides in global quantitative phosphoproteomic analyses. Here are some of the preferred technologies:\n\n1. TiO2 beads: TiO2 beads are one of the most widely used technologies for the enrichment of phosphorylated peptides. They are coated with TiO2 nanoparticles that have a high affinity for phosphorylated serine/threonine residues. The beads are mixed with the sample and then washed to remove unbound peptides. The phosphorylated peptides are then eluted and subjected to mass spectrometry analysis.\n2. IMAC (immobilized metal affinity chromatography): IMAC is another popular technology for the enrichment of phosphorylated peptides. In this method, metal ions such as nickel or gold are immobilized on a column and the sample is passed through the column. Phosphorylated peptides bind to the metal ions, while non-phosphorylated peptides do not. The bound peptides are then eluted and subjected to mass spectrometry analysis.\n3. StrepTactin beads: StrepTactin beads are another type of beads that are used for the enrichment of phosphorylated peptides. They are coated with a protein called StrepTactin that has a high affinity for phosphorylated tyrosine residues. The beads are mixed with the sample and then washed to remove unbound peptides. The phosphorylated peptides are then eluted and subjected to mass spectrometry analysis.\n4. Phosphopeptide enrichment by liquid chromatography (LC): Liquid chromatography (LC) can also be used for the enrichment of phosphorylated peptides. In this method, the sample is passed through a column that is coated with a ligand that selectively binds to phosphorylated peptides. The bound peptides are then eluted and subjected to mass spectrometry analysis.\n\nOverall, the choice of technology for the enrichment of phosphoryl",
    "llama-7b_fact_raw": "1. TiO2 beads are widely used for the enrichment of phosphorylated peptides and their affinity is for phosphorylated serine/threonine residues.\n2. Immobilized metal affinity chromatography (IMAC) is a technology that enriches phosphorylated peptides by utilizing metal ions like nickel or gold on a column to which phosphorylated peptides bind.\n3. StrepTactin beads are used to enrich phosphorylated peptides due to their affinity for phosphorylated tyrosine residues.\n4. Liquid chromatography (LC) is employed for phosphorylated peptide enrichment through the use of a ligand-coated column that selectively binds phosphorylated peptides.\n5. Mass spectrometry analysis is a subsequent step following the enrichment of phosphorylated peptides using the mentioned technologies.",
    "llama-7b_fact": [
      "TiO2 beads are widely used for the enrichment of phosphorylated peptides and their affinity is for phosphorylated serine/threonine residues.",
      "Immobilized metal affinity chromatography (IMAC) is a technology that enriches phosphorylated peptides by utilizing metal ions like nickel or gold on a column to which phosphorylated peptides bind.",
      "StrepTactin beads are used to enrich phosphorylated peptides due to their affinity for phosphorylated tyrosine residues.",
      "Liquid chromatography (LC) is employed for phosphorylated peptide enrichment through the use of a ligand-coated column that selectively binds phosphorylated peptides.",
      "Mass spectrometry analysis is a subsequent step following the enrichment of phosphorylated peptides using the mentioned technologies."
    ]
  },
  {
    "id": 901,
    "user_query": "You MUST give a detailed answer to the following question: Which disorder is rated by Palmini classification?",
    "llama-7b_response": "The Palmini classification is a system used to rate the severity of eating disorders, such as anorexia nervosa, bulimia nervosa, and binge eating disorder. The classification is based on the patient's body mass index (BMI), which is calculated by dividing a person's weight in kilograms by their height in meters squared.\n\nThe Palmini classification is as follows:\n\n* Class 1: BMI < 17.5\n* Class 2: BMI 17.5-18.4\n* Class 3: BMI 18.5-20.9\n* Class 4: BMI 21-23.9\n* Class 5: BMI 24-27.4\n* Class 6: BMI 27.5-30.9\n* Class 7: BMI 31-34.9\n* Class 8: BMI 35-39.9\n* Class 9: BMI 40-49.9\n* Class 10: BMI 50-59.9\n* Class 11: BMI 60-69.9\n* Class 12: BMI 70-81.9\n* Class 13: BMI 82-91.9\n* Class 14: BMI 92-100\n* Class 15: BMI 101-110\n* Class 16: BMI 111-120\n* Class 17: BMI 121-130\n* Class 18: BMI 131-140\n* Class 19: BMI 141-150\n* Class 20: BMI 151-160\n* Class 21: BMI 161-170\n* Class 22: BMI 171-180\n* Class 23: BMI 181-190\n* Class 24: BMI 191-200\n* Class 25: BMI 201-2",
    "llama-7b_fact_raw": "1. The Palmini classification is used to rate the severity of eating disorders.\n2. The Palmini classification measures the severity using the patient's body mass index (BMI).\n3. Anorexia nervosa, bulimia nervosa, and binge eating disorder are examples of eating disorders rated by Palmini classification.\n4. Class 1 of the Palmini classification is characterized by a BMI of less than 17.5.\n5. The Palmini classification extends up to Class 25, where a BMI of 201-2 is indicated.",
    "llama-7b_fact": [
      "The Palmini classification is used to rate the severity of eating disorders.",
      "The Palmini classification measures the severity using the patient's body mass index (BMI).",
      "Anorexia nervosa, bulimia nervosa, and binge eating disorder are examples of eating disorders rated by Palmini classification.",
      "Class 1 of the Palmini classification is characterized by a BMI of less than 17.5.",
      "The Palmini classification extends up to Class 25, where a BMI of 201-2 is indicated."
    ]
  },
  {
    "id": 905,
    "user_query": "You MUST give a detailed answer to the following question: Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-7b_response": "No, viruses are not typically involved in the etiology of human subacute thyroiditis. Subacute thyroiditis is an inflammatory condition of the thyroid gland that is typically caused by a viral infection of the upper respiratory tract, such as a cold or the flu. However, the association between viral infections and subacute thyroiditis is not well established, and other factors, such as autoimmune disorders, may also play a role in the development of this condition.",
    "llama-7b_fact_raw": "1. Viruses are not typically involved in the etiology of human subacute thyroiditis.\n2. Subacute thyroiditis is an inflammatory condition of the thyroid gland.\n3. Subacute thyroiditis is typically caused by a viral infection of the upper respiratory tract.\n4. Common viral infections of the upper respiratory tract include colds and the flu.\n5. Other factors, such as autoimmune disorders, may play a role in the development of subacute thyroiditis.",
    "llama-7b_fact": [
      "Viruses are not typically involved in the etiology of human subacute thyroiditis.",
      "Subacute thyroiditis is an inflammatory condition of the thyroid gland.",
      "Subacute thyroiditis is typically caused by a viral infection of the upper respiratory tract.",
      "Common viral infections of the upper respiratory tract include colds and the flu.",
      "Other factors, such as autoimmune disorders, may play a role in the development of subacute thyroiditis."
    ]
  },
  {
    "id": 963,
    "user_query": "You MUST give a detailed answer to the following question: Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-7b_response": "STAT3 (signal transducer and activator of transcription 3) is a transcription factor that plays a crucial role in various cellular processes, including cell growth, differentiation, and immune response. STAT3 has been implicated in the regulation of autophagy, a cellular process involved in the degradation and recycling of cellular components. However, the role of STAT3 in EIF2AK2-dependent suppression of autophagy is not well understood.\n\nEIF2AK2 (eukaryotic initiation factor 2 alpha kinase 2), also known as PKR (double-stranded RNA-dependent protein kinase), is a protein kinase that plays a key role in the regulation of cellular stress responses, including the suppression of autophagy. EIF2AK2 has been shown to interact with STAT3 and regulate its transcriptional activity. However, the precise mechanism by which EIF2AK2 regulates STAT3 in the suppression of autophagy is not fully understood.\n\nSome studies have suggested that STAT3 may play a role in the regulation of autophagy. For example, STAT3 has been shown to regulate the expression of autophagy-related genes, such as BECN1 (Beclin 1) and ATG5 (autophagy-related 5), which are key components of the autophagy machinery. Additionally, STAT3 has been shown to interact with and regulate the activity of other autophagy-related proteins, such as ULK1 (unc-51-like kinase 1) and ATG9 (autophagy-related 9). However, the role of STAT3 in EIF2AK2-dependent suppression of autophagy is not well understood.\n\nIn summary, while there is some evidence to suggest that STAT3 may be involved in the regulation of autophagy, the precise role of STAT3 in EIF2AK2-dependent suppression of autophagy is not well understood. Further research is needed to elucidate the precise mechanisms by which STAT3 and EIF2AK2 interact to regulate autophagy.",
    "llama-7b_fact_raw": "1. STAT3 is a transcription factor that plays a crucial role in cell growth, differentiation, and immune response.\n2. EIF2AK2, also known as PKR, is a protein kinase that plays a key role in suppression of autophagy during cellular stress responses.\n3. STAT3 has been implicated in the regulation of autophagy by regulating the expression of autophagy-related genes like BECN1 and ATG5.\n4. STAT3 has been shown to interact with other autophagy-related proteins, including ULK1 and ATG9.\n5. The precise role of STAT3 in EIF2AK2-dependent suppression of autophagy is not clearly understood, necessitating further research.",
    "llama-7b_fact": [
      "STAT3 is a transcription factor that plays a crucial role in cell growth, differentiation, and immune response.",
      "EIF2AK2, also known as PKR, is a protein kinase that plays a key role in suppression of autophagy during cellular stress responses.",
      "STAT3 has been implicated in the regulation of autophagy by regulating the expression of autophagy-related genes like BECN1 and ATG5.",
      "STAT3 has been shown to interact with other autophagy-related proteins, including ULK1 and ATG9.",
      "The precise role of STAT3 in EIF2AK2-dependent suppression of autophagy is not clearly understood, necessitating further research."
    ]
  },
  {
    "id": 973,
    "user_query": "You MUST give a detailed answer to the following question: Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-7b_response": "The Theatre software tool is a genomic analysis tool that is used to visualize and analyze large-scale genomic data sets. It is designed to help researchers and clinicians better understand the structure and organization of the human genome, as well as identify genetic variations that may be associated with disease.\n\nTheatre allows users to view and analyze genomic data on a large scale, making it easier to identify patterns and relationships that may not be visible using other tools. It can be used to visualize and analyze a wide range of genomic data, including whole-genome and exome sequencing data, as well as data from other types of genomic studies.\n\nOne of the key features of Theatre is its ability to handle large data sets. It can be used to analyze data from thousands of individuals, allowing researchers to identify patterns and relationships that may not be visible using other tools. This makes it a valuable tool for identifying genetic variants that may be associated with disease, as well as for studying the genetic basis of complex traits and diseases.\n\nIn addition to its ability to handle large data sets, Theatre also has a number of other features that make it a powerful tool for genomic analysis. It includes a range of visualization tools that allow users to explore and analyze genomic data in a variety of ways. It also includes a number of analysis tools that can be used to identify genetic variants that may be associated with disease, as well as to study the genetic basis of complex traits and diseases.\n\nOverall, the Theatre software tool is a valuable tool for genomic analysis. It is designed to help researchers and clinicians better understand the structure and organization of the human genome, as well as identify genetic variations that may be associated with disease. Its ability to handle large data sets and its range of visualization and analysis tools make it a powerful tool for genomic analysis.",
    "llama-7b_fact_raw": "1. The Theatre software tool is used for visualizing and analyzing large-scale genomic data sets.\n2. Theatre helps in understanding the structure and organization of the human genome.\n3. The tool can identify genetic variations that may be associated with disease.\n4. Theatre is capable of analyzing data from thousands of individuals.\n5. Theatre includes visualization and analysis tools for studying the genetic basis of complex traits and diseases.",
    "llama-7b_fact": [
      "The Theatre software tool is used for visualizing and analyzing large-scale genomic data sets.",
      "Theatre helps in understanding the structure and organization of the human genome.",
      "The tool can identify genetic variations that may be associated with disease.",
      "Theatre is capable of analyzing data from thousands of individuals.",
      "Theatre includes visualization and analysis tools for studying the genetic basis of complex traits and diseases."
    ]
  },
  {
    "id": 997,
    "user_query": "You MUST give a detailed answer to the following question: Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-7b_response": "The Smith-Waterman algorithm is a dynamic programming algorithm used for the alignment of two sequences. The execution time (complexity) of the Smith-Waterman algorithm depends on several factors, including the length of the sequences being aligned, the similarity between the sequences, and the gap penalty and gap extension parameters used in the algorithm.\n\nIn general, the execution time of the Smith-Waterman algorithm increases exponentially with the length of the sequences being aligned. For example, the time complexity of the algorithm for aligning two sequences of length n is O(n^2). This means that as the length of the sequences increases, the algorithm becomes slower and slower.\n\nThe Smith-Waterman algorithm also has a time complexity that depends on the similarity between the sequences being aligned. Sequences that are more similar will take less time to align than sequences that are less similar.\n\nThe gap penalty and gap extension parameters used in the Smith-Waterman algorithm also affect the execution time of the algorithm. Gap penalties are used to penalize the algorithm for inserting or deleting gaps in the alignment, while gap extensions are used to extend the length of gaps in the alignment. The choice of gap penalty and gap extension parameters can significantly affect the execution time of the algorithm.\n\nIn summary, the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences depends on the length of the sequences, the similarity between the sequences, and the gap penalty and gap extension parameters used in the algorithm. The time complexity of the algorithm is generally O(n^2) and can be affected by the similarity between the sequences and the choice of gap penalty and gap extension parameters.",
    "llama-7b_fact_raw": "1. The Smith-Waterman algorithm is a dynamic programming algorithm used for sequence alignment.\n2. The execution time (complexity) of the Smith-Waterman algorithm generally increases exponentially with the length of the sequences being aligned.\n3. The time complexity of the algorithm for aligning two sequences of length n is O(n^2).\n4. The execution time of the Smith-Waterman algorithm can be affected by the similarity between the sequences being aligned.\n5. The selection of gap penalty and gap extension parameters impacts the execution time of the Smith-Waterman algorithm.",
    "llama-7b_fact": [
      "The Smith-Waterman algorithm is a dynamic programming algorithm used for sequence alignment.",
      "The execution time (complexity) of the Smith-Waterman algorithm generally increases exponentially with the length of the sequences being aligned.",
      "The time complexity of the algorithm for aligning two sequences of length n is O(n^2).",
      "The execution time of the Smith-Waterman algorithm can be affected by the similarity between the sequences being aligned.",
      "The selection of gap penalty and gap extension parameters impacts the execution time of the Smith-Waterman algorithm."
    ]
  },
  {
    "id": 1004,
    "user_query": "You MUST give a detailed answer to the following question: Which SLC family is FLVCR1 a member of?",
    "llama-7b_response": "FLVCR1, also known as folliculin, is a protein that belongs to the SLC26 family of solute carrier transporters. The SLC26 family is one of the subfamilies of the larger SLC (Solute Carrier) family of transporters, which are involved in the transport of a wide variety of molecules across cell membranes.\n\nThe SLC26 family is specifically involved in the transport of small molecules, such as ions, amino acids, and sugars, and is found in a wide range of organisms, including bacteria, plants, and animals. The family includes several subfamilies, each of which is characterized by a specific structure and function.\n\nFLVCR1 is a member of the SLC26A1 subfamily, which is specifically involved in the transport of small molecules such as amino acids, sugars, and other organic compounds. The SLC26A1 subfamily is found in a wide range of organisms, including bacteria, plants, and animals, and is involved in a variety of cellular processes, including metabolism, signaling, and transport.\n\nIn summary, FLVCR1 is a member of the SLC26 family, which is a subfamily of the larger SLC family of transporters. The SLC26 family is specifically involved in the transport of small molecules, and FLVCR1 is a member of the SLC26A1 subfamily, which is involved in the transport of amino acids, sugars, and other organic compounds.",
    "llama-7b_fact_raw": "1. FLVCR1 is a protein that is part of the SLC26 family of solute carrier transporters.\n2. The SLC26 family includes subfamilies each with specific structures and functions, involved in the transport of small molecules like ions, amino acids, and sugars.\n3. The SLC26 family is found in a wide range of organisms such as bacteria, plants, and animals.\n4. FLVCR1 is specifically a member of the SLC26A1 subfamily within the SLC26 family.\n5. The SLC26A1 subfamily is involved in the transport of small molecules including amino acids, sugars, and other organic compounds.",
    "llama-7b_fact": [
      "FLVCR1 is a protein that is part of the SLC26 family of solute carrier transporters.",
      "The SLC26 family includes subfamilies each with specific structures and functions, involved in the transport of small molecules like ions, amino acids, and sugars.",
      "The SLC26 family is found in a wide range of organisms such as bacteria, plants, and animals.",
      "FLVCR1 is specifically a member of the SLC26A1 subfamily within the SLC26 family.",
      "The SLC26A1 subfamily is involved in the transport of small molecules including amino acids, sugars, and other organic compounds."
    ]
  },
  {
    "id": 1047,
    "user_query": "You MUST give a detailed answer to the following question: List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-7b_response": "GATA-1 (GATA binding protein 1) is a transcription factor that plays a crucial role in regulating the expression of genes involved in various cellular processes, including hematopoiesis, cardiovascular development, and immune function. GATA-1 interacts with a variety of proteins to regulate its target genes, and the biotinylation tagging approach has been used to identify some of these interacting partners.\n\nOne study used the biotinylation tagging approach to identify proteins that interact with GATA-1 in hematopoietic stem cells (HSCs). The study found that GATA-1 interacts with several proteins involved in HSC self-renewal and differentiation, including the transcription factors RUNX1, PU.1, and Gfi-1b, as well as the protein kinase AKT1.\n\nAnother study used the biotinylation tagging approach to identify proteins that interact with GATA-1 in cardiac progenitor cells. The study found that GATA-1 interacts with several proteins involved in cardiac development and maturation, including the transcription factors NKX2.5 and GATA4, as well as the protein kinase AKT1.\n\nOverall, the biotinylation tagging approach has identified several proteins that interact with GATA-1, including transcription factors, kinases, and other proteins involved in various cellular processes. These interactions provide insight into the mechanisms by which GATA-1 regulates gene expression and contributes to cellular function.",
    "llama-7b_fact_raw": "1. GATA-1 is a transcription factor that regulates gene expression in hematopoiesis, cardiovascular development, and immune function.\n2. The biotinylation tagging approach has been used to identify GATA-1 interacting partners.\n3. GATA-1 was found to interact with transcription factors RUNX1, PU.1, and Gfi-1b in hematopoietic stem cells.\n4. GATA-1 was also found to interact with the protein kinase AKT1 in hematopoietic stem cells.\n5. In cardiac progenitor cells, GATA-1 was found to interact with transcription factors NKX2.5 and GATA4.",
    "llama-7b_fact": [
      "GATA-1 is a transcription factor that regulates gene expression in hematopoiesis, cardiovascular development, and immune function.",
      "The biotinylation tagging approach has been used to identify GATA-1 interacting partners.",
      "GATA-1 was found to interact with transcription factors RUNX1, PU.1, and Gfi-1b in hematopoietic stem cells.",
      "GATA-1 was also found to interact with the protein kinase AKT1 in hematopoietic stem cells.",
      "In cardiac progenitor cells, GATA-1 was found to interact with transcription factors NKX2.5 and GATA4."
    ]
  },
  {
    "id": 1072,
    "user_query": "You MUST give a detailed answer to the following question: What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-7b_response": "TAF10 is a transcriptional co-activator that interacts with GATA1, a transcription factor that plays a crucial role in the regulation of gene expression in various tissues and cell types. The interaction between TAF10 and GATA1 can lead to the activation of target genes involved in various biological processes, including cell growth, differentiation, and development.\n\nThe outcome of TAF10 interacting with GATA1 depends on the specific context and the target genes being regulated. However, in general, the interaction between TAF10 and GATA1 leads to the recruitment of TAF10 to the promoter region of target genes, where it helps to stabilize the interaction between GATA1 and other transcriptional co-activators, such as CBP and p300. This, in turn, enhances the recruitment of RNA polymerase II and other transcriptional machinery to the promoter, leading to increased transcription of target genes.\n\nThe specific genes that are activated by the interaction between TAF10 and GATA1 depend on the tissue and cell type in question. For example, in hematopoietic cells, the interaction between TAF10 and GATA1 has been shown to play a crucial role in the regulation of genes involved in the differentiation and maturation of immune cells. In particular, the interaction between TAF10 and GATA1 has been shown to activate genes involved in the differentiation of T cells, B cells, and dendritic cells.\n\nIn summary, the outcome of TAF10 interacting with GATA1 is the activation of target genes involved in various biological processes, including cell growth, differentiation, and development. The specific genes that are activated by this interaction depend on the tissue and cell type in question.",
    "llama-7b_fact_raw": "1. TAF10 is a transcriptional co-activator that interacts with GATA1, a transcription factor.\n2. The interaction between TAF10 and GATA1 generally leads to the recruitment of TAF10 to the promoter region of target genes.\n3. This interaction helps stabilize the interaction between GATA1 and other transcriptional co-activators, including CBP and p300.\n4. The result of the interaction enhances the recruitment of RNA polymerase II, leading to increased transcription of target genes.\n5. In hematopoietic cells, the interaction between TAF10 and GATA1 is crucial for regulating genes involved in the differentiation of immune cells such as T cells, B cells, and dendritic cells.",
    "llama-7b_fact": [
      "TAF10 is a transcriptional co-activator that interacts with GATA1, a transcription factor.",
      "The interaction between TAF10 and GATA1 generally leads to the recruitment of TAF10 to the promoter region of target genes.",
      "This interaction helps stabilize the interaction between GATA1 and other transcriptional co-activators, including CBP and p300.",
      "The result of the interaction enhances the recruitment of RNA polymerase II, leading to increased transcription of target genes.",
      "In hematopoietic cells, the interaction between TAF10 and GATA1 is crucial for regulating genes involved in the differentiation of immune cells such as T cells, B cells, and dendritic cells."
    ]
  },
  {
    "id": 1082,
    "user_query": "You MUST give a detailed answer to the following question: Are there any Decision support systems for chronic pain management ?",
    "llama-7b_response": "",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 1149,
    "user_query": "You MUST give a detailed answer to the following question: Which is the subcellular localization of the protein angiogenin?",
    "llama-7b_response": "Angiogenin is a protein that plays a role in the process of angiogenesis, which is the formation of new blood vessels. It is a glycoprotein that is synthesized and secreted by a variety of cells, including endothelial cells, fibroblasts, and smooth muscle cells.\n\nAngiogenin is primarily localized to the cytoplasm of cells, although it can also be found in the nucleus of some cells. It is thought to play a role in the regulation of gene expression, and has been shown to bind to specific DNA sequences known as angiogenin response elements (AngREs). These AngREs are found in the promoter regions of genes that are involved in the process of angiogenesis, and the binding of angiogenin to these elements is thought to play a role in the regulation of gene expression.\n\nIn addition to its role in angiogenesis, angiogenin has also been implicated in the regulation of cell proliferation, differentiation, and survival. It has been shown to promote the growth and survival of endothelial cells, and to play a role in the development of tumors.\n\nOverall, the subcellular localization of angiogenin is primarily in the cytoplasm, although it can also be found in the nucleus of some cells. It plays a role in the regulation of gene expression, and has been implicated in the regulation of cell proliferation, differentiation, and survival.",
    "llama-7b_fact_raw": "1. Angiogenin is a protein involved in angiogenesis, the formation of new blood vessels.\n2. It is a glycoprotein that is synthesized and secreted by cells such as endothelial cells, fibroblasts, and smooth muscle cells.\n3. Angiogenin is primarily localized to the cytoplasm of cells.\n4. It can also be found in the nucleus of some cells.\n5. Angiogenin binds to specific DNA sequences called angiogenin response elements (AngREs) in the promoter regions of genes involved in angiogenesis.",
    "llama-7b_fact": [
      "Angiogenin is a protein involved in angiogenesis, the formation of new blood vessels.",
      "It is a glycoprotein that is synthesized and secreted by cells such as endothelial cells, fibroblasts, and smooth muscle cells.",
      "Angiogenin is primarily localized to the cytoplasm of cells.",
      "It can also be found in the nucleus of some cells.",
      "Angiogenin binds to specific DNA sequences called angiogenin response elements (AngREs) in the promoter regions of genes involved in angiogenesis."
    ]
  },
  {
    "id": 1161,
    "user_query": "You MUST give a detailed answer to the following question: How does ranolazine affect kinase signaling activation in the heart?",
    "llama-7b_response": "Ranolazine is a medication that is used to treat chronic angina, a type of chest pain that occurs when the heart muscle does not receive enough oxygen-rich blood. It works by blocking the voltage-gated sodium channels in the heart, which helps to reduce the electrical activity in the heart and reduce the frequency of angina attacks.\n\nOne of the ways that ranolazine affects kinase signaling activation in the heart is by inhibiting the activity of protein kinases. Protein kinases are enzymes that play a key role in many cellular processes, including signal transduction pathways that are involved in the regulation of the heart's electrical activity. By inhibiting the activity of protein kinases, ranolazine can help to reduce the electrical activity in the heart and reduce the frequency of angina attacks.\n\nIn addition to inhibiting protein kinases, ranolazine also affects kinase signaling activation in the heart by inhibiting the activity of other enzymes that are involved in the regulation of the heart's electrical activity. For example, ranolazine has been shown to inhibit the activity of the enzyme L-type calcium channels, which are involved in the regulation of the heart's electrical activity. By inhibiting the activity of L-type calcium channels, ranolazine can help to reduce the electrical activity in the heart and reduce the frequency of angina attacks.\n\nOverall, ranolazine affects kinase signaling activation in the heart by inhibiting the activity of protein kinases and other enzymes that are involved in the regulation of the heart's electrical activity. This helps to reduce the electrical activity in the heart and reduce the frequency of angina attacks.",
    "llama-7b_fact_raw": "1. Ranolazine is used to treat chronic angina by blocking voltage-gated sodium channels in the heart.\n2. Inhibiting protein kinases is one way ranolazine affects kinase signaling activation in the heart.\n3. Protein kinases play a significant role in signal transduction pathways relating to the heart's electrical activity regulation.\n4. Ranolazine inhibits the activity of L-type calcium channels in the heart.\n5. The inhibition of protein kinases and L-type calcium channels by ranolazine helps reduce the electrical activity in the heart and the frequency of angina attacks.",
    "llama-7b_fact": [
      "Ranolazine is used to treat chronic angina by blocking voltage-gated sodium channels in the heart.",
      "Inhibiting protein kinases is one way ranolazine affects kinase signaling activation in the heart.",
      "Protein kinases play a significant role in signal transduction pathways relating to the heart's electrical activity regulation.",
      "Ranolazine inhibits the activity of L-type calcium channels in the heart.",
      "The inhibition of protein kinases and L-type calcium channels by ranolazine helps reduce the electrical activity in the heart and the frequency of angina attacks."
    ]
  },
  {
    "id": 1225,
    "user_query": "You MUST give a detailed answer to the following question: Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-7b_response": "The regulation of the VSR endonuclease in bacteria is not necessarily independent of the growth phase. While the expression of VSR endonuclease has been shown to be influenced by growth phase in some studies, other studies have found that the regulation of VSR endonuclease is complex and can be influenced by a variety of factors, including growth phase, environmental cues, and the presence of antibiotics.\n\nFor example, one study found that the expression of VSR endonuclease in Escherichia coli was influenced by growth phase, with the highest levels of expression occurring in the stationary phase of growth. However, other studies have found that the regulation of VSR endonuclease is more complex, with the expression of the enzyme being influenced by a variety of factors, including the presence of antibiotics, nutrient availability, and environmental cues.\n\nOverall, while the regulation of VSR endonuclease in bacteria may be influenced by growth phase in some cases, the regulation of the enzyme is likely to be complex and influenced by a variety of factors. Further research is needed to fully understand the regulation of VSR endonuclease in bacteria and how it is influenced by growth phase and other factors.",
    "llama-7b_fact_raw": "1. The expression of VSR endonuclease in bacteria can be influenced by the growth phase.\n2. Studies have shown that Escherichia coli's VSR endonuclease expression levels are highest during the stationary phase of growth.\n3. The regulation of VSR endonuclease is complex and may be influenced by environmental cues.\n4. The presence of antibiotics can influence the expression of VSR endonuclease in bacteria.\n5. The regulation of VSR endonuclease in bacteria may also be affected by nutrient availability.",
    "llama-7b_fact": [
      "The expression of VSR endonuclease in bacteria can be influenced by the growth phase.",
      "Studies have shown that Escherichia coli's VSR endonuclease expression levels are highest during the stationary phase of growth.",
      "The regulation of VSR endonuclease is complex and may be influenced by environmental cues.",
      "The presence of antibiotics can influence the expression of VSR endonuclease in bacteria.",
      "The regulation of VSR endonuclease in bacteria may also be affected by nutrient availability."
    ]
  },
  {
    "id": 1233,
    "user_query": "You MUST give a detailed answer to the following question: What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-7b_response": "There are several computational tools available for the prediction of beta-barrel transmembrane proteins. Here are some of the most popular ones:\n\n1. TMHMM: TMHMM (Transmembrane Helices of Microbial Homologues) is a web-based tool that uses hidden Markov models to predict transmembrane helices in proteins. It can also predict beta-barrels, which are composed of multiple transmembrane helices. TMHMM has a high accuracy in predicting transmembrane helices and beta-barrels, and it is widely used in bioinformatics research.\n2. SMART: SMART (Simple Modular Architecture Research Tool) is a web-based tool that predicts the occurrence of domains and functional sites in proteins. It can also predict beta-barrels and transmembrane helices. SMART has a high accuracy in predicting beta-barrels and transmembrane helices, and it is widely used in bioinformatics research.\n3. PSIPRED: PSIPRED (Protein Secondary Structure Prediction by Hidden Markov Models) is a web-based tool that uses hidden Markov models to predict protein secondary structure. It can also predict beta-barrels, which are composed of multiple transmembrane helices. PSIPRED has a high accuracy in predicting beta-barrels and transmembrane helices, and it is widely used in bioinformatics research.\n4. IUPred: IUPred (Improved Prediction of Protein Secondary Structure) is a web-based tool that uses machine learning algorithms to predict protein secondary structure. It can also predict beta-barrels, which are composed of multiple transmembrane helices. IUPred has a high accuracy in predicting beta-barrels and transmembrane helices, and it is widely used in bioinformatics research.\n\nOverall, these computational tools are useful for predicting beta-barrel transmembrane proteins, and they can be used in combination to improve the accuracy of the predictions.",
    "llama-7b_fact_raw": "1. TMHMM is a computational tool used to predict transmembrane helices and beta-barrels in proteins.\n2. SMART is a web-based tool that predicts domains, functional sites, beta-barrels, and transmembrane helices in proteins.\n3. PSIPRED uses hidden Markov models to predict protein secondary structure, including beta-barrels composed of transmembrane helices.\n4. IUPred employs machine learning algorithms to predict protein secondary structure and is capable of predicting beta-barrels and transmembrane helices.\n5. The computational tools TMHMM, SMART, PSIPRED, and IUPred are widely used in bioinformatics research for the prediction of beta-barrel transmembrane proteins.",
    "llama-7b_fact": [
      "TMHMM is a computational tool used to predict transmembrane helices and beta-barrels in proteins.",
      "SMART is a web-based tool that predicts domains, functional sites, beta-barrels, and transmembrane helices in proteins.",
      "PSIPRED uses hidden Markov models to predict protein secondary structure, including beta-barrels composed of transmembrane helices.",
      "IUPred employs machine learning algorithms to predict protein secondary structure and is capable of predicting beta-barrels and transmembrane helices.",
      "The computational tools TMHMM, SMART, PSIPRED, and IUPred are widely used in bioinformatics research for the prediction of beta-barrel transmembrane proteins."
    ]
  },
  {
    "id": 1251,
    "user_query": "You MUST give a detailed answer to the following question: Galassi classification is used for which disorder?",
    "llama-7b_response": "Galassi classification is a system used to classify the severity of aortic stenosis, a condition in which the aortic valve narrows, making it difficult for blood to flow properly from the heart to the rest of the body. The classification system is based on the degree of narrowing of the aortic valve and is named after the Italian cardiologist who first described it, Giuseppe Galassi.\n\nGalassi classifies aortic stenosis into three categories:\n\n1. Galassi I: Mild aortic stenosis with a mean aortic valve area of 1.0 cm or more.\n2. Galassi II: Moderate aortic stenosis with a mean aortic valve area of 0.6-1.0 cm.\n3. Galassi III: Severe aortic stenosis with a mean aortic valve area of less than 0.6 cm.\n\nGalassi classification is used to determine the severity of aortic stenosis and guide treatment options. It is typically used in conjunction with other diagnostic tests, such as echocardiography, to assess the condition of the aortic valve and determine the best course of treatment.",
    "llama-7b_fact_raw": "1. The Galassi classification is used to classify the severity of aortic stenosis.\n2. Aortic stenosis is a condition where the aortic valve narrows, hindering proper blood flow from the heart to the body.\n3. Giuseppe Galassi, an Italian cardiologist, first described the Galassi classification system.\n4. Galassi classification divides aortic stenosis into three categories: Galassi I (mild), Galassi II (moderate), and Galassi III (severe).\n5. Galassi III classification indicates severe aortic stenosis with a mean aortic valve area of less than 0.6 cm.",
    "llama-7b_fact": [
      "The Galassi classification is used to classify the severity of aortic stenosis.",
      "Aortic stenosis is a condition where the aortic valve narrows, hindering proper blood flow from the heart to the body.",
      "Giuseppe Galassi, an Italian cardiologist, first described the Galassi classification system.",
      "Galassi classification divides aortic stenosis into three categories: Galassi I (mild), Galassi II (moderate), and Galassi III (severe).",
      "Galassi III classification indicates severe aortic stenosis with a mean aortic valve area of less than 0.6 cm."
    ]
  },
  {
    "id": 1304,
    "user_query": "You MUST give a detailed answer to the following question: List common features of Shapiro syndrome",
    "llama-7b_response": "",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 1320,
    "user_query": "You MUST give a detailed answer to the following question: Which disease is linked to mutations within BRAG1?",
    "llama-7b_response": "BRAG1 (BRCA1-associated glycoprotein 1) is a protein that plays a role in the repair of damaged DNA. Mutations in the BRAG1 gene have been linked to an increased risk of certain types of cancer, including breast, ovarian, and prostate cancer.\n\nSpecifically, mutations in the BRAG1 gene have been found to be associated with an increased risk of hereditary breast and ovarian cancer syndrome (HBOC), which is a genetic disorder that increases the risk of developing breast and ovarian cancer. Individuals with mutations in the BRAG1 gene may also have an increased risk of developing other types of cancer, such as prostate cancer.\n\nIn summary, mutations in the BRAG1 gene have been linked to an increased risk of cancer, particularly breast, ovarian, and prostate cancer. These mutations are associated with hereditary breast and ovarian cancer syndrome and may also increase the risk of developing other types of cancer.",
    "llama-7b_fact_raw": "1. Mutations in the BRAG1 gene are linked to an increased risk of certain types of cancer.\n2. BRAG1 (BRCA1-associated glycoprotein 1) is involved in the DNA repair process.\n3. Mutations in the BRAG1 gene are associated with an increased risk of breast cancer.\n4. Mutations in the BRAG1 gene are associated with an increased risk of ovarian cancer.\n5. Hereditary breast and ovarian cancer syndrome (HBOC) is linked to mutations in the BRAG1 gene.",
    "llama-7b_fact": [
      "Mutations in the BRAG1 gene are linked to an increased risk of certain types of cancer.",
      "BRAG1 (BRCA1-associated glycoprotein 1) is involved in the DNA repair process.",
      "Mutations in the BRAG1 gene are associated with an increased risk of breast cancer.",
      "Mutations in the BRAG1 gene are associated with an increased risk of ovarian cancer.",
      "Hereditary breast and ovarian cancer syndrome (HBOC) is linked to mutations in the BRAG1 gene."
    ]
  },
  {
    "id": 1362,
    "user_query": "You MUST give a detailed answer to the following question: Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "llama-7b_response": "The main inhibitor of protein phosphatase 1 (PP1) is a protein called \"protein inhibitor of activated STAT1 (PIAS1)\". PIAS1 is a member of the protein inhibitor of activated STAT (PIAS) family of proteins, which are known to inhibit a variety of protein kinases and phosphatases, including PP1.\n\nPP1 is a serine/threonine protein phosphatase that plays a crucial role in regulating a variety of cellular processes, including cell growth, differentiation, and apoptosis. It is activated by the binding of its regulatory subunit, PP1gamma, to its substrate, protein kinase A (PKA). However, PP1 activity can also be inhibited by the binding of specific inhibitors, such as PIAS1.\n\nPIAS1 is a ubiquitously expressed protein that binds to and inhibits the activity of STAT1, a transcription factor that plays a key role in the immune response. PIAS1 also has been shown to inhibit a number of other protein kinases and phosphatases, including PP1.\n\nIn summary, PIAS1 is the main inhibitor of protein phosphatase 1 (PP1), and it plays an important role in regulating cellular processes by inhibiting the activity of a variety of protein kinases and phosphatases, including PP1.",
    "llama-7b_fact_raw": "1. Protein inhibitor of activated STAT1 (PIAS1) is the main inhibitor of protein phosphatase 1 (PP1).\n2. PP1 is a serine/threonine protein phosphatase involved in cellular processes like cell growth, differentiation, and apoptosis.\n3. PIAS1 is a member of the protein inhibitor of activated STAT family, which inhibits various protein kinases and phosphatases.\n4. PIAS1 ubiquitously binds to and inhibits the activity of STAT1, a transcription factor important for the immune response.\n5. PP1 is activated by the binding of its regulatory subunit PP1gamma to its substrate, protein kinase A (PKA).",
    "llama-7b_fact": [
      "Protein inhibitor of activated STAT1 (PIAS1) is the main inhibitor of protein phosphatase 1 (PP1).",
      "PP1 is a serine/threonine protein phosphatase involved in cellular processes like cell growth, differentiation, and apoptosis.",
      "PIAS1 is a member of the protein inhibitor of activated STAT family, which inhibits various protein kinases and phosphatases.",
      "PIAS1 ubiquitously binds to and inhibits the activity of STAT1, a transcription factor important for the immune response.",
      "PP1 is activated by the binding of its regulatory subunit PP1gamma to its substrate, protein kinase A (PKA)."
    ]
  },
  {
    "id": 1374,
    "user_query": "You MUST give a detailed answer to the following question: Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-7b_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a process by which bacteria, such as Bacillus subtilis, undergo a significant increase in mutation rates in response to stressful conditions, such as starvation or exposure to antibiotics. This increase in mutation rates allows the bacteria to adapt and survive in these stressful environments.\n\nThere are several mechanisms that underlie adaptive mutagenesis in B. subtilis:\n\n1. DNA Damage: One of the key mechanisms underlying adaptive mutagenesis is DNA damage. When bacteria are exposed to stressful conditions, such as starvation or exposure to antibiotics, they undergo a significant increase in DNA damage. This DNA damage can lead to mutations, which can help the bacteria adapt and survive in these environments.\n2. Mutator Mutations: Another mechanism that underlies adaptive mutagenesis is the presence of mutator mutations. Mutator mutations are mutations that increase the mutation rate in the bacteria. These mutations can occur spontaneously or be passed down from one generation to the next. When bacteria with mutator mutations are exposed to stressful conditions, they undergo a significant increase in mutation rates, allowing them to adapt and survive in these environments.\n3. RecA Protein: The RecA protein is a key player in the repair of DNA damage in bacteria. When bacteria are exposed to stressful conditions, such as starvation or exposure to antibiotics, the RecA protein is activated, leading to an increase in the mutation rate. This increase in mutation rate allows the bacteria to repair DNA damage and adapt to the stressful environment.\n4. Transcriptional Activation: Another mechanism that underlies adaptive mutagenesis is transcriptional activation. When bacteria are exposed to stressful conditions, such as starvation or exposure to antibiotics, certain genes are activated, leading to an increase in the mutation rate. This increase in mutation rate allows the bacteria to adapt and survive in these environments.\n\nOverall, adaptive mutagenesis is a complex process that involves multiple mechanisms, including DNA damage, mutator mutations, the RecA protein,",
    "llama-7b_fact_raw": "1. Adaptive mutagenesis in Bacillus subtilis leads to an increased mutation rate in response to stressful conditions like starvation or antibiotics exposure.\n2. DNA damage is one of the mechanisms that contribute to the increased mutation rates during adaptive mutagenesis in Bacillus subtilis.\n3. Mutator mutations in Bacillus subtilis can increase the mutation rate, contributing to adaptive mutagenesis.\n4. The RecA protein plays a role in repairing DNA damage and increasing the mutation rate under stressful conditions in Bacillus subtilis.\n5. Transcriptional activation of certain genes in Bacillus subtilis can lead to an increased mutation rate during adaptive mutagenesis.",
    "llama-7b_fact": [
      "Adaptive mutagenesis in Bacillus subtilis leads to an increased mutation rate in response to stressful conditions like starvation or antibiotics exposure.",
      "DNA damage is one of the mechanisms that contribute to the increased mutation rates during adaptive mutagenesis in Bacillus subtilis.",
      "Mutator mutations in Bacillus subtilis can increase the mutation rate, contributing to adaptive mutagenesis.",
      "The RecA protein plays a role in repairing DNA damage and increasing the mutation rate under stressful conditions in Bacillus subtilis.",
      "Transcriptional activation of certain genes in Bacillus subtilis can lead to an increased mutation rate during adaptive mutagenesis."
    ]
  },
  {
    "id": 1399,
    "user_query": "You MUST give a detailed answer to the following question: What causes erucism?",
    "llama-7b_response": "Erucic acid is a type of fatty acid that is found in rapeseed (also known as canola) and other oilseed crops. Erucism is a condition that is caused by the consumption of foods that contain high levels of erucic acid.\n\nErucism is a rare condition that can cause a variety of symptoms, including nerve damage, muscle weakness, and heart problems. The exact cause of erucism is not fully understood, but it is believed to be related to the accumulation of erucic acid in the body.\n\nWhen erucic acid is consumed in large amounts, it can build up in the body and cause damage to cells and tissues. This can lead to a range of symptoms, including nerve damage, muscle weakness, and heart problems. Erucic acid can also interfere with the body's ability to use other fats, which can further contribute to the development of erucism.\n\nIt is worth noting that erucism is a rare condition and is typically only seen in people who consume large amounts of rapeseed oil or other foods that contain high levels of erucic acid. In most cases, the consumption of small amounts of rapeseed oil or other foods that contain erucic acid is not likely to cause any harm.",
    "llama-7b_fact_raw": "1. Erucism is a condition caused by the consumption of high levels of erucic acid found in foods.\n2. Erucic acid is found in rapeseed (also known as canola) and other oilseed crops.\n3. Symptoms of erucism may include nerve damage, muscle weakness, and heart problems.\n4. Accumulation of erucic acid in the body is linked to cell and tissue damage associated with erucism.\n5. Erucism is considered a rare condition, primarily affecting individuals who consume large amounts of foods high in erucic acid.",
    "llama-7b_fact": [
      "Erucism is a condition caused by the consumption of high levels of erucic acid found in foods.",
      "Erucic acid is found in rapeseed (also known as canola) and other oilseed crops.",
      "Symptoms of erucism may include nerve damage, muscle weakness, and heart problems.",
      "Accumulation of erucic acid in the body is linked to cell and tissue damage associated with erucism.",
      "Erucism is considered a rare condition, primarily affecting individuals who consume large amounts of foods high in erucic acid."
    ]
  },
  {
    "id": 1413,
    "user_query": "You MUST give a detailed answer to the following question: What are the indications for hydrochlorothiazide?",
    "llama-7b_response": "",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 1447,
    "user_query": "You MUST give a detailed answer to the following question: Has silicon been used in treatment of  incontinence ?",
    "llama-7b_response": "Yes, silicone has been used in the treatment of urinary incontinence. Silicone is a synthetic material that is commonly used in medical devices and has been found to be effective in treating stress urinary incontinence (SUI), which is a type of incontinence that occurs due to pressure on the bladder during activities that put stress on the abdomen, such as coughing, sneezing, or lifting.\n\nSilicone is used to create a device called a urinary sling, which is a type of mesh implant that is placed around the urethra to support it and prevent urine from leaking out. The sling is typically made of silicone and is placed through a minimally invasive procedure that requires only small incisions in the abdomen.\n\nSilicone has several advantages as a material for urinary sling implants. It is biocompatible, meaning that it is not recognized as foreign by the body and is not likely to cause an immune response. It is also highly durable and can withstand the forces placed on the bladder during activities that cause SUI. Additionally, silicone is flexible and can conform to the shape of the body, which allows it to provide a stable support for the urethra while still allowing for normal movement and function.\n\nOverall, silicone has been found to be a safe and effective material for the treatment of urinary incontinence, particularly stress urinary incontinence. However, as with any medical treatment, there are potential risks and complications associated with the use of silicone implants, and patients should discuss the risks and benefits with their healthcare provider before deciding on a treatment option.",
    "llama-7b_fact_raw": "1. Silicone has been used in the treatment of urinary incontinence.\n2. Silicone is used to create a device known as a urinary sling to support the urethra and prevent urine from leaking out.\n3. The procedure for placing a urinary sling is minimally invasive, requiring only small incisions in the abdomen.\n4. Silicone is considered biocompatible, meaning it is not likely to cause an immune response when used in medical devices.\n5. Silicone has been found to be a safe and effective material for treating stress urinary incontinence (SUI).",
    "llama-7b_fact": [
      "Silicone has been used in the treatment of urinary incontinence.",
      "Silicone is used to create a device known as a urinary sling to support the urethra and prevent urine from leaking out.",
      "The procedure for placing a urinary sling is minimally invasive, requiring only small incisions in the abdomen.",
      "Silicone is considered biocompatible, meaning it is not likely to cause an immune response when used in medical devices.",
      "Silicone has been found to be a safe and effective material for treating stress urinary incontinence (SUI)."
    ]
  },
  {
    "id": 1454,
    "user_query": "You MUST give a detailed answer to the following question: What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-7b_response": "The association between the moon cycle and rupture risk of intracranial aneurysms is a topic of ongoing research and debate. Some studies have suggested that there may be a link between the phases of the moon and the rupture risk of intracranial aneurysms, while others have found no such association.\n\nIntracranial aneurysms are abnormal balloon-like bulges in the walls of blood vessels that supply the brain. These aneurysms can rupture and cause stroke, which is a leading cause of disability and death worldwide. Rupture of an intracranial aneurysm is a medical emergency that requires immediate treatment.\n\nSeveral studies have investigated the potential association between the moon cycle and the rupture risk of intracranial aneurysms. Some studies have found that the risk of rupture may be higher during certain phases of the moon, such as the full moon or the new moon. For example, one study found that the risk of rupture was highest during the full moon, while another study found that the risk was highest during the new moon.\n\nOther studies, however, have not found a consistent association between the moon cycle and the rupture risk of intracranial aneurysms. Some studies have suggested that the association may be due to confounding factors, such as changes in blood pressure or blood flow that occur during the different phases of the moon.\n\nOverall, the association between the moon cycle and the rupture risk of intracranial aneurysms is still not well understood, and more research is needed to clarify this relationship. It is important for patients with intracranial aneurysms to follow their doctor's recommendations for monitoring and management of their condition, regardless of the phase of the moon.",
    "llama-7b_fact_raw": "1. Some studies suggest a link between the phases of the moon and the rupture risk of intracranial aneurysms, while others find no association.\n2. Intracranial aneurysms are balloon-like bulges in the walls of blood vessels in the brain, which can rupture and cause stroke.\n3. The rupture of an intracranial aneurysm is a leading cause of disability and death worldwide.\n4. One study found the risk of intracranial aneurysm rupture to be highest during the full moon phase.\n5. Another study found the risk of intracranial aneurysm rupture to be highest during the new moon phase.",
    "llama-7b_fact": [
      "Some studies suggest a link between the phases of the moon and the rupture risk of intracranial aneurysms, while others find no association.",
      "Intracranial aneurysms are balloon-like bulges in the walls of blood vessels in the brain, which can rupture and cause stroke.",
      "The rupture of an intracranial aneurysm is a leading cause of disability and death worldwide.",
      "One study found the risk of intracranial aneurysm rupture to be highest during the full moon phase.",
      "Another study found the risk of intracranial aneurysm rupture to be highest during the new moon phase."
    ]
  },
  {
    "id": 1477,
    "user_query": "You MUST give a detailed answer to the following question: Does HuR protein regulate the splicing process?",
    "llama-7b_response": "The HuR (ELAVL1) protein is a member of the ELAV (embryonic lethal, abnormal vision) family of RNA-binding proteins, which play a role in the regulation of RNA metabolism. While there is evidence to suggest that HuR may be involved in the regulation of the splicing process, the precise mechanisms by which it does so are not fully understood.\n\nHuR has been shown to interact with a variety of RNAs, including mRNAs, microRNAs, and long non-coding RNAs (lncRNAs), and to play a role in the transport and stabilization of these RNAs. In addition, HuR has been implicated in the regulation of alternative splicing, a process by which different splicing variants of a single gene can be produced from a single gene transcript.\n\nFor example, studies have shown that HuR can interact with pre-mRNA splicing factors and modulate their activity, leading to changes in alternative splicing patterns. HuR has also been shown to interact with lncRNAs, which have been implicated in the regulation of alternative splicing, and to play a role in the transport and stabilization of these RNAs.\n\nOverall, while the precise mechanisms by which HuR regulates the splicing process are not fully understood, there is evidence to suggest that it may play a role in the regulation of alternative splicing by interacting with splicing factors and lncRNAs and modulating their activity. Further research is needed to fully elucidate the role of HuR in the regulation of the splicing process.",
    "llama-7b_fact_raw": "1. The HuR (ELAVL1) protein is a member of the ELAV family of RNA-binding proteins.\n2. HuR may be involved in the regulation of the splicing process, but the precise mechanisms are not fully understood.\n3. HuR has been shown to interact with various RNAs, including mRNAs, microRNAs, and long non-coding RNAs (lncRNAs).\n4. HuR has been implicated in the regulation of alternative splicing.\n5. Studies have shown that HuR can interact with pre-mRNA splicing factors and modulate their activity, affecting alternative splicing patterns.",
    "llama-7b_fact": [
      "The HuR (ELAVL1) protein is a member of the ELAV family of RNA-binding proteins.",
      "HuR may be involved in the regulation of the splicing process, but the precise mechanisms are not fully understood.",
      "HuR has been shown to interact with various RNAs, including mRNAs, microRNAs, and long non-coding RNAs (lncRNAs).",
      "HuR has been implicated in the regulation of alternative splicing.",
      "Studies have shown that HuR can interact with pre-mRNA splicing factors and modulate their activity, affecting alternative splicing patterns."
    ]
  },
  {
    "id": 1492,
    "user_query": "You MUST give a detailed answer to the following question: Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-7b_response": "Prothymosin alpha (PTMA) is a small protein that is expressed in a variety of tissues and plays a role in the regulation of cell growth and differentiation. The C-terminal peptide of PTMA, which is the portion of the protein that is located at the end of the polypeptide chain, has several known functions.\n\nOne known function of the PTMA C-terminal peptide is its ability to bind to and activate the JAK/STAT signaling pathway. The JAK/STAT pathway is a key signaling pathway that plays a role in the regulation of cell growth and differentiation, and it is activated in response to a variety of stimuli, such as growth factors and cytokines. The PTMA C-terminal peptide can bind to and activate the JAK/STAT pathway by interacting with the receptor for erythropoietin (EPO), which is a hormone that plays a role in the regulation of red blood cell production.\n\nAnother known function of the PTMA C-terminal peptide is its ability to regulate the activity of the androgen receptor (AR). The AR is a nuclear receptor that plays a role in the regulation of male sex characteristics, and it is activated in response to androgens, such as testosterone. The PTMA C-terminal peptide can bind to and activate the AR by interacting with the ligand-binding domain of the receptor.\n\nIn addition to its functions in the JAK/STAT and androgen receptor signaling pathways, the PTMA C-terminal peptide has also been shown to have other functions. For example, it has been shown to play a role in the regulation of cell survival and apoptosis, and it has also been shown to have anti-inflammatory effects.\n\nOverall, the PTMA C-terminal peptide has several known functions, including its ability to activate the JAK/STAT and androgen receptor signaling pathways, regulate cell survival and apoptosis, and have anti-inflammatory effects. These functions make the PTMA C-terminal peptide a promising target for the development of therapeutics for a",
    "llama-7b_fact_raw": "1. Prothymosin alpha (PTMA) is expressed in a variety of tissues and is involved in the regulation of cell growth and differentiation.\n2. The C-terminal peptide of PTMA can bind to and activate the JAK/STAT signaling pathway.\n3. The PTMA C-terminal peptide interacts with the receptor for erythropoietin (EPO) to regulate red blood cell production.\n4. The PTMA C-terminal peptide can regulate the activity of the androgen receptor (AR) by interacting with its ligand-binding domain.\n5. The PTMA C-terminal peptide is involved in regulation of cell survival and apoptosis, and exhibits anti-inflammatory effects.",
    "llama-7b_fact": [
      "Prothymosin alpha (PTMA) is expressed in a variety of tissues and is involved in the regulation of cell growth and differentiation.",
      "The C-terminal peptide of PTMA can bind to and activate the JAK/STAT signaling pathway.",
      "The PTMA C-terminal peptide interacts with the receptor for erythropoietin (EPO) to regulate red blood cell production.",
      "The PTMA C-terminal peptide can regulate the activity of the androgen receptor (AR) by interacting with its ligand-binding domain.",
      "The PTMA C-terminal peptide is involved in regulation of cell survival and apoptosis, and exhibits anti-inflammatory effects."
    ]
  },
  {
    "id": 1516,
    "user_query": "You MUST give a detailed answer to the following question: Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-7b_response": "The peptide that plays a pivotal role in human cystatin C fibrillization is the C-terminal domain (CTD) of cystatin C.\n\nCystatin C is a cysteine protease inhibitor that is widely expressed in various tissues and fluids, including plasma and urine. It plays an important role in regulating proteolytic activity and has been implicated in various physiological and pathological processes, including kidney function, inflammation, and neurodegeneration.\n\nCystatin C can exist in two forms: a soluble, monomeric form and a fibrillar, insoluble form. The fibrillar form of cystatin C is characterized by the formation of amyloid fibrils, which are insoluble, cross-linked aggregates of misfolded proteins. The fibrillization of cystatin C has been implicated in various diseases, including nephropathies, neurodegenerative disorders, and cardiovascular diseases.\n\nThe CTD of cystatin C has been shown to play a pivotal role in the fibrillization of cystatin C. The CTD is a highly conserved region of cystatin C that contains multiple disulfide bonds and is responsible for its enzymatic activity and interactions with other proteins. Studies have shown that mutations in the CTD of cystatin C can lead to the formation of amyloid fibrils and the development of cystatin C-related diseases.\n\nIn summary, the CTD of cystatin C plays a pivotal role in the fibrillization of cystatin C by promoting the formation of amyloid fibrils. Understanding the mechanisms underlying cystatin C fibrillization may provide insights into the pathogenesis of cystatin C-related diseases and may lead to the development of novel therapeutic strategies for their treatment.",
    "llama-7b_fact_raw": "1. The C-terminal domain (CTD) of cystatin C plays a pivotal role in human cystatin C fibrillization.\n2. Cystatin C is widely expressed in human tissues and fluids, including plasma and urine.\n3. Cystatin C acts as a cysteine protease inhibitor and is involved in regulating proteolytic activity.\n4. Amyloid fibrils formed during cystatin C fibrillization are insoluble, cross-linked aggregates of misfolded proteins.\n5. Mutations in the CTD of cystatin C can lead to the formation of amyloid fibrils and associated diseases.",
    "llama-7b_fact": [
      "The C-terminal domain (CTD) of cystatin C plays a pivotal role in human cystatin C fibrillization.",
      "Cystatin C is widely expressed in human tissues and fluids, including plasma and urine.",
      "Cystatin C acts as a cysteine protease inhibitor and is involved in regulating proteolytic activity.",
      "Amyloid fibrils formed during cystatin C fibrillization are insoluble, cross-linked aggregates of misfolded proteins.",
      "Mutations in the CTD of cystatin C can lead to the formation of amyloid fibrils and associated diseases."
    ]
  },
  {
    "id": 1574,
    "user_query": "You MUST give a detailed answer to the following question: Does the concentration of protein HIF-1 increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-7b_response": "The concentration of protein hypoxia-inducible factor 1 alpha (HIF-1) has not been extensively studied in relation to the administration of the cytoprotective prodrug amifostine (ethyol). However, there is some evidence to suggest that amifostine may protect against hypoxia-induced HIF-1 accumulation.\n\nHIF-1 is a transcription factor that plays a crucial role in the response to hypoxia. Under normoxic conditions, HIF-1 is rapidly degraded by the proteasome. However, under hypoxic conditions, HIF-1 accumulates and translocates to the nucleus, where it binds to DNA and activates the expression of genes involved in adaptive responses to hypoxia, such as angiogenesis, erythropoiesis, and glycolysis.\n\nAmifostine is a cytoprotective prodrug that has been shown to protect against the toxic effects of chemotherapy and radiation by reducing oxidative stress and inflammation. Amifostine has also been shown to protect against hypoxia-induced cell death in vitro and in vivo. However, the mechanisms by which amifostine exerts its cytoprotective effects are not fully understood.\n\nIt is possible that amifostine may protect against hypoxia-induced HIF-1 accumulation by reducing oxidative stress and inflammation. Oxidative stress and inflammation have been shown to play a role in the accumulation of HIF-1 under hypoxic conditions. Therefore, it is possible that amifostine may protect against hypoxia-induced HIF-1 accumulation by reducing oxidative stress and inflammation.\n\nIn summary, while there is some evidence to suggest that amifostine may protect against hypoxia-induced HIF-1 accumulation, the concentration of HIF-1 has not been extensively studied in relation to the administration of amifostine. Further research is needed to fully understand the mechanisms by which amifostine exerts its cytoprotective effects.",
    "llama-7b_fact_raw": "1. The concentration of HIF-1 in relation to amifostine administration has not been extensively studied.\n2. HIF-1 is a transcription factor involved in the body's response to hypoxia.\n3. Under normoxic conditions, HIF-1 is rapidly degraded, but under hypoxic conditions, it accumulates and activates genes related to hypoxia adaptation.\n4. Amifostine is known to protect against the toxic effects of chemotherapy and radiation by reducing oxidative stress and inflammation.\n5. There is evidence suggesting that amifostine may protect against hypoxia-induced HIF-1 accumulation.",
    "llama-7b_fact": [
      "The concentration of HIF-1 in relation to amifostine administration has not been extensively studied.",
      "HIF-1 is a transcription factor involved in the body's response to hypoxia.",
      "Under normoxic conditions, HIF-1 is rapidly degraded, but under hypoxic conditions, it accumulates and activates genes related to hypoxia adaptation.",
      "Amifostine is known to protect against the toxic effects of chemotherapy and radiation by reducing oxidative stress and inflammation.",
      "There is evidence suggesting that amifostine may protect against hypoxia-induced HIF-1 accumulation."
    ]
  },
  {
    "id": 1588,
    "user_query": "You MUST give a detailed answer to the following question: Which histone marks are deposited by Set7?",
    "llama-7b_response": "Set7 is an enzyme that adds a methyl group to histone H3 lysine 9 (H3K9me2) and histone H3 lysine 27 (H3K27me3) to mark specific regions of the genome for transcriptional repression.\n\nH3K9me2 is a mark that is associated with transcriptionally active regions of the genome, such as promoters and enhancers. It is deposited by Set7 and other histone methyltransferases, including G9a and ESET. H3K9me2 is typically found in euchromatic regions of the genome and is thought to play a role in the regulation of gene expression during development and differentiation.\n\nH3K27me3 is a mark that is associated with transcriptionally repressed regions of the genome, such as heterochromatin. It is deposited by Set7 and other histone methyltransferases, including G9a and ESET. H3K27me3 is typically found in heterochromatic regions of the genome and is thought to play a role in the silencing of repetitive elements and transposable elements.\n\nIn summary, Set7 deposits both H3K9me2 and H3K27me3 histone marks, which are involved in the regulation of gene expression and the silencing of repetitive elements and transposable elements in the genome.",
    "llama-7b_fact_raw": "1. Set7 adds a methyl group to histone H3 lysine 9, resulting in the histone mark H3K9me2.\n2. Set7 also adds a methyl group to histone H3 lysine 27, resulting in the histone mark H3K27me3.\n3. The histone mark H3K9me2 is associated with transcriptionally active regions of the genome.\n4. The histone mark H3K27me3 is associated with transcriptionally repressed regions of the genome.\n5. Other histone methyltransferases besides Set7, such as G9a and ESET, can also deposit H3K9me2 and H3K27me3 marks.",
    "llama-7b_fact": [
      "Set7 adds a methyl group to histone H3 lysine 9, resulting in the histone mark H3K9me2.",
      "Set7 also adds a methyl group to histone H3 lysine 27, resulting in the histone mark H3K27me3.",
      "The histone mark H3K9me2 is associated with transcriptionally active regions of the genome.",
      "The histone mark H3K27me3 is associated with transcriptionally repressed regions of the genome.",
      "Other histone methyltransferases besides Set7, such as G9a and ESET, can also deposit H3K9me2 and H3K27me3 marks."
    ]
  },
  {
    "id": 1620,
    "user_query": "You MUST give a detailed answer to the following question: How many disulfide bridges has the protein hepcidin got?",
    "llama-7b_response": "Hepcidin is a protein that plays a crucial role in regulating iron metabolism in the body. It is produced primarily by hepatocytes in the liver and acts as a negative regulator of iron absorption from the gut. Hepcidin binds to the iron transporter divalent metal transporter 1 (DMT1) on the surface of enterocytes in the small intestine, leading to the internalization and degradation of DMT1. This in turn reduces the absorption of dietary iron.\n\nDisulfide bridges are covalent bonds between two cysteine residues that have been oxidized and then reduced, resulting in the formation of a disulfide bond. The number of disulfide bridges in a protein can provide information about its structure, stability, and function.\n\nTo answer the question of how many disulfide bridges hepcidin has, we need to determine the amino acid sequence of the protein. Disulfide bridges are formed between cysteine residues that are located within a certain distance of each other, typically no more than 60-80 amino acids apart. Therefore, the number of disulfide bridges in hepcidin will depend on the number of cysteine residues present in the protein and their proximity to each other.\n\nIt is not possible for me to accurately determine the number of disulfide bridges in hepcidin without access to the amino acid sequence of the protein. However, it is known that hepcidin contains several cysteine residues, which are likely to form disulfide bridges. The exact number of disulfide bridges in hepcidin will depend on the specific amino acid sequence of the protein.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 1643,
    "user_query": "You MUST give a detailed answer to the following question: What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-7b_response": "DNAJC11 is a protein that is encoded by a gene located on chromosome 11q23.3. It is a member of the DNAJ (HSP40) family of proteins, which are involved in the transport and folding of proteins within the endoplasmic reticulum (ER) of eukaryotic cells.\n\nThe localization of DNAJC11 within the cell is important for its function in protein folding and transport. Studies have shown that DNAJC11 is primarily localized to the ER lumen, where it interacts with other ER-resident chaperones and proteins to facilitate the folding and assembly of newly synthesized proteins.\n\nIn addition to its role in protein folding, DNAJC11 has also been implicated in the regulation of autophagy, a cellular process involved in the degradation and recycling of damaged organelles and proteins. Studies have shown that DNAJC11 can interact with autophagy-related proteins and play a role in the formation of autophagosomes, the membrane-bound structures that engulf and degrade damaged organelles and proteins.\n\nOverall, the localization of DNAJC11 to the ER lumen and its involvement in autophagy make it an important protein for maintaining cellular homeostasis and preventing the accumulation of damaged proteins and organelles.",
    "llama-7b_fact_raw": "1. The gene encoding DNAJC11 is located on chromosome 11q23.3.\n2. DNAJC11 is a member of the DNAJ (HSP40) family of proteins.\n3. DNAJC11 is involved in protein folding and transport within the endoplasmic reticulum.\n4. Studies indicate that DNAJC11 is primarily localized to the ER lumen.\n5. DNAJC11 has been implicated in the regulation of autophagy and may play a role in the formation of autophagosomes.",
    "llama-7b_fact": [
      "The gene encoding DNAJC11 is located on chromosome 11q23.3.",
      "DNAJC11 is a member of the DNAJ (HSP40) family of proteins.",
      "DNAJC11 is involved in protein folding and transport within the endoplasmic reticulum.",
      "Studies indicate that DNAJC11 is primarily localized to the ER lumen.",
      "DNAJC11 has been implicated in the regulation of autophagy and may play a role in the formation of autophagosomes."
    ]
  },
  {
    "id": 1655,
    "user_query": "You MUST give a detailed answer to the following question: Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-7b_response": "Ultraconserved elements (UCEs) are non-coding regions of the human genome that are highly conserved across different individuals and populations. They are defined as regions of at least 200 nucleotides that are identical in at least 95% of the human population. UCEs are thought to be functionally important and have been implicated in a variety of biological processes, including embryonic development, gene regulation, and disease susceptibility.\n\nCopy number variants (CNVs) are variations in the number of copies of a particular genomic region in an individual's genome. CNVs can arise through a variety of mechanisms, including duplication, deletion, and translocation, and have been implicated in a number of human diseases, including autism, schizophrenia, and cancer.\n\nIt is not clear whether UCEs are depleted among CNVs. Some studies have reported that UCEs are overrepresented among CNVs, suggesting that CNVs may be more likely to disrupt UCEs than other regions of the genome. However, other studies have found that UCEs are underrepresented among CNVs, suggesting that CNVs may be less likely to disrupt UCEs than other regions of the genome.\n\nOverall, the relationship between UCEs and CNVs is complex and not well understood. Further research is needed to clarify the frequency and impact of UCEs among CNVs.",
    "llama-7b_fact_raw": "1. Ultraconserved elements (UCEs) are regions of at least 200 nucleotides that are identical in at least 95% of the human population.\n2. UCEs are highly conserved across different individuals and populations.\n3. UCEs have been implicated in embryonic development, gene regulation, and disease susceptibility.\n4. Copy number variants (CNVs) are variations in the number of copies of a particular genomic region in an individual's genome.\n5. CNVs have been implicated in a number of human diseases, including autism, schizophrenia, and cancer.",
    "llama-7b_fact": [
      "Ultraconserved elements (UCEs) are regions of at least 200 nucleotides that are identical in at least 95% of the human population.",
      "UCEs are highly conserved across different individuals and populations.",
      "UCEs have been implicated in embryonic development, gene regulation, and disease susceptibility.",
      "Copy number variants (CNVs) are variations in the number of copies of a particular genomic region in an individual's genome.",
      "CNVs have been implicated in a number of human diseases, including autism, schizophrenia, and cancer."
    ]
  },
  {
    "id": 1665,
    "user_query": "You MUST give a detailed answer to the following question: Which is the substrate of the haspin kinase during mitosis?",
    "llama-7b_response": "The Haspin kinase is a serine/threonine kinase that plays a role in regulating the mitotic spindle assembly checkpoint in eukaryotic cells. During mitosis, the Haspin kinase is activated in response to spindle damage or kinetochore misalignment, and it phosphorylates several proteins to prevent the progression of anaphase until all spindle checkpoint proteins are properly attached to kinetochores.\n\nThe substrate of the Haspin kinase during mitosis is not well understood, and there is ongoing research to identify the specific proteins that are phosphorylated by the Haspin kinase. However, some studies have suggested that the Haspin kinase may phosphorylate and activate the protein BubR1, which is a key regulator of the mitotic spindle assembly checkpoint. Other potential substrates of the Haspin kinase during mitosis include the protein Mad2, which is also involved in the spindle checkpoint, and the protein Aurora B, which is involved in the formation and maintenance of the mitotic spindle.\n\nOverall, the substrate of the Haspin kinase during mitosis is an area of active research, and further studies are needed to fully understand the specific proteins that are phosphorylated by the Haspin kinase and how these phosphorylation events contribute to the regulation of the mitotic spindle assembly checkpoint.",
    "llama-7b_fact_raw": "1. The Haspin kinase is a serine/threonine kinase involved in regulating the mitotic spindle assembly checkpoint.\n2. The Haspin kinase becomes activated during mitosis in response to spindle damage or kinetochore misalignment.\n3. Studies have suggested that the Haspin kinase may phosphorylate the protein BubR1 during mitosis.\n4. The protein Mad2, involved in the spindle checkpoint, is a potential substrate of the Haspin kinase during mitosis.\n5. Aurora B, a protein involved in mitotic spindle formation and maintenance, might be phosphorylated by the Haspin kinase during mitosis.",
    "llama-7b_fact": [
      "The Haspin kinase is a serine/threonine kinase involved in regulating the mitotic spindle assembly checkpoint.",
      "The Haspin kinase becomes activated during mitosis in response to spindle damage or kinetochore misalignment.",
      "Studies have suggested that the Haspin kinase may phosphorylate the protein BubR1 during mitosis.",
      "The protein Mad2, involved in the spindle checkpoint, is a potential substrate of the Haspin kinase during mitosis.",
      "Aurora B, a protein involved in mitotic spindle formation and maintenance, might be phosphorylated by the Haspin kinase during mitosis."
    ]
  },
  {
    "id": 1696,
    "user_query": "You MUST give a detailed answer to the following question: What is the mechanism of viroid replication?",
    "llama-7b_response": "Viroid replication is a process that occurs in the cytoplasm of infected plant cells. Viroids are small, circular, single-stranded RNA molecules that lack a protein coat and are unable to replicate on their own. Instead, they rely on the host cell's machinery for replication.\n\nThe mechanism of viroid replication involves the following steps:\n\n1. Entry into the host cell: Viroids enter the host cell through various mechanisms, such as by penetration of the cell membrane or uptake via endocytosis.\n2. Uncoating of the viroid: Once inside the host cell, the viroid is released from its protein coat.\n3. RNA replication: The viroid uses the host cell's ribonucleic acid (RNA) polymerase to synthesize a complementary strand of RNA. This process is initiated at the 5' end of the viroid and proceeds in the 5' to 3' direction.\n4. Maturation of the viroid: Once the complementary strand of RNA has been synthesized, the viroid undergoes maturation to form a double-stranded RNA molecule. This process involves the formation of a stem-loop structure at the 3' end of the viroid.\n5. Release of the mature viroid: The mature viroid is released from the host cell and can infect other cells.\n\nOverall, the mechanism of viroid replication involves the use of the host cell's RNA polymerase to synthesize a complementary strand of RNA, followed by maturation of the viroid into a double-stranded RNA molecule. This process occurs in the cytoplasm of infected plant cells and is essential for the survival and spread of viroids.",
    "llama-7b_fact_raw": "1. Viroid replication occurs in the cytoplasm of infected plant cells.\n2. Viroids are composed of small, circular, single-stranded RNA molecules without a protein coat.\n3. The replication of viroids involves hijacking the host cell's RNA polymerase to synthesize a complementary strand of RNA.\n4. The replication process of viroids starts at the 5' end and proceeds in the 5' to 3' direction.\n5. The mature viroid forms a double-stranded RNA molecule that includes a stem-loop structure at the 3' end.",
    "llama-7b_fact": [
      "Viroid replication occurs in the cytoplasm of infected plant cells.",
      "Viroids are composed of small, circular, single-stranded RNA molecules without a protein coat.",
      "The replication of viroids involves hijacking the host cell's RNA polymerase to synthesize a complementary strand of RNA.",
      "The replication process of viroids starts at the 5' end and proceeds in the 5' to 3' direction.",
      "The mature viroid forms a double-stranded RNA molecule that includes a stem-loop structure at the 3' end."
    ]
  },
  {
    "id": 1723,
    "user_query": "You MUST give a detailed answer to the following question: Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-7b_response": "Fibronectin is a protein that plays a role in cell-matrix adhesion and is found in the extracellular matrix. It is not a serum biomarker for Duchenne muscular dystrophy.\n\nDuchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. The disease is caused by mutations in the dystrophin gene, which results in the absence of the protein dystrophin. Dystrophin is essential for maintaining the structure and function of muscle fibers.\n\nFibronectin is a protein that is found in the extracellular matrix and plays a role in cell-matrix adhesion. It is not directly related to the pathophysiology of DMD. While fibronectin has been studied in the context of muscular dystrophy, it has not been shown to be a serum biomarker for DMD.\n\nThere are several serum biomarkers that have been studied in the context of DMD, including creatine kinase, muscle-specific kinase, and myoglobin. These biomarkers can be used to diagnose and monitor the progression of the disease. However, they are not specific to DMD and can also be elevated in other muscle disorders.\n\nIn summary, while fibronectin is a protein that plays a role in muscle function, it is not a serum biomarker for Duchenne muscular dystrophy. There are other serum biomarkers that have been studied in the context of DMD, including creatine kinase, muscle-specific kinase, and myoglobin. These biomarkers can be used to diagnose and monitor the progression of the disease, but they are not specific to DMD and can also be elevated in other muscle disorders.",
    "llama-7b_fact_raw": "1. Fibronectin is not a serum biomarker for Duchenne muscular dystrophy (DMD).\n2. Duchenne muscular dystrophy is caused by mutations in the dystrophin gene.\n3. The absence of the dystrophin protein leads to progressive muscle degeneration and weakness in DMD.\n4. Fibronectin plays a role in cell-matrix adhesion and is found in the extracellular matrix.\n5. Creatine kinase, muscle-specific kinase, and myoglobin are examples of serum biomarkers studied in the context of DMD.",
    "llama-7b_fact": [
      "Fibronectin is not a serum biomarker for Duchenne muscular dystrophy (DMD).",
      "Duchenne muscular dystrophy is caused by mutations in the dystrophin gene.",
      "The absence of the dystrophin protein leads to progressive muscle degeneration and weakness in DMD.",
      "Fibronectin plays a role in cell-matrix adhesion and is found in the extracellular matrix.",
      "Creatine kinase, muscle-specific kinase, and myoglobin are examples of serum biomarkers studied in the context of DMD."
    ]
  },
  {
    "id": 1763,
    "user_query": "You MUST give a detailed answer to the following question: Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-7b_response": "The DeepBlue epigenomic data server contains data from several major epigenome projects, including:\n\n1. ENCODE (Encyclopedia of DNA Elements): This project aims to identify and characterize all functional elements in the human genome, including regulatory elements such as promoters, enhancers, and silencers. The ENCODE data in DeepBlue includes ChIP-seq (chromatin immunoprecipitation sequencing) data for histone modifications, transcription factors, and other regulatory elements.\n2. Roadmap Epigenomics Project: This project aims to create a comprehensive resource for epigenomic data across human cells and tissues. The Roadmap Epigenomics data in DeepBlue includes ChIP-seq data for histone modifications, transcription factors, and other regulatory elements, as well as bisulfite sequencing data for DNA methylation.\n3. Epigenomic Roadmap Project: This project aims to create a comprehensive resource for epigenomic data across mouse cells and tissues. The Epigenomic Roadmap data in DeepBlue includes ChIP-seq data for histone modifications, transcription factors, and other regulatory elements, as well as bisulfite sequencing data for DNA methylation.\n4. Human Epigenome Atlas: This project aims to create a comprehensive resource for epigenomic data across a variety of human tissues and cell types. The Human Epigenome Atlas data in DeepBlue includes ChIP-seq data for histone modifications, transcription factors, and other regulatory elements, as well as bisulfite sequencing data for DNA methylation.\n\nThese are just a few examples of the major epigenome projects that are represented in the DeepBlue epigenomic data server. The server also contains data from many other smaller projects and individual research groups, providing a comprehensive resource for epigenomic data across a wide range of organisms and tissues.",
    "llama-7b_fact_raw": "1. The DeepBlue epigenomic data server contains data from the ENCODE project, which focuses on identifying all functional elements in the human genome.\n2. The ENCODE project data within DeepBlue includes ChIP-seq data for histone modifications and transcription factors.\n3. The Roadmap Epigenomics Project data, which is aimed at creating a comprehensive resource for human epigenomic data, is contained within the DeepBlue epigenomic data server.\n4. The Epigenomic Roadmap Project, aiming at mouse cells and tissues, also contributes epigenomic data to the DeepBlue epigenomic data server.\n5. The DeepBlue epigenomic data server includes data from the Human Epigenome Atlas, which provides epigenomic data across various human tissues and cell types.",
    "llama-7b_fact": [
      "The DeepBlue epigenomic data server contains data from the ENCODE project, which focuses on identifying all functional elements in the human genome.",
      "The ENCODE project data within DeepBlue includes ChIP-seq data for histone modifications and transcription factors.",
      "The Roadmap Epigenomics Project data, which is aimed at creating a comprehensive resource for human epigenomic data, is contained within the DeepBlue epigenomic data server.",
      "The Epigenomic Roadmap Project, aiming at mouse cells and tissues, also contributes epigenomic data to the DeepBlue epigenomic data server.",
      "The DeepBlue epigenomic data server includes data from the Human Epigenome Atlas, which provides epigenomic data across various human tissues and cell types."
    ]
  },
  {
    "id": 1792,
    "user_query": "You MUST give a detailed answer to the following question: Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-7b_response": "One tool that employs self-organizing maps (SOMs) for analyzing synonymous codon usage is the software package PAML (Phylogenetic Analysis by Maximum Likelihood).\n\nSOMs are a type of unsupervised machine learning algorithm that can be used to analyze and visualize high-dimensional data. In the context of codon usage analysis, SOMs can be used to identify clusters of synonymous codons that exhibit similar patterns of usage across different species.\n\nPAML is a widely used software package for conducting phylogenetic analysis of molecular sequences. It includes a module called \"ModelAver\" that can be used to analyze synonymous codon usage patterns across different species. ModelAver uses SOMs to identify clusters of synonymous codons that exhibit similar patterns of usage, and it can also perform statistical tests to compare the usage patterns of different codons within each cluster.\n\nOverall, PAML is a powerful tool for analyzing synonymous codon usage patterns across multiple species, and its use of SOMs provides a useful way to visualize and interpret the results of these analyses.",
    "llama-7b_fact_raw": "1. Self-organizing maps (SOMs) are employed by the software package PAML for analyzing synonymous codon usage.\n2. SOMs are a type of unsupervised machine learning algorithm.\n3. PAML is a software package used for conducting phylogenetic analysis of molecular sequences.\n4. The module \"ModelAver\" within PAML can analyze synonymous codon usage patterns across different species.\n5. ModelAver in PAML uses SOMs to identify clusters of synonymous codons with similar usage patterns and can perform statistical tests within clusters.",
    "llama-7b_fact": [
      "Self-organizing maps (SOMs) are employed by the software package PAML for analyzing synonymous codon usage.",
      "SOMs are a type of unsupervised machine learning algorithm.",
      "PAML is a software package used for conducting phylogenetic analysis of molecular sequences.",
      "The module \"ModelAver\" within PAML can analyze synonymous codon usage patterns across different species.",
      "ModelAver in PAML uses SOMs to identify clusters of synonymous codons with similar usage patterns and can perform statistical tests within clusters."
    ]
  },
  {
    "id": 1793,
    "user_query": "You MUST give a detailed answer to the following question: What is MINDY-1?",
    "llama-7b_response": "I'm sorry, but I am not familiar with the term \"MINDY-1.\" Can you provide more context or information about what you are referring to? This will help me better understand your question and provide a more accurate answer.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 1810,
    "user_query": "You MUST give a detailed answer to the following question: Which software package is available for the analysis of conserved genomic loci?",
    "llama-7b_response": "There are several software packages available for the analysis of conserved genomic loci, including:\n\n1. RepeatMasker: RepeatMasker is a software tool that can be used to identify repetitive elements in genomic DNA and to predict the location of conserved genomic regions. It can be used to identify repetitive elements such as microsatellites, minisatellites, and transposable elements, and to predict the location of conserved genomic regions such as genes, regulatory elements, and other functional elements.\n2. RepeatScout: RepeatScout is a software tool that can be used to identify repetitive elements in genomic DNA and to predict the location of conserved genomic regions. It can be used to identify repetitive elements such as microsatellites, minisatellites, and transposable elements, and to predict the location of conserved genomic regions such as genes, regulatory elements, and other functional elements.\n3. Genomic Repeats Finder: Genomic Repeats Finder is a software tool that can be used to identify repetitive elements in genomic DNA and to predict the location of conserved genomic regions. It can be used to identify repetitive elements such as microsatellites, minisatellites, and transposable elements, and to predict the location of conserved genomic regions such as genes, regulatory elements, and other functional elements.\n4. RepeatAnno: RepeatAnno is a software tool that can be used to identify repetitive elements in genomic DNA and to predict the location of conserved genomic regions. It can be used to identify repetitive elements such as microsatellites, minisatellites, and transposable elements, and to predict the location of conserved genomic regions such as genes, regulatory elements, and other functional elements.\n5. RepeatModeler: RepeatModeler is a software tool that can be used to identify repetitive elements in genomic DNA and to predict the location of conserved genomic regions. It can be used to identify repetitive elements such as microsatellites, minisatellites, and transposable elements, and to predict the location of conserved genomic regions such as genes, regulatory elements, and other functional elements.\n\nThese are just a few examples of the many software packages available",
    "llama-7b_fact_raw": "1. RepeatMasker is a software tool used for identifying repetitive elements and predicting conserved genomic regions.\n2. RepeatScout is a software tool designed to identify repetitive elements in genomic DNA.\n3. Genomic Repeats Finder is used for identifying repetitive elements and predicting the location of conserved genomic regions.\n4. RepeatAnno can be utilized to identify repetitive elements such as microsatellites and transposable elements in genomic DNA.\n5. RepeatModeler is a software tool that helps in identifying repetitive elements and predicting conserved regions in genomic DNA.",
    "llama-7b_fact": [
      "RepeatMasker is a software tool used for identifying repetitive elements and predicting conserved genomic regions.",
      "RepeatScout is a software tool designed to identify repetitive elements in genomic DNA.",
      "Genomic Repeats Finder is used for identifying repetitive elements and predicting the location of conserved genomic regions.",
      "RepeatAnno can be utilized to identify repetitive elements such as microsatellites and transposable elements in genomic DNA.",
      "RepeatModeler is a software tool that helps in identifying repetitive elements and predicting conserved regions in genomic DNA."
    ]
  },
  {
    "id": 1860,
    "user_query": "You MUST give a detailed answer to the following question: Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-7b_response": "The PIEZO2 gene is associated with several diseases, including:\n\n1. Hereditary hemorrhagic telangiectasia (HHT): HHT is a genetic disorder that causes abnormal blood vessels to form in the skin, mucous membranes, and organs. The PIEZO2 gene plays a role in the development of blood vessels, and mutations in this gene can increase the risk of HHT.\n2. Ehlers-Danlos syndrome (EDS): EDS is a group of genetic disorders that affect the connective tissues in the body, including the skin, joints, and blood vessels. Mutations in the PIEZO2 gene have been associated with a specific subtype of EDS known as EDS type 3B.\n3. Autosomal dominant polycystic kidney disease (ADPKD): ADPKD is a genetic disorder that causes the kidneys to become enlarged and filled with cysts. The PIEZO2 gene plays a role in the development of the kidneys, and mutations in this gene can increase the risk of ADPKD.",
    "llama-7b_fact_raw": "1. PIEZO2 gene mutations can increase the risk of hereditary hemorrhagic telangiectasia (HHT).\n2. Mutations in the PIEZO2 gene have been associated with a specific subtype of Ehlers-Danlos syndrome (EDS) known as EDS type 3B.\n3. The PIEZO2 gene plays a role in kidney development, and mutations in this gene can increase the risk of autosomal dominant polycystic kidney disease (ADPKD).",
    "llama-7b_fact": [
      "PIEZO2 gene mutations can increase the risk of hereditary hemorrhagic telangiectasia (HHT).",
      "Mutations in the PIEZO2 gene have been associated with a specific subtype of Ehlers-Danlos syndrome (EDS) known as EDS type 3B.",
      "The PIEZO2 gene plays a role in kidney development, and mutations in this gene can increase the risk of autosomal dominant polycystic kidney disease (ADPKD)."
    ]
  },
  {
    "id": 1867,
    "user_query": "You MUST give a detailed answer to the following question: What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-7b_response": "ERAP1 and ERAP2 are two proteins that are involved in the processing of antigenic peptides presented on the surface of antigen-presenting cells (APCs), such as dendritic cells and macrophages. These proteins belong to the ERAP (endoplasmic reticulum aminopeptidase) family and play a crucial role in the maturation and presentation of peptides derived from pathogens and self-antigens.\n\nERAP1 and ERAP2 are both expressed in the endoplasmic reticulum (ER) of APCs, where they process and trim peptides derived from pathogens and self-antigens. ERAP1 and ERAP2 then transport these peptides to the Golgi apparatus, where they are further processed and presented on the surface of APCs in the context of major histocompatibility complex (MHC) molecules.\n\nERAP1 and ERAP2 can exist as monomers or dimers in the ER and Golgi apparatus. The dimerization of ERAP1 and ERAP2 has been shown to play an important role in the processing and presentation of antigenic peptides. When ERAP1 and ERAP2 form a dimer, they can interact with each other and process peptides more efficiently, leading to the production of higher-quality peptides that are better suited for presentation on the surface of APCs.\n\nIn addition, ERAP1-ERAP2 dimerization has been shown to play a role in the regulation of the immune response. For example, ERAP1 and ERAP2 can interact with each other and with other immune signaling molecules, such as Toll-like receptors (TLRs) and interleukin-1 (IL-1), to regulate the production of pro-inflammatory cytokines and the activation of immune cells.\n\nOverall, ERAP1-ERAP2 dimerization plays an important role in the processing and presentation of antigenic peptides, as well as in the regulation of the immune response. Dimerization allows ERAP1 and ERAP2 to interact with each other and with other immune signaling molecules, leading to the production of higher-quality peptides and the regulation of",
    "llama-7b_fact_raw": "1. ERAP1 and ERAP2 are involved in the processing of antigenic peptides presented on the surface of antigen-presenting cells.\n2. ERAP1-ERAP2 dimerization is important for the efficient processing and presentation of peptides in the context of major histocompatibility complex (MHC) molecules.\n3. ERAP1 and ERAP2 are part of the endoplasmic reticulum aminopeptidase (ERAP) family and are expressed in the endoplasmic reticulum of antigen-presenting cells.\n4. The dimerization of ERAP1 and ERAP2 leads to more efficient interaction and processing of peptides, resulting in higher-quality peptides for presentation.\n5. ERAP1-ERAP2 dimerization is involved in the regulation of the immune response, including the regulation of pro-inflammatory cytokines and the activation of immune cells.",
    "llama-7b_fact": [
      "ERAP1 and ERAP2 are involved in the processing of antigenic peptides presented on the surface of antigen-presenting cells.",
      "ERAP1-ERAP2 dimerization is important for the efficient processing and presentation of peptides in the context of major histocompatibility complex (MHC) molecules.",
      "ERAP1 and ERAP2 are part of the endoplasmic reticulum aminopeptidase (ERAP) family and are expressed in the endoplasmic reticulum of antigen-presenting cells.",
      "The dimerization of ERAP1 and ERAP2 leads to more efficient interaction and processing of peptides, resulting in higher-quality peptides for presentation.",
      "ERAP1-ERAP2 dimerization is involved in the regulation of the immune response, including the regulation of pro-inflammatory cytokines and the activation of immune cells."
    ]
  },
  {
    "id": 1890,
    "user_query": "You MUST give a detailed answer to the following question: What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-7b_response": "R-spondin 1 and noggin are two proteins that play important roles in the regulation of gallbladder development and function.\n\nR-spondin 1 is a member of the R-spondin family of proteins, which are secreted by various tissues and have been implicated in the regulation of bone growth and development. In the gallbladder, R-spondin 1 has been shown to play a role in the regulation of cholesterol synthesis and secretion. Specifically, R-spondin 1 has been shown to stimulate the expression of genes involved in cholesterol synthesis and secretion in gallbladder cells.\n\nNoggin, on the other hand, is a protein that has been shown to inhibit the activity of bone morphogenetic proteins (BMPs), which are signaling molecules that play important roles in the regulation of cell growth and differentiation. In the gallbladder, noggin has been shown to play a role in the regulation of cholesterol synthesis and secretion. Specifically, noggin has been shown to inhibit the activity of BMPs, which in turn has been shown to inhibit the expression of genes involved in cholesterol synthesis and secretion in gallbladder cells.\n\nIn summary, R-spondin 1 and noggin play important roles in the regulation of cholesterol synthesis and secretion in the gallbladder. R-spondin 1 stimulates the expression of genes involved in cholesterol synthesis and secretion, while noggin inhibits the activity of BMPs, which in turn inhibits the expression of genes involved in cholesterol synthesis and secretion.",
    "llama-7b_fact_raw": "1. R-spondin 1 is involved in regulating cholesterol synthesis and secretion in gallbladder cells.\n2. R-spondin 1 stimulates the expression of genes involved in cholesterol synthesis and secretion in gallbladder cells.\n3. Noggin is known to inhibit the activity of bone morphogenetic proteins (BMPs).\n4. BMPs are involved in the regulation of cell growth and differentiation.\n5. In the gallbladder, noggin inhibits the expression of genes involved in cholesterol synthesis and secretion by affecting BMP activity.",
    "llama-7b_fact": [
      "R-spondin 1 is involved in regulating cholesterol synthesis and secretion in gallbladder cells.",
      "R-spondin 1 stimulates the expression of genes involved in cholesterol synthesis and secretion in gallbladder cells.",
      "Noggin is known to inhibit the activity of bone morphogenetic proteins (BMPs).",
      "BMPs are involved in the regulation of cell growth and differentiation.",
      "In the gallbladder, noggin inhibits the expression of genes involved in cholesterol synthesis and secretion by affecting BMP activity."
    ]
  },
  {
    "id": 1937,
    "user_query": "You MUST give a detailed answer to the following question: Does NADPH oxidase 5 require any subunit for function?",
    "llama-7b_response": "Yes, NADPH oxidase 5 (NOX5) requires multiple subunits for its function. NOX5 is a member of the NADPH oxidase family of enzymes, which generate reactive oxygen species (ROS) through the oxidation of NADPH.\n\nNOX5 is composed of two catalytic subunits, p22phox and p40phox, and two regulatory subunits, p67phox and p41phox. The p22phox and p40phox subunits are required for the enzymatic activity of NOX5, while the p67phox and p41phox subunits play a role in the targeting and localization of NOX5 to specific cellular compartments.\n\nIn the absence of one or more of the NOX5 subunits, the enzymatic activity of NOX5 is reduced or absent, leading to a decrease in ROS production and a corresponding impact on cellular function. For example, mice lacking the p22phox subunit have a reduced ability to mount an immune response to bacterial infections, while mice lacking the p41phox subunit have an increased susceptibility to inflammation and tissue damage.\n\nOverall, NOX5 requires all of its subunits for proper function, and the absence of any one of these subunits can result in altered ROS production and cellular responses.",
    "llama-7b_fact_raw": "1. NADPH oxidase 5 (NOX5) requires multiple subunits for its function.\n2. NOX5 includes two catalytic subunits named p22phox and p40phox.\n3. NOX5 contains two regulatory subunits called p67phox and p41phox.\n4. The enzymatic activity of NOX5 can be reduced or absent without one or more of its subunits.\n5. Mice lacking the p22phox subunit show a reduced ability to mount an immune response to bacterial infections.",
    "llama-7b_fact": [
      "NADPH oxidase 5 (NOX5) requires multiple subunits for its function.",
      "NOX5 includes two catalytic subunits named p22phox and p40phox.",
      "NOX5 contains two regulatory subunits called p67phox and p41phox.",
      "The enzymatic activity of NOX5 can be reduced or absent without one or more of its subunits.",
      "Mice lacking the p22phox subunit show a reduced ability to mount an immune response to bacterial infections."
    ]
  },
  {
    "id": 1944,
    "user_query": "You MUST give a detailed answer to the following question: What is the connection between furin and hepcidin?",
    "llama-7b_response": "Furin and hepcidin are two distinct proteins that have different functions in the body. Furin is an enzyme that plays a role in the processing and activation of other proteins, while hepcidin is a hormone that regulates iron absorption and storage in the body.\n\nFurin is an asparaginyl endopeptidase enzyme that cleaves peptide bonds between asparagine residues in proteins. It is involved in the processing and activation of various proteins, including growth factors, cytokines, and hormones. Furin is expressed in many tissues, including the liver, kidney, and pancreas, and plays a role in the regulation of various physiological processes, including cell growth, differentiation, and inflammation.\n\nHepcidin, on the other hand, is a hormone that is produced by hepatocytes in the liver. It is the primary regulator of iron absorption and storage in the body. Hepcidin binds to and inhibits the expression of divalent metal transporter 1 (DMT1), a transmembrane protein that facilitates the uptake of iron from the diet into enterocytes in the small intestine. By inhibiting DMT1, hepcidin prevents the absorption of dietary iron and maintains iron homeostasis in the body.\n\nDespite their different functions, there is a connection between furin and hepcidin. Recent studies have shown that furin can play a role in the regulation of hepcidin expression and activity. For example, furin has been shown to cleave and activate hepcidin, which can enhance its biological activity and increase iron absorption. Conversely, inhibition of furin activity has been shown to decrease hepcidin expression and iron absorption.\n\nFurthermore, there is evidence to suggest that hepcidin can regulate the activity of furin. For example, hepcidin has been shown to inhibit the activity of furin, which can decrease the processing and activation of other proteins.\n\nIn summary, while furin and hepcidin are two distinct proteins with different functions, there is a connection between them. Furin can play a role in the",
    "llama-7b_fact_raw": "1. Furin is an enzyme that aids in processing and activating various proteins, such as growth factors, cytokines, and hormones.\n2. Hepcidin is a hormone produced by hepatocytes in the liver and regulates iron absorption and storage in the body.\n3. Furin is an asparaginyl endopeptidase that cleaves peptide bonds between asparagine residues in proteins.\n4. Hepcidin functions by binding to and inhibiting the expression of divalent metal transporter 1 (DMT1), impeding dietary iron absorption.\n5. Research suggests furin can regulate hepcidin expression and activity, and conversely, hepcidin can regulate the activity of furin.",
    "llama-7b_fact": [
      "Furin is an enzyme that aids in processing and activating various proteins, such as growth factors, cytokines, and hormones.",
      "Hepcidin is a hormone produced by hepatocytes in the liver and regulates iron absorption and storage in the body.",
      "Furin is an asparaginyl endopeptidase that cleaves peptide bonds between asparagine residues in proteins.",
      "Hepcidin functions by binding to and inhibiting the expression of divalent metal transporter 1 (DMT1), impeding dietary iron absorption.",
      "Research suggests furin can regulate hepcidin expression and activity, and conversely, hepcidin can regulate the activity of furin."
    ]
  },
  {
    "id": 1956,
    "user_query": "You MUST give a detailed answer to the following question: Which is the largest metabolic gene cluster in yeast?",
    "llama-7b_response": "The largest metabolic gene cluster in yeast is the pyruvate dehydrogenase (PDH) complex, which is responsible for converting pyruvate into acetyl-CoA, an important intermediate in cellular metabolism. The PDH complex is composed of four subunits: E1 (pyruvate dehydrogenase), E2 (dihydrolipoyl succinyltransferase), E3 (dihydrolipoyl dehydrogenase), and E4 (dihydrolipoyl dehydrogenase).\n\nThe PDH complex is one of the largest metabolic gene clusters in yeast because it is composed of multiple genes that are co-transcribed and co-translated. The genes for the four subunits of the PDH complex are located on different chromosomes, but they are transcribed as a single unit and translated as a single polypeptide chain. This co-transcription and co-translation of multiple genes is a common feature of many metabolic gene clusters in yeast and other organisms.\n\nThe PDH complex is also one of the largest metabolic gene clusters in yeast because it plays a critical role in cellular metabolism. The conversion of pyruvate into acetyl-CoA is an important step in the citric acid cycle, which is the primary means by which cells generate energy in the form of ATP. Disruption of the PDH complex can lead to a variety of metabolic disorders, including lactic acidosis, diabetes, and liver disease.\n\nOverall, the PDH complex is the largest metabolic gene cluster in yeast because it is composed of multiple genes that are co-transcribed and co-translated, and it plays a critical role in cellular metabolism.",
    "llama-7b_fact_raw": "1. The pyruvate dehydrogenase (PDH) complex is the largest metabolic gene cluster in yeast.\n2. The PDH complex is responsible for converting pyruvate into acetyl-CoA.\n3. The PDH complex is composed of four subunits: E1, E2, E3, and E4.\n4. The genes for the four subunits of the PDH complex are transcribed as a single unit and translated as a single polypeptide chain.\n5. Disruption of the PDH complex can lead to metabolic disorders such as lactic acidosis, diabetes, and liver disease.",
    "llama-7b_fact": [
      "The pyruvate dehydrogenase (PDH) complex is the largest metabolic gene cluster in yeast.",
      "The PDH complex is responsible for converting pyruvate into acetyl-CoA.",
      "The PDH complex is composed of four subunits: E1, E2, E3, and E4.",
      "The genes for the four subunits of the PDH complex are transcribed as a single unit and translated as a single polypeptide chain.",
      "Disruption of the PDH complex can lead to metabolic disorders such as lactic acidosis, diabetes, and liver disease."
    ]
  },
  {
    "id": 1967,
    "user_query": "You MUST give a detailed answer to the following question: What is the role of LIMT lncRNA?",
    "llama-7b_response": "Long non-coding RNA (lncRNA) LIMT has been shown to play a crucial role in various biological processes, including cell proliferation, differentiation, and apoptosis. LIMT lncRNA has also been implicated in the regulation of gene expression at the transcriptional level.\n\nOne of the key functions of LIMT lncRNA is to act as a competing endogenous RNA (ceRNA) molecule. ceRNAs are non-coding RNAs that can bind to microRNAs (miRNAs) and prevent them from binding to their target mRNAs, thereby regulating gene expression. LIMT lncRNA has been shown to function as a miRNA sponge, binding to miRNAs and preventing them from targeting specific mRNAs.\n\nFor example, LIMT lncRNA has been shown to bind to let-7 family miRNAs and prevent them from targeting PTEN, a tumor suppressor gene. This leads to the deregulation of PTEN expression and contributes to the development of various cancers.\n\nIn addition to its ceRNA function, LIMT lncRNA has also been shown to regulate gene expression at the transcriptional level. LIMT lncRNA has been shown to bind to the promoter region of target genes and recruit transcriptional co-activators, leading to the activation of gene transcription.\n\nFurthermore, LIMT lncRNA has also been shown to play a role in the regulation of cellular signaling pathways. For example, LIMT lncRNA has been shown to bind to the androgen receptor (AR) and enhance its transcriptional activity, thereby promoting the growth of prostate cancer cells.\n\nIn summary, LIMT lncRNA plays a crucial role in regulating gene expression at the transcriptional and post-transcriptional levels, and contributes to various biological processes, including cell proliferation, differentiation, and apoptosis. Its deregulation has been implicated in the development of various diseases, including cancer.",
    "llama-7b_fact_raw": "1. LIMT lncRNA is involved in cell proliferation, differentiation, and apoptosis.\n2. LIMT lncRNA functions as a competing endogenous RNA (ceRNA) that can bind to microRNAs.\n3. LIMT lncRNA has been shown to bind to let-7 family microRNAs, affecting the expression of the PTEN tumor suppressor gene.\n4. LIMT lncRNA can bind to the promoter region of target genes and recruit transcriptional co-activators.\n5. LIMT lncRNA is implicated in enhancing the transcriptional activity of the androgen receptor (AR), affecting prostate cancer cell growth.",
    "llama-7b_fact": [
      "LIMT lncRNA is involved in cell proliferation, differentiation, and apoptosis.",
      "LIMT lncRNA functions as a competing endogenous RNA (ceRNA) that can bind to microRNAs.",
      "LIMT lncRNA has been shown to bind to let-7 family microRNAs, affecting the expression of the PTEN tumor suppressor gene.",
      "LIMT lncRNA can bind to the promoter region of target genes and recruit transcriptional co-activators.",
      "LIMT lncRNA is implicated in enhancing the transcriptional activity of the androgen receptor (AR), affecting prostate cancer cell growth."
    ]
  },
  {
    "id": 1984,
    "user_query": "You MUST give a detailed answer to the following question: Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-7b_response": "There are several R/Bioconductor packages that can be used for performing SNP (Single Nucleotide Polymorphism) enrichment analysis, including:\n\n1. snpEff: The snpEff package is a widely used R/Bioconductor package for predicting the functional consequences of SNPs. It uses a combination of machine learning algorithms and databases of known functional SNPs to predict the effect of a given SNP on gene expression, protein function, and other biological processes.\n2. Genome-Wide Association Studies (GWAS): The GWAS package is another R/Bioconductor package that can be used for performing SNP enrichment analysis. It provides tools for analyzing genome-wide association studies (GWAS), which involve analyzing large datasets of SNPs to identify associations between SNPs and certain traits or diseases.\n3. GenABEL: The GenABEL package is a general-purpose R/Bioconductor package for analyzing gene expression data. It can be used for performing SNP enrichment analysis by comparing the expression levels of SNP-associated genes to those of non-SNP-associated genes.\n4. DESeq2: The DESeq2 package is another R/Bioconductor package that can be used for analyzing gene expression data. It can be used for performing SNP enrichment analysis by comparing the expression levels of SNP-associated genes to those of non-SNP-associated genes.\n\nOverall, the choice of which R/Bioconductor package to use for performing SNP enrichment analysis will depend on the specific goals of the analysis and the type of data being analyzed.",
    "llama-7b_fact_raw": "1. The snpEff package is an R/Bioconductor package used for predicting the functional consequences of SNPs.\n2. The GWAS package is used for analyzing genome-wide association studies and can perform SNP enrichment analysis.\n3. The GenABEL package is a general-purpose R/Bioconductor package for analyzing gene expression data, including SNP enrichment analysis.\n4. DESeq2 is an R/Bioconductor package that can perform SNP enrichment analysis by comparing the expression levels of SNP-associated genes with non-SNP-associated genes.",
    "llama-7b_fact": [
      "The snpEff package is an R/Bioconductor package used for predicting the functional consequences of SNPs.",
      "The GWAS package is used for analyzing genome-wide association studies and can perform SNP enrichment analysis.",
      "The GenABEL package is a general-purpose R/Bioconductor package for analyzing gene expression data, including SNP enrichment analysis.",
      "DESeq2 is an R/Bioconductor package that can perform SNP enrichment analysis by comparing the expression levels of SNP-associated genes with non-SNP-associated genes."
    ]
  },
  {
    "id": 2015,
    "user_query": "You MUST give a detailed answer to the following question: Which are the key players on radial glial specification to ependymal cells?",
    "llama-7b_response": "Radial glial cells are a type of glial cell that give rise to the ependymal cells that line the ventricular system of the brain and spinal cord. The process of radial glial specification to ependymal cells involves a series of molecular signals and cellular interactions that occur during embryonic development.\n\nOne of the key players in the specification of radial glial cells to ependymal cells is the transcription factor Sox2. Sox2 is expressed in radial glial cells and is necessary for the specification of these cells to ependymal cells. Sox2 works by activating the expression of genes that are specific to ependymal cells, such as the ependymin gene.\n\nAnother key player in the specification of radial glial cells to ependymal cells is the transcription factor Nkx2.1. Nkx2.1 is expressed in a subset of radial glial cells and is necessary for the specification of these cells to ependymal cells. Nkx2.1 works by activating the expression of genes that are specific to ependymal cells, such as the ependymin gene.\n\nIn addition to Sox2 and Nkx2.1, other transcription factors that have been implicated in the specification of radial glial cells to ependymal cells include Olig2, Ngn2, and Ascl1. These transcription factors work by activating the expression of genes that are specific to ependymal cells, or by inhibiting the expression of genes that are specific to other cell types.\n\nOverall, the specification of radial glial cells to ependymal cells involves a complex interplay of molecular signals and cellular interactions. The transcription factors Sox2, Nkx2.1, Olig2, Ngn2, and Ascl1 are all important players in this process, and further research is needed to fully understand how they work together to specify radial glial cells to ependymal cells.",
    "llama-7b_fact_raw": "1. Radial glial cells give rise to ependymal cells that line the ventricular system of the brain and spinal cord.\n2. The transcription factor Sox2 is necessary for the specification of radial glial cells to ependymal cells.\n3. Sox2 activates the expression of genes specific to ependymal cells, including the ependymin gene.\n4. The transcription factor Nkx2.1 is expressed in radial glial cells and is necessary for their specification to ependymal cells.\n5. Other transcription factors involved in the specification of radial glial cells to ependymal cells include Olig2, Ngn2, and Ascl1.",
    "llama-7b_fact": [
      "Radial glial cells give rise to ependymal cells that line the ventricular system of the brain and spinal cord.",
      "The transcription factor Sox2 is necessary for the specification of radial glial cells to ependymal cells.",
      "Sox2 activates the expression of genes specific to ependymal cells, including the ependymin gene.",
      "The transcription factor Nkx2.1 is expressed in radial glial cells and is necessary for their specification to ependymal cells.",
      "Other transcription factors involved in the specification of radial glial cells to ependymal cells include Olig2, Ngn2, and Ascl1."
    ]
  },
  {
    "id": 2065,
    "user_query": "You MUST give a detailed answer to the following question: How are triple negative gliomas characterized?",
    "llama-7b_response": "Triple negative breast cancers are characterized by the absence of three receptors for hormones and growth factors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). These cancers do not overexpress HER2, which is a positive prognostic factor in other types of breast cancer. Triple negative breast cancers are more aggressive and tend to have a worse prognosis than other types of breast cancer. They are also more likely to recur and to metastasize to other parts of the body.\n\nTriple negative gliomas are a type of brain tumor that are characterized by the absence of three receptors for hormones and growth factors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). These cancers do not overexpress HER2, which is a positive prognostic factor in other types of gliomas. Triple negative gliomas are more aggressive and tend to have a worse prognosis than other types of gliomas. They are also more likely to recur and to metastasize to other parts of the body.\n\nTriple negative breast cancers and triple negative gliomas are characterized by the absence of three receptors for hormones and growth factors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). These cancers do not overexpress HER2, which is a positive prognostic factor in other types of cancer.\n\nTriple negative breast cancers and triple negative gliomas are characterized by the absence of three receptors for hormones and growth factors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). These cancers do not overexpress HER2, which is a positive prognostic factor in other types of cancer.\n\nTriple negative breast cancers and triple negative gliomas are characterized by the absence of three receptors for hormones and growth factors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal",
    "llama-7b_fact_raw": "1. Triple negative gliomas are characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).\n2. HER2 overexpression is a positive prognostic factor in other types of gliomas and breast cancer, but not in triple negative gliomas.\n3. Triple negative gliomas tend to have a more aggressive behavior and worse prognosis compared to other glioma types.\n4. Triple negative gliomas are more likely to recur after treatment than other types of gliomas.\n5. Triple negative gliomas have a higher likelihood of metastasizing to other parts of the body compared to other glioma types.",
    "llama-7b_fact": [
      "Triple negative gliomas are characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).",
      "HER2 overexpression is a positive prognostic factor in other types of gliomas and breast cancer, but not in triple negative gliomas.",
      "Triple negative gliomas tend to have a more aggressive behavior and worse prognosis compared to other glioma types.",
      "Triple negative gliomas are more likely to recur after treatment than other types of gliomas.",
      "Triple negative gliomas have a higher likelihood of metastasizing to other parts of the body compared to other glioma types."
    ]
  },
  {
    "id": 2069,
    "user_query": "You MUST give a detailed answer to the following question: What is TOPAZ1?",
    "llama-7b_response": "TOPAZ1 is a cryptocurrency that was created in 2014 as a hard fork of the Litecoin blockchain. It is a peer-to-peer electronic cash system and a decentralized digital currency that operates on a proof-of-work consensus algorithm. TOPAZ1 is similar to Litecoin in many ways, but it has a few key differences, such as a different block time and a different proof-of-work algorithm. TOPAZ1 is not as widely used or well-known as some other cryptocurrencies, but it has a dedicated community of users and developers.",
    "llama-7b_fact_raw": "1. TOPAZ1 was created in 2014 as a hard fork of the Litecoin blockchain.\n2. It uses a proof-of-work consensus algorithm.\n3. TOPAZ1 has a different block time compared to Litecoin.\n4. TOPAZ1 employs a different proof-of-work algorithm than Litecoin.\n5. TOPAZ1 has a community of users and developers.",
    "llama-7b_fact": [
      "TOPAZ1 was created in 2014 as a hard fork of the Litecoin blockchain.",
      "It uses a proof-of-work consensus algorithm.",
      "TOPAZ1 has a different block time compared to Litecoin.",
      "TOPAZ1 employs a different proof-of-work algorithm than Litecoin.",
      "TOPAZ1 has a community of users and developers."
    ]
  },
  {
    "id": 2075,
    "user_query": "You MUST give a detailed answer to the following question: Which gene controls the expression of GATA-1 isoforms?",
    "llama-7b_response": "GATA-1 is a transcription factor that plays an important role in the development and function of various tissues, including the heart, kidney, and immune system. GATA-1 isoforms are different forms of the protein that are produced by alternative splicing of the GATA-1 mRNA.\n\nThe gene that controls the expression of GATA-1 isoforms is the GATA-1 gene itself. Alternative splicing of the GATA-1 gene results in the production of multiple transcripts that can encode different isoforms of the GATA-1 protein. The choice of which exons to include in each transcript is determined by a complex network of regulatory elements in the GATA-1 gene, including promoter regions, enhancers, silencers, and other cis-acting elements.\n\nThe expression of GATA-1 isoforms can be regulated at different levels, including transcriptional, post-transcriptional, and post-translational modifications. For example, the transcriptional regulation of GATA-1 isoforms can be influenced by the binding of transcription factors to specific regulatory elements in the GATA-1 gene, as well as by the availability of cofactors and co-regulators that modulate the activity of the transcriptional machinery.\n\nOverall, the expression of GATA-1 isoforms is a complex process that involves the coordinated action of multiple genetic and epigenetic factors. The precise regulation of GATA-1 isoform expression is critical for the proper development and function of various tissues, and dysregulation of GATA-1 isoform expression has been implicated in a number of human diseases, including cardiovascular disease, immune disorders, and cancer.",
    "llama-7b_fact_raw": "1. GATA-1 is a transcription factor important for the development and function of heart, kidney, and immune system tissues.\n2. GATA-1 isoforms are produced through alternative splicing of the GATA-1 mRNA.\n3. The gene responsible for the expression of GATA-1 isoforms is the GATA-1 gene.\n4. The GATA-1 gene contains regulatory elements such as promoter regions, enhancers, silencers, and other cis-acting elements that determine exon inclusion during mRNA splicing.\n5. Dysregulation of GATA-1 isoform expression has been linked to human diseases, including cardiovascular disease, immune disorders, and cancer.",
    "llama-7b_fact": [
      "GATA-1 is a transcription factor important for the development and function of heart, kidney, and immune system tissues.",
      "GATA-1 isoforms are produced through alternative splicing of the GATA-1 mRNA.",
      "The gene responsible for the expression of GATA-1 isoforms is the GATA-1 gene.",
      "The GATA-1 gene contains regulatory elements such as promoter regions, enhancers, silencers, and other cis-acting elements that determine exon inclusion during mRNA splicing.",
      "Dysregulation of GATA-1 isoform expression has been linked to human diseases, including cardiovascular disease, immune disorders, and cancer."
    ]
  },
  {
    "id": 2076,
    "user_query": "You MUST give a detailed answer to the following question: What is MIRA-seq?",
    "llama-7b_response": "MIRA-seq (Mutually Informative Regions by Association) is a method used in genomics to identify regions of the genome that are associated with multiple traits or diseases. The method is based on the idea that regions of the genome that are associated with multiple traits or diseases are likely to contain genes that are involved in common biological pathways or processes.\n\nMIRA-seq works by comparing the genetic information of individuals with a particular trait or disease to a reference population without the trait or disease. The method identifies regions of the genome that are overrepresented in the individuals with the trait or disease compared to the reference population. These regions are then prioritized for further investigation to determine if they contain genes that are involved in common biological pathways or processes.\n\nOne advantage of MIRA-seq is that it can identify regions of the genome that may be involved in multiple traits or diseases, which can be difficult to identify using other methods. Additionally, MIRA-seq can be used to identify genes that are involved in common biological pathways or processes, which can provide insights into the underlying biology of a particular trait or disease.\n\nOverall, MIRA-seq is a powerful method for identifying regions of the genome that are associated with multiple traits or diseases, and can provide valuable insights into the biology of complex traits and diseases.",
    "llama-7b_fact_raw": "1. MIRA-seq stands for Mutually Informative Regions by Association.\n2. MIRA-seq is used to identify genomic regions associated with multiple traits or diseases.\n3. The method compares genetic information of affected individuals to a reference population without the trait or disease.\n4. MIRA-seq is used to find overrepresented genomic regions in individuals with certain traits or diseases compared to a reference population.\n5. The identified regions from MIRA-seq are prioritized for further investigation to explore common biological pathways or processes.",
    "llama-7b_fact": [
      "MIRA-seq stands for Mutually Informative Regions by Association.",
      "MIRA-seq is used to identify genomic regions associated with multiple traits or diseases.",
      "The method compares genetic information of affected individuals to a reference population without the trait or disease.",
      "MIRA-seq is used to find overrepresented genomic regions in individuals with certain traits or diseases compared to a reference population.",
      "The identified regions from MIRA-seq are prioritized for further investigation to explore common biological pathways or processes."
    ]
  },
  {
    "id": 2108,
    "user_query": "You MUST give a detailed answer to the following question: What is the indication of ARCALYST?",
    "llama-7b_response": "The indication of ARCALYST (rilonacept) is the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), in adults and children who are at least 12 years old. ARCALYST is also used to treat adults and children who are at least 12 years old with Familial Mediterranean Fever (FMF) who are intolerant of, or have failed, colchicine treatment.",
    "llama-7b_fact_raw": "1. ARCALYST (rilonacept) is indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS).\n2. ARCALYST is used to treat Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).\n3. The medication is approved for use in adults and children who are at least 12 years old.\n4. ARCALYST is also indicated for the treatment of Familial Mediterranean Fever (FMF) in those who are intolerant of, or have failed, colchicine treatment.\n5. The medication can be used for FMF in both adults and children aged 12 or older.",
    "llama-7b_fact": [
      "ARCALYST (rilonacept) is indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS).",
      "ARCALYST is used to treat Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).",
      "The medication is approved for use in adults and children who are at least 12 years old.",
      "ARCALYST is also indicated for the treatment of Familial Mediterranean Fever (FMF) in those who are intolerant of, or have failed, colchicine treatment.",
      "The medication can be used for FMF in both adults and children aged 12 or older."
    ]
  },
  {
    "id": 2170,
    "user_query": "You MUST give a detailed answer to the following question: List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-7b_response": "Robertsonian translocation is a type of chromosomal rearrangement that results in the fusion of two acrocentric chromosomes. The human acrocentric chromosomes involved in Robertsonian translocation are:\n\n1. Chromosome 16 and Chromosome 17\n2. Chromosome 21 and Chromosome 22\n3. Chromosome 22 and Chromosome 23\n4. Chromosome 23 and Chromosome 24\n5. Chromosome 24 and Chromosome 25\n6. Chromosome 25 and Chromosome 26\n7. Chromosome 26 and Chromosome 27\n8. Chromosome 27 and Chromosome 28\n9. Chromosome 28 and Chromosome 29\n10. Chromosome 29 and Chromosome 30\n11. Chromosome 30 and Chromosome 31\n12. Chromosome 31 and Chromosome 32\n13. Chromosome 32 and Chromosome 33\n14. Chromosome 33 and Chromosome 34\n15. Chromosome 34 and Chromosome 35\n16. Chromosome 35 and Chromosome 36\n17. Chromosome 36 and Chromosome 37\n18. Chromosome 37 and Chromosome 38\n19. Chromosome 38 and Chromosome 39\n20. Chromosome 39 and Chromosome 40\n21. Chromosome 40 and Chromosome 41\n22. Chromosome 41 and Chromosome 42\n23. Chromosome 42 and Chromosome 43\n24. Chromosome 43 and Chromosome 44\n25. Chromosome 44",
    "llama-7b_fact_raw": "1. The answer lists Chromosome 16 as an acrocentric chromosome involved in Robertsonian translocation.\n2. The answer lists Chromosome 21 as an acrocentric chromosome involved in Robertsonian translocation.\n3. The answer lists Chromosome 22 as an acrocentric chromosome involved in Robertsonian translocation.\n4. The answer suggests Chromosome 23 is an acrocentric chromosome; however, humans only have 23 pairs of chromosomes, numbering up to 46 total.\n5. Robertsonian translocation is described as a fusion of two acrocentric chromosomes.",
    "llama-7b_fact": [
      "The answer lists Chromosome 16 as an acrocentric chromosome involved in Robertsonian translocation.",
      "The answer lists Chromosome 21 as an acrocentric chromosome involved in Robertsonian translocation.",
      "The answer lists Chromosome 22 as an acrocentric chromosome involved in Robertsonian translocation.",
      "The answer suggests Chromosome 23 is an acrocentric chromosome; however, humans only have 23 pairs of chromosomes, numbering up to 46 total.",
      "Robertsonian translocation is described as a fusion of two acrocentric chromosomes."
    ]
  },
  {
    "id": 2237,
    "user_query": "You MUST give a detailed answer to the following question: Which R package could be used for the identification of pediatric brain tumors?",
    "llama-7b_response": "There is no single R package that can be used for the identification of pediatric brain tumors. However, there are several R packages that can be used for analyzing and visualizing data related to brain tumors, including pediatric brain tumors. Some of these packages include:\n\n1. ggplot2: This package is used for data visualization and can be used to create plots and charts of brain tumor data, including pediatric brain tumors.\n2. RColorBrewer: This package is used for creating color palettes and can be used to create color-coded maps of brain tumor data, including pediatric brain tumors.\n3. reshape2: This package is used for reshaping and munging data and can be used to restructure brain tumor data, including pediatric brain tumors, for analysis.\n4. dplyr: This package is used for data manipulation and can be used to filter and aggregate brain tumor data, including pediatric brain tumors.\n5. tidyr: This package is used for data tidying and can be used to restructure brain tumor data, including pediatric brain tumors, for analysis.\n6. caret: This package is used for machine learning and can be used to build predictive models for the identification of pediatric brain tumors.\n7. survival: This package is used for survival analysis and can be used to analyze and interpret time-to-event data, such as survival data for pediatric brain tumor patients.\n\nOverall, the choice of R package(s) for analyzing and visualizing brain tumor data, including pediatric brain tumors, will depend on the specific research question and the type of data being analyzed.",
    "llama-7b_fact_raw": "1. ggplot2 is an R package used for data visualization, including plots and charts of brain tumor data.\n2. RColorBrewer is an R package that provides color palettes for color-coding maps, applicable to brain tumor data.\n3. reshape2 is an R package intended for reshaping and munging data, usable for restructuring brain tumor data.\n4. dplyr is an R package used for data manipulation tasks such as filtering and aggregating brain tumor data.\n5. caret is an R package designed for machine learning, and can be used for building predictive models in the context of pediatric brain tumors.",
    "llama-7b_fact": [
      "ggplot2 is an R package used for data visualization, including plots and charts of brain tumor data.",
      "RColorBrewer is an R package that provides color palettes for color-coding maps, applicable to brain tumor data.",
      "reshape2 is an R package intended for reshaping and munging data, usable for restructuring brain tumor data.",
      "dplyr is an R package used for data manipulation tasks such as filtering and aggregating brain tumor data.",
      "caret is an R package designed for machine learning, and can be used for building predictive models in the context of pediatric brain tumors."
    ]
  },
  {
    "id": 2246,
    "user_query": "You MUST give a detailed answer to the following question: Is NEMO a zinc finger protein?",
    "llama-7b_response": "No, NEMO (NF-B essential modulator) is not a zinc finger protein.\n\nZinc finger proteins are a class of proteins that contain zinc ions bound to amino acid residues in their structure, which allows them to recognize and bind to specific DNA or RNA sequences. Zinc finger proteins are known for their ability to regulate gene expression by binding to specific DNA sequences and modulating the activity of other proteins.\n\nNEMO, on the other hand, is a protein that plays a crucial role in the regulation of the NF-B signaling pathway. NF-B is a transcription factor that regulates the expression of genes involved in immune and inflammatory responses. NEMO acts as a negative regulator of NF-B by inhibiting its activation and preventing it from binding to DNA.\n\nWhile NEMO does not contain zinc finger domains, it does contain several other domains that are important for its function in regulating the NF-B signaling pathway. These domains include an N-terminal death domain, a central ring finger domain, and a C-terminal coiled-coil domain that interacts with other proteins to regulate NF-B activity.\n\nIn summary, while NEMO is not a zinc finger protein, it is an important regulator of the NF-B signaling pathway and plays a crucial role in the regulation of immune and inflammatory responses.",
    "llama-7b_fact_raw": "1. NEMO (NF-B essential modulator) is not a zinc finger protein.\n2. Zinc finger proteins have zinc ions bound to amino acid residues that help them bind to specific DNA or RNA sequences.\n3. NEMO plays a role in regulating the NF-B signaling pathway.\n4. NF-B is a transcription factor that regulates genes involved in immune and inflammatory responses.\n5. NEMO contains a death domain, a central ring finger domain, and a C-terminal coiled-coil domain.",
    "llama-7b_fact": [
      "NEMO (NF-B essential modulator) is not a zinc finger protein.",
      "Zinc finger proteins have zinc ions bound to amino acid residues that help them bind to specific DNA or RNA sequences.",
      "NEMO plays a role in regulating the NF-B signaling pathway.",
      "NF-B is a transcription factor that regulates genes involved in immune and inflammatory responses.",
      "NEMO contains a death domain, a central ring finger domain, and a C-terminal coiled-coil domain."
    ]
  },
  {
    "id": 2247,
    "user_query": "You MUST give a detailed answer to the following question: Does TFIIS affect nucleosome positioning?",
    "llama-7b_response": "Yes, TFIIS (Transcription Factor IIS) can affect nucleosome positioning. TFIIS is a general transcription factor that plays a crucial role in the initiation of RNA polymerase II-mediated transcription. It is involved in the formation of the pre-initiation complex, which is the first step in the transcription process.\n\nDuring the formation of the pre-initiation complex, TFIIS interacts with the RNA polymerase II holoenzyme and other transcription factors, such as TFIIE and TFIIB. This interaction helps to position the RNA polymerase II holoenzyme at the promoter region of the gene, where it can initiate transcription.\n\nIn addition to its role in positioning the RNA polymerase II holoenzyme, TFIIS can also affect nucleosome positioning. Nucleosomes are the basic units of chromatin, which consist of DNA wrapped around a core of histone proteins. The positioning of nucleosomes can affect the accessibility of the DNA to the RNA polymerase II holoenzyme and other transcription factors, which can in turn affect the rate and efficiency of transcription.\n\nTFIIS has been shown to interact with histone proteins, such as histone H1 and histone H3. These interactions can affect the positioning of nucleosomes and the accessibility of the DNA to the RNA polymerase II holoenzyme. For example, TFIIS has been shown to stimulate the dissociation of nucleosomes from the promoter region of the gene, which can increase the accessibility of the DNA to the RNA polymerase II holoenzyme and other transcription factors.\n\nIn summary, TFIIS can affect nucleosome positioning by interacting with histone proteins and stimulating the dissociation of nucleosomes from the promoter region of the gene, which can increase the accessibility of the DNA to the RNA polymerase II holoenzyme and other transcription factors. This, in turn, can affect the rate and efficiency of transcription.",
    "llama-7b_fact_raw": "1. TFIIS is involved in the formation of the pre-initiation complex, which is important for the initiation of RNA polymerase II-mediated transcription.\n2. TFIIS interacts with the RNA polymerase II holoenzyme and other transcription factors to help position the holoenzyme at the promoter region of a gene.\n3. Nucleosomes are composed of DNA wrapped around a core of histone proteins and are fundamental units of chromatin.\n4. The positioning of nucleosomes influences the accessibility of DNA to the RNA polymerase II holoenzyme and other transcription factors, impacting transcription rates and efficiency.\n5. TFIIS has been shown to stimulate the dissociation of nucleosomes from the promoter region of genes, thus potentially increasing DNA accessibility to transcriptional machinery.",
    "llama-7b_fact": [
      "TFIIS is involved in the formation of the pre-initiation complex, which is important for the initiation of RNA polymerase II-mediated transcription.",
      "TFIIS interacts with the RNA polymerase II holoenzyme and other transcription factors to help position the holoenzyme at the promoter region of a gene.",
      "Nucleosomes are composed of DNA wrapped around a core of histone proteins and are fundamental units of chromatin.",
      "The positioning of nucleosomes influences the accessibility of DNA to the RNA polymerase II holoenzyme and other transcription factors, impacting transcription rates and efficiency.",
      "TFIIS has been shown to stimulate the dissociation of nucleosomes from the promoter region of genes, thus potentially increasing DNA accessibility to transcriptional machinery."
    ]
  },
  {
    "id": 2262,
    "user_query": "You MUST give a detailed answer to the following question: Do origins of replication close to yeast centromeres fire early or late?",
    "llama-7b_response": "The question of whether origins of replication close to yeast centromeres fire early or late is an important one in the field of genetics and cell biology. The answer to this question has important implications for our understanding of how chromosomes are duplicated during the cell cycle, and how errors in this process can lead to genetic instability and the development of cancer.\n\nTo understand the answer to this question, it is first necessary to understand a bit about the process of DNA replication and the structure of chromosomes. During DNA replication, the double helix structure of DNA is unwound, and each strand of DNA is copied by an enzyme called DNA polymerase. The process of replication begins at specific points on the chromosome, known as origins of replication, and proceeds in the direction of the chromosome.\n\nIn yeast, as in many other organisms, the origins of replication are clustered near the centromere region of the chromosome. The centromere is a specialized region of the chromosome that plays a crucial role in the proper separation of chromosomes during cell division.\n\nThe question of whether origins of replication close to yeast centromeres fire early or late refers to the timing of the initiation of DNA replication at these origins. Do the origins of replication fire early, before the chromosomes reach the centromere, or do they fire late, after the chromosomes have reached the centromere?\n\nThe answer to this question is not straightforward, and has been the subject of much research in the field of genetics and cell biology. Some studies have suggested that origins of replication close to yeast centromeres fire early, before the chromosomes reach the centromere, while other studies have suggested that they fire late, after the chromosomes have reached the centromere.\n\nThe exact timing of replication initiation at origins of replication close to yeast centromeres is likely to depend on a variety of factors, including the structure of the chromosome, the activity of specific proteins that regulate replication, and the cellular environment in which replication is taking place.\n\nIn summary, the answer to the question of whether origins of replication close to yeast centromeres fire early",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 2268,
    "user_query": "You MUST give a detailed answer to the following question: Which are the properties of mammalian GA-sequences?",
    "llama-7b_response": "Mammalian GA-sequences are a type of non-coding RNA that have been identified in a wide range of mammalian tissues, including the brain, heart, liver, kidney, and pancreas. They are typically found in the cytoplasm of cells and are thought to play a role in regulating gene expression.\n\nOne of the key properties of mammalian GA-sequences is their length, which is typically between 200 and 400 nucleotides in length. They are also characterized by the presence of two distinct regions: a 5' untranslated region (UTR) and a 3' UTR. The 5' UTR is typically longer than the 3' UTR and is thought to play a role in regulating the stability and translation of the GA-sequence.\n\nAnother important property of mammalian GA-sequences is their ability to form complexes with other non-coding RNAs, including microRNAs (miRNAs) and small interfering RNAs (siRNAs). These complexes have been shown to play a role in regulating gene expression by targeting specific mRNAs for degradation or translational inhibition.\n\nIn addition to their role in regulating gene expression, mammalian GA-sequences have also been implicated in a number of other cellular processes, including cell differentiation, cell proliferation, and cell death. They have also been shown to play a role in the development of certain diseases, including cancer.\n\nOverall, the properties of mammalian GA-sequences make them an important and intriguing area of research, with potential applications in the development of new therapeutics for a wide range of diseases.",
    "llama-7b_fact_raw": "1. Mammalian GA-sequences are a type of non-coding RNA found in various tissues including the brain, heart, liver, kidney, and pancreas.\n2. The typical length of mammalian GA-sequences ranges between 200 and 400 nucleotides.\n3. Mammalian GA-sequences consist of two distinct regions: a longer 5' untranslated region (UTR) and a shorter 3' UTR.\n4. These sequences can form complexes with other non-coding RNAs such as microRNAs (miRNAs) and small interfering RNAs (siRNAs).\n5. Mammalian GA-sequences are implicated in cellular processes like differentiation, proliferation, and cell death, as well as in the development of diseases like cancer.",
    "llama-7b_fact": [
      "Mammalian GA-sequences are a type of non-coding RNA found in various tissues including the brain, heart, liver, kidney, and pancreas.",
      "The typical length of mammalian GA-sequences ranges between 200 and 400 nucleotides.",
      "Mammalian GA-sequences consist of two distinct regions: a longer 5' untranslated region (UTR) and a shorter 3' UTR.",
      "These sequences can form complexes with other non-coding RNAs such as microRNAs (miRNAs) and small interfering RNAs (siRNAs).",
      "Mammalian GA-sequences are implicated in cellular processes like differentiation, proliferation, and cell death, as well as in the development of diseases like cancer."
    ]
  },
  {
    "id": 2291,
    "user_query": "You MUST give a detailed answer to the following question: How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-7b_response": "The number of Groucho-related genes (GRG) contained in the mouse genome is not a fixed or well-defined quantity. The term \"Groucho-related genes\" can refer to a family of transcriptional repressors that share structural similarity with the Groucho protein, which is involved in regulating the expression of certain genes in the Drosophila melanogaster (fruit fly) and Caenorhabditis elegans (roundworm) genomes. However, the extent to which these genes are present and functional in the mouse genome is not well understood.\n\nThere are several genes in the mouse genome that have been identified as members of the Groucho family of transcriptional repressors, but the number of these genes can vary depending on the specific criteria used for identification. For example, some studies have identified as few as three Groucho-related genes in the mouse genome, while other studies have identified as many as nine Groucho-related genes.\n\nIn summary, the number of Groucho-related genes (GRG) contained in the mouse genome is not a fixed or well-defined quantity, and can vary depending on the specific criteria used for identification.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 2304,
    "user_query": "You MUST give a detailed answer to the following question: Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-7b_response": "RNA polymerase II is the enzyme responsible for transcribing DNA into RNA in eukaryotic cells. It is composed of multiple subunits, and one of these subunits, the RNA cleavage subunit, carries the RNA cleavage activity.\n\nThe RNA cleavage subunit of RNA polymerase II is called PTC1. PTC1 is a component of the RNA polymerase II holoenzyme, which is the active form of the enzyme that is responsible for transcribing DNA into RNA. PTC1 is involved in the process of transcription elongation, which is the phase of transcription where the RNA polymerase II holoenzyme moves along the DNA template and transcribes the genetic information into RNA.\n\nDuring transcription elongation, PTC1 interacts with the DNA template and with other components of the RNA polymerase II holoenzyme. It also plays a role in the process of transcription termination, which is the phase of transcription where the RNA polymerase II holoenzyme stops transcribing the DNA template and disassembles.\n\nIn summary, PTC1 is the RNA cleavage subunit of RNA polymerase II, and it is involved in the process of transcription elongation and transcription termination. It carries the RNA cleavage activity and is a key component of the RNA polymerase II holoenzyme, which is responsible for transcribing DNA into RNA in eukaryotic cells.",
    "llama-7b_fact_raw": "1. RNA polymerase II is responsible for transcribing DNA into RNA in eukaryotic cells.\n2. RNA polymerase II is composed of multiple subunits.\n3. The RNA cleavage subunit of RNA polymerase II is referred to as PTC1.\n4. PTC1 is involved in the process of transcription elongation.\n5. PTC1 also plays a role in the process of transcription termination.",
    "llama-7b_fact": [
      "RNA polymerase II is responsible for transcribing DNA into RNA in eukaryotic cells.",
      "RNA polymerase II is composed of multiple subunits.",
      "The RNA cleavage subunit of RNA polymerase II is referred to as PTC1.",
      "PTC1 is involved in the process of transcription elongation.",
      "PTC1 also plays a role in the process of transcription termination."
    ]
  },
  {
    "id": 2321,
    "user_query": "You MUST give a detailed answer to the following question: What is the genetic basis of Ohdo syndrome?",
    "llama-7b_response": "Ohdo syndrome is a rare genetic disorder that is characterized by a range of physical and developmental abnormalities. The genetic basis of Ohdo syndrome is complex and involves mutations in multiple genes.\n\nThe disorder is caused by mutations in the genes that encode for proteins involved in the development and function of various tissues and organs. Some of the genes that have been associated with Ohdo syndrome include:\n\n1. FGFR3: Fibroblast growth factor receptor 3 (FGFR3) is a protein that plays a crucial role in the development of bones and other tissues. Mutations in the FGFR3 gene have been identified in a significant proportion of patients with Ohdo syndrome. These mutations can lead to the formation of extra digits (polydactyly) and other skeletal abnormalities.\n2. PHOX2B: PHOX2B is a gene that encodes for a protein involved in the development of the respiratory system. Mutations in the PHOX2B gene have been associated with Ohdo syndrome, as they can lead to abnormal development of the lungs and other respiratory structures.\n3. KCNQ3: KCNQ3 is a gene that encodes for a protein involved in the function of heart muscle cells (cardiomyocytes). Mutations in the KCNQ3 gene have been associated with Ohdo syndrome, as they can lead to abnormal heart rhythms and other cardiac abnormalities.\n4. TBX1: TBX1 is a gene that encodes for a transcription factor involved in the development of various tissues and organs, including the heart, kidneys, and limbs. Mutations in the TBX1 gene have been associated with Ohdo syndrome, as they can lead to abnormal development of these structures.\n\nIn summary, the genetic basis of Ohdo syndrome involves mutations in multiple genes, including FGFR3, PHOX2B, KCNQ3, and TBX1. These mutations can disrupt the normal development and function of various tissues and organs, leading to the range of physical and developmental abnormalities characteristic of the disorder.",
    "llama-7b_fact_raw": "1. Ohdo syndrome is a rare genetic disorder characterized by a range of physical and developmental abnormalities.\n2. Mutations in the FGFR3 gene have been identified in patients with Ohdo syndrome and can lead to skeletal abnormalities like polydactyly.\n3. Mutations in the PHOX2B gene are associated with Ohdo syndrome and can affect the development of the respiratory system.\n4. Mutations in the KCNQ3 gene, related to Ohdo syndrome, can cause abnormal heart rhythms and other cardiac issues.\n5. TBX1 gene mutations are associated with Ohdo syndrome and can lead to abnormal development of the heart, kidneys, and limbs.",
    "llama-7b_fact": [
      "Ohdo syndrome is a rare genetic disorder characterized by a range of physical and developmental abnormalities.",
      "Mutations in the FGFR3 gene have been identified in patients with Ohdo syndrome and can lead to skeletal abnormalities like polydactyly.",
      "Mutations in the PHOX2B gene are associated with Ohdo syndrome and can affect the development of the respiratory system.",
      "Mutations in the KCNQ3 gene, related to Ohdo syndrome, can cause abnormal heart rhythms and other cardiac issues.",
      "TBX1 gene mutations are associated with Ohdo syndrome and can lead to abnormal development of the heart, kidneys, and limbs."
    ]
  },
  {
    "id": 2331,
    "user_query": "You MUST give a detailed answer to the following question: Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-7b_response": "One R/Bioconductor package that has been developed for the analysis of psychiatric disease genes is the \"PsychiatricGWAS\" package. This package provides tools for the analysis of genome-wide association studies (GWAS) of psychiatric disorders, including schizophrenia, bipolar disorder, and major depressive disorder.\n\nThe package includes functions for genotype imputation, association testing, and gene set analysis, as well as tools for visualizing and interpreting the results of these analyses. It also provides access to a large database of psychiatric GWAS data, which can be used to perform these analyses on a large scale.\n\nIn addition to the \"PsychiatricGWAS\" package, there are several other R/Bioconductor packages that may be useful for the analysis of psychiatric disease genes, including the \"rnaseqtest\" package for RNA sequencing data analysis, the \"edgeR\" package for gene expression analysis, and the \"limma\" package for microarray data analysis. These packages can be used in combination with the \"PsychiatricGWAS\" package to perform more comprehensive analyses of psychiatric disease genes.",
    "llama-7b_fact_raw": "1. The \"PsychiatricGWAS\" package is an R/Bioconductor package developed for the analysis of psychiatric disease genes.\n2. The \"PsychiatricGWAS\" package specifically caters to genome-wide association studies (GWAS) of psychiatric disorders such as schizophrenia, bipolar disorder, and major depressive disorder.\n3. Functions within the \"PsychiatricGWAS\" package allow for genotype imputation, association testing, and gene set analysis.\n4. The package \"PsychiatricGWAS\" includes tools for result visualization and interpretation.\n5. The \"PsychiatricGWAS\" package provides access to a large database of psychiatric GWAS data.",
    "llama-7b_fact": [
      "The \"PsychiatricGWAS\" package is an R/Bioconductor package developed for the analysis of psychiatric disease genes.",
      "The \"PsychiatricGWAS\" package specifically caters to genome-wide association studies (GWAS) of psychiatric disorders such as schizophrenia, bipolar disorder, and major depressive disorder.",
      "Functions within the \"PsychiatricGWAS\" package allow for genotype imputation, association testing, and gene set analysis.",
      "The package \"PsychiatricGWAS\" includes tools for result visualization and interpretation.",
      "The \"PsychiatricGWAS\" package provides access to a large database of psychiatric GWAS data."
    ]
  },
  {
    "id": 2360,
    "user_query": "You MUST give a detailed answer to the following question: Describe swirl sign in intracerebral hemorrhage.",
    "llama-7b_response": "A swirl sign in intracerebral hemorrhage (ICH) is a radiologic finding that is seen on computed tomography (CT) or magnetic resonance imaging (MRI) scans of the brain. It is characterized by a swirling pattern of blood within the hemisphere of the brain that is affected by the hemorrhage.\n\nThe swirl sign is caused by the movement of blood within the hemisphere as it spreads out from the site of the hemorrhage. This movement can cause the blood to appear as a swirling pattern on the CT or MRI scan. The swirl sign is typically seen in the early stages of ICH, before the hemorrhage has had a chance to expand significantly.\n\nThe swirl sign is an important radiologic finding because it can help diagnose ICH and guide treatment decisions. It is often used in conjunction with other radiologic findings, such as the location and size of the hemorrhage, to assess the severity of the injury and determine the best course of treatment.\n\nIn some cases, the swirl sign may be accompanied by other radiologic findings, such as midline shift or hematoma expansion. These findings can indicate a more severe injury and may require more aggressive treatment, such as surgical intervention.\n\nOverall, the swirl sign in ICH is an important radiologic finding that can help diagnose and assess the severity of this type of brain injury.",
    "llama-7b_fact_raw": "1. The swirl sign in intracerebral hemorrhage (ICH) is a radiologic finding that can be seen on computed tomography (CT) or magnetic resonance imaging (MRI) scans.\n2. This swirl sign is characterized by a pattern of blood that appears to be swirling within the affected hemisphere of the brain.\n3. It typically presents in the early stages of an ICH.\n4. The swirl sign is used to help diagnose ICH and make treatment decisions.\n5. Accompanying radiologic findings such as midline shift or hematoma expansion may indicate a more severe injury and could necessitate surgical intervention.",
    "llama-7b_fact": [
      "The swirl sign in intracerebral hemorrhage (ICH) is a radiologic finding that can be seen on computed tomography (CT) or magnetic resonance imaging (MRI) scans.",
      "This swirl sign is characterized by a pattern of blood that appears to be swirling within the affected hemisphere of the brain.",
      "It typically presents in the early stages of an ICH.",
      "The swirl sign is used to help diagnose ICH and make treatment decisions.",
      "Accompanying radiologic findings such as midline shift or hematoma expansion may indicate a more severe injury and could necessitate surgical intervention."
    ]
  },
  {
    "id": 2392,
    "user_query": "You MUST give a detailed answer to the following question: What induces Arabidopsis ROF1 expression?",
    "llama-7b_response": "ROF1 (Regulator of Flowering 1) is a transcription factor that plays a crucial role in the regulation of flowering time in Arabidopsis thaliana. ROF1 expression is regulated by various environmental and developmental cues, including light, temperature, and hormones such as auxin and cytokinin.\n\nOne of the key inducers of ROF1 expression is light. ROF1 is a photoreceptor that responds to both red and far-red light. Exposure to these wavelengths of light leads to an increase in ROF1 expression, which in turn regulates the expression of downstream genes involved in flowering time control.\n\nAnother inducer of ROF1 expression is temperature. ROF1 expression is induced by both high and low temperatures, with higher temperatures leading to a more rapid increase in ROF1 expression. This suggests that ROF1 may play a role in the acclimation of plants to changing environmental temperatures.\n\nIn addition to light and temperature, ROF1 expression can also be regulated by hormones such as auxin and cytokinin. For example, auxin has been shown to inhibit ROF1 expression, while cytokinin has been shown to induce ROF1 expression.\n\nOverall, the regulation of ROF1 expression is complex and involves the integration of multiple environmental and developmental cues. A better understanding of the regulatory mechanisms controlling ROF1 expression may provide insights into the control of flowering time and the regulation of plant growth and development.",
    "llama-7b_fact_raw": "1. ROF1 (Regulator of Flowering 1) is involved in the regulation of flowering time in Arabidopsis thaliana.\n2. Light, including both red and far-red wavelengths, induces the expression of ROF1.\n3. ROF1 expression in Arabidopsis thaliana can be induced by extremes in temperature.\n4. The hormone cytokinin has been shown to induce the expression of ROF1.\n5. Auxin has been reported to inhibit the expression of ROF1.",
    "llama-7b_fact": [
      "ROF1 (Regulator of Flowering 1) is involved in the regulation of flowering time in Arabidopsis thaliana.",
      "Light, including both red and far-red wavelengths, induces the expression of ROF1.",
      "ROF1 expression in Arabidopsis thaliana can be induced by extremes in temperature.",
      "The hormone cytokinin has been shown to induce the expression of ROF1.",
      "Auxin has been reported to inhibit the expression of ROF1."
    ]
  },
  {
    "id": 2398,
    "user_query": "You MUST give a detailed answer to the following question: What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-7b_response": "The most common cause of hereditary renal amyloidosis is transthyretin (TTR). Amyloidosis is a group of diseases characterized by the deposit of an abnormal protein called amyloid in various tissues and organs of the body. Hereditary renal amyloidosis is a type of amyloidosis that affects the kidneys and is passed down through families. TTR is a protein that is normally found in the blood and is involved in transporting thyroid hormone and retinol (vitamin A) throughout the body. In hereditary renal amyloidosis, mutations in the TTR gene cause the production of abnormal TTR protein that accumulates in the kidneys, leading to damage and eventually loss of kidney function. Treatment for hereditary renal amyloidosis typically involves managing symptoms and slowing the progression of the disease, as there is currently no cure for the condition.",
    "llama-7b_fact_raw": "1. Transthyretin (TTR) is the most common cause of hereditary renal amyloidosis.\n2. Amyloidosis is characterized by the deposit of an abnormal protein called amyloid in tissues and organs.\n3. Hereditary renal amyloidosis specifically affects the kidneys and is genetic.\n4. TTR protein is normally involved in transporting thyroid hormone and retinol (vitamin A).\n5. Mutations in the TTR gene can lead to the accumulation of abnormal TTR protein in the kidneys.",
    "llama-7b_fact": [
      "Transthyretin (TTR) is the most common cause of hereditary renal amyloidosis.",
      "Amyloidosis is characterized by the deposit of an abnormal protein called amyloid in tissues and organs.",
      "Hereditary renal amyloidosis specifically affects the kidneys and is genetic.",
      "TTR protein is normally involved in transporting thyroid hormone and retinol (vitamin A).",
      "Mutations in the TTR gene can lead to the accumulation of abnormal TTR protein in the kidneys."
    ]
  },
  {
    "id": 2407,
    "user_query": "You MUST give a detailed answer to the following question: Has the proteome of mice hippocampus been analysed?",
    "llama-7b_response": "Yes, the proteome of mice hippocampus has been analyzed. The hippocampus is a region of the brain that is critical for learning and memory, and studies have used a variety of techniques to identify and characterize the proteins present in this region of the mouse brain.\n\nOne approach to studying the proteome of the mouse hippocampus is to use mass spectrometry, which can be used to identify and quantify proteins present in a sample. This approach has been used in a number of studies to identify and characterize the proteins present in the mouse hippocampus.\n\nFor example, one study used mass spectrometry to identify over 3,000 proteins present in the mouse hippocampus, including both known and novel proteins. The study also used bioinformatics tools to analyze the data and identify potential functions for many of the proteins identified.\n\nAnother study used a similar approach to identify over 2,000 proteins present in the mouse hippocampus, and also used bioinformatics tools to analyze the data and identify potential roles for many of the proteins identified.\n\nOverall, these studies have provided a wealth of information about the proteins present in the mouse hippocampus, and have helped to advance our understanding of the molecular mechanisms underlying learning and memory.",
    "llama-7b_fact_raw": "1. The proteome of the mouse hippocampus has been analyzed using various techniques.\n2. Mass spectrometry is one of the techniques used to study the mouse hippocampus proteome.\n3. Over 3,000 proteins have been identified in the mouse hippocampus in one study using mass spectrometry.\n4. Another study using mass spectrometry identified over 2,000 proteins in the mouse hippocampus.\n5. Bioinformatics tools have been used in conjunction with mass spectrometry to analyze proteins and identify potential functions in the mouse hippocampus.",
    "llama-7b_fact": [
      "The proteome of the mouse hippocampus has been analyzed using various techniques.",
      "Mass spectrometry is one of the techniques used to study the mouse hippocampus proteome.",
      "Over 3,000 proteins have been identified in the mouse hippocampus in one study using mass spectrometry.",
      "Another study using mass spectrometry identified over 2,000 proteins in the mouse hippocampus.",
      "Bioinformatics tools have been used in conjunction with mass spectrometry to analyze proteins and identify potential functions in the mouse hippocampus."
    ]
  },
  {
    "id": 2409,
    "user_query": "You MUST give a detailed answer to the following question: Are mouse chromosomes acrocentric?",
    "llama-7b_response": "No, mouse chromosomes are not acrocentric.\n\nAcrocentric chromosomes are a type of chromosome that have their centromeres located towards the ends of the chromosome rather than in the middle. This is in contrast to metacentric chromosomes, which have their centromeres located in the middle of the chromosome.\n\nIn the mouse genome, there are 20 autosomal chromosomes and two sex chromosomes (X and Y). The centromeres of the mouse autosomal chromosomes are located in the middle of each chromosome, which is consistent with the definition of metacentric chromosomes. Therefore, mouse chromosomes are not acrocentric.",
    "llama-7b_fact_raw": "1. Mouse chromosomes are not acrocentric.\n2. Acrocentric chromosomes have their centromeres located towards the ends of the chromosome.\n3. Metacentric chromosomes have their centromeres located in the middle of the chromosome.\n4. The mouse genome contains 20 autosomal chromosomes.\n5. The mouse genome includes two sex chromosomes, X and Y.",
    "llama-7b_fact": [
      "Mouse chromosomes are not acrocentric.",
      "Acrocentric chromosomes have their centromeres located towards the ends of the chromosome.",
      "Metacentric chromosomes have their centromeres located in the middle of the chromosome.",
      "The mouse genome contains 20 autosomal chromosomes.",
      "The mouse genome includes two sex chromosomes, X and Y."
    ]
  },
  {
    "id": 2417,
    "user_query": "You MUST give a detailed answer to the following question: Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-7b_response": "One siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer is GSK2879552.\n\nGSK2879552 is an RNA interference (RNAi) therapeutic candidate that is being developed by GlaxoSmithKline (GSK) for the treatment of various types of cancer, including pancreatic cancer. The drug works by using small interfering RNA (siRNA) molecules to silence specific genes that are involved in the growth and survival of cancer cells.\n\nGSK2879552 has shown promising results in preclinical studies, and it is currently being tested in phase 1 and phase 2 clinical trials for the treatment of various types of solid tumors, including pancreatic cancer. In these trials, the drug is being administered intravenously to patients with advanced or metastatic cancer.\n\nSo far, the results of the clinical trials have been encouraging, with some patients experiencing partial or complete responses to the treatment. However, more research is needed to fully understand the safety and efficacy of GSK2879552 for the treatment of pancreatic cancer, and the drug is not yet approved for use in patients.",
    "llama-7b_fact_raw": "1. GSK2879552 is an siRNA-based drug in clinical trials for the treatment of pancreatic cancer.\n2. The drug is developed by GlaxoSmithKline (GSK).\n3. GSK2879552 uses small interfering RNA (siRNA) molecules to silence genes involved in cancer cell growth and survival.\n4. The drug is currently being tested in phase 1 and phase 2 clinical trials for various types of solid tumors, including pancreatic cancer.\n5. GSK2879552 is administered intravenously to patients with advanced or metastatic cancer in the trials.",
    "llama-7b_fact": [
      "GSK2879552 is an siRNA-based drug in clinical trials for the treatment of pancreatic cancer.",
      "The drug is developed by GlaxoSmithKline (GSK).",
      "GSK2879552 uses small interfering RNA (siRNA) molecules to silence genes involved in cancer cell growth and survival.",
      "The drug is currently being tested in phase 1 and phase 2 clinical trials for various types of solid tumors, including pancreatic cancer.",
      "GSK2879552 is administered intravenously to patients with advanced or metastatic cancer in the trials."
    ]
  },
  {
    "id": 2419,
    "user_query": "You MUST give a detailed answer to the following question: What is the HPG pore?",
    "llama-7b_response": "The HPG (hypothalamus-pituitary-gonadal) axis is a system of hormonal communication between the hypothalamus, pituitary gland, and gonads (ovaries or testes) that regulates reproductive processes and other physiological functions. The HPG pore is a hypothetical structure that is thought to exist in the hypothalamus and regulate the release of hormones into the bloodstream.\n\nThe hypothalamus is a region of the brain that plays a key role in the regulation of many bodily functions, including reproductive processes. The hypothalamus produces hormones that regulate the release of gonadotropin-releasing hormone (GnRH) from the pituitary gland. GnRH is a peptide hormone that stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland, which in turn stimulate the ovaries or testes to produce sex hormones.\n\nThe HPG pore is a hypothetical structure that is thought to exist in the hypothalamus and regulate the release of hormones into the bloodstream. It is believed that the HPG pore opens and closes in response to various stimuli, allowing hormones to be released into the bloodstream and regulate reproductive processes and other physiological functions. However, there is currently no scientific evidence to support the existence of the HPG pore.",
    "llama-7b_fact_raw": "1. The HPG axis involves communication between the hypothalamus, pituitary gland, and gonads.\n2. The hypothalamus plays a key role in regulating reproductive processes.\n3. The hypothalamus produces hormones that regulate the release of gonadotropin-releasing hormone (GnRH).\n4. Gonadotropin-releasing hormone (GnRH) stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland.\n5. The HPG pore is described as a hypothetical structure purported to regulate the release of hormones into the bloodstream from the hypothalamus.",
    "llama-7b_fact": [
      "The HPG axis involves communication between the hypothalamus, pituitary gland, and gonads.",
      "The hypothalamus plays a key role in regulating reproductive processes.",
      "The hypothalamus produces hormones that regulate the release of gonadotropin-releasing hormone (GnRH).",
      "Gonadotropin-releasing hormone (GnRH) stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland.",
      "The HPG pore is described as a hypothetical structure purported to regulate the release of hormones into the bloodstream from the hypothalamus."
    ]
  },
  {
    "id": 2472,
    "user_query": "You MUST give a detailed answer to the following question: What is the 959 Nematode Genomes initiative?",
    "llama-7b_response": "The 959 Nematode Genomes initiative is a large-scale project aimed at sequencing and analyzing the genomes of 959 species of roundworms, also known as nematodes. Nematodes are a diverse group of microscopic worms that are found in a wide range of environments, including soil, water, and the guts of animals. They are one of the most species-rich phyla of animals, with over 100,000 known species.\n\nThe 959 Nematode Genomes initiative is a collaborative effort between researchers from around the world, with the goal of creating a comprehensive resource for the study of nematode biology and evolution. The project involves sequencing the genomes of a representative sample of nematode species, using a combination of next-generation sequencing technologies and traditional Sanger sequencing. The sequenced genomes are then analyzed using a variety of computational methods, including comparative genomics, transcriptomics, and functional annotation.\n\nThe 959 Nematode Genomes initiative is expected to have a significant impact on our understanding of nematode biology and evolution. By analyzing the genomes of a diverse set of nematode species, researchers hope to identify conserved genes and functional modules that are shared across different species, as well as genes that are specific to individual species or groups of species. This information will be used to gain insights into the evolutionary history of nematodes, as well as to identify potential targets for the development of new drugs and other applications.\n\nOverall, the 959 Nematode Genomes initiative is a landmark project that will provide a valuable resource for the study of nematode biology and evolution, with implications for a wide range of fields, including medicine, agriculture, and ecology.",
    "llama-7b_fact_raw": "1. The 959 Nematode Genomes initiative aims to sequence and analyze the genomes of 959 species of roundworms, also known as nematodes.\n2. Nematodes are found in a wide range of environments and there are over 100,000 known species of them.\n3. The initiative is a collaborative project involving researchers from around the world.\n4. Researchers are using a combination of next-generation sequencing technologies and traditional Sanger sequencing for the project.\n5. The goal of the 959 Nematode Genomes initiative is to provide insights into nematode biology and evolution, which may have implications for medicine, agriculture, and ecology.",
    "llama-7b_fact": [
      "The 959 Nematode Genomes initiative aims to sequence and analyze the genomes of 959 species of roundworms, also known as nematodes.",
      "Nematodes are found in a wide range of environments and there are over 100,000 known species of them.",
      "The initiative is a collaborative project involving researchers from around the world.",
      "Researchers are using a combination of next-generation sequencing technologies and traditional Sanger sequencing for the project.",
      "The goal of the 959 Nematode Genomes initiative is to provide insights into nematode biology and evolution, which may have implications for medicine, agriculture, and ecology."
    ]
  },
  {
    "id": 2557,
    "user_query": "You MUST give a detailed answer to the following question: Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-7b_response": "There are several R packages that have been developed for analyzing Non-invasive prenatal testing (NIPT) data. Some of the most popular ones include:\n\n1. \"NIPT\" package: This package provides functions for analyzing and visualizing data from non-invasive prenatal testing. It includes functions for imputation of missing data, quality control, and statistical analysis of the data.\n2. \"NIPT-R\" package: This package provides functions for analyzing and visualizing data from non-invasive prenatal testing using R. It includes functions for imputation of missing data, quality control, and statistical analysis of the data.\n3. \"NIPTdata\" package: This package provides functions for analyzing and visualizing data from non-invasive prenatal testing using R. It includes functions for imputation of missing data, quality control, and statistical analysis of the data.\n4. \"NIPT-R\" package: This package provides functions for analyzing and visualizing data from non-invasive prenatal testing using R. It includes functions for imputation of missing data, quality control, and statistical analysis of the data.\n5. \"NIPTdata\" package: This package provides functions for analyzing and visualizing data from non-invasive prenatal testing using R. It includes functions for imputation of missing data, quality control, and statistical analysis of the data.\n6. \"NIPT-R\" package: This package provides functions for analyzing and visualizing data from non-invasive prenatal testing using R. It includes functions for imputation of missing data, quality control, and statistical analysis of the data.\n7. \"NIPTdata\" package: This package provides functions for analyzing and visualizing data from non-invasive prenatal testing using R. It includes functions for imputation of missing data, quality control, and statistical analysis of the data.\n8. \"NIPT-R\" package: This package provides functions for analyzing and visualizing data from non-invasive prenatal testing using R. It includes functions for imputation of missing data, quality control, and statistical analysis of the data.\n9. \"NIPTdata\" package: This package provides functions for analyzing and visualizing data from non-invasive prenatal testing using",
    "llama-7b_fact_raw": "1. The \"NIPT\" R package has been developed for analyzing and visualizing Non-invasive prenatal testing (NIPT) data.\n2. The \"NIPT\" R package includes functions for imputation of missing data.\n3. The \"NIPT\" R package provides functions for quality control.\n4. The \"NIPT\" R package offers statistical analysis functions for NIPT data.\n5. The \"NIPTdata\" R package has been developed for analyzing and visualizing Non-invasive prenatal testing (NIPT) data.",
    "llama-7b_fact": [
      "The \"NIPT\" R package has been developed for analyzing and visualizing Non-invasive prenatal testing (NIPT) data.",
      "The \"NIPT\" R package includes functions for imputation of missing data.",
      "The \"NIPT\" R package provides functions for quality control.",
      "The \"NIPT\" R package offers statistical analysis functions for NIPT data.",
      "The \"NIPTdata\" R package has been developed for analyzing and visualizing Non-invasive prenatal testing (NIPT) data."
    ]
  },
  {
    "id": 2560,
    "user_query": "You MUST give a detailed answer to the following question: Describe Achenbachs syndrome.",
    "llama-7b_response": "Achenbach's syndrome, also known as Achenbach's triad, is a rare neurological disorder characterized by a triad of symptoms, including hemiparesis (weakness on one side of the body), ataxia (lack of coordination and balance), and cerebellar signs such as dysarthria (speech difficulties) and nystagmus (rapid, involuntary eye movements).\n\nThe syndrome is named after German neurologist August Achenbach, who first described it in 1881. It is believed to be caused by a lesion or injury to the cerebellum, which is a part of the brain responsible for coordination and balance.\n\nThe symptoms of Achenbach's syndrome can vary in severity and may be accompanied by other neurological symptoms such as dizziness, headache, and difficulty with speech and swallowing. The syndrome can occur at any age, but it is more common in older adults.\n\nDiagnosis of Achenbach's syndrome typically involves a thorough neurological examination, including tests to assess coordination, balance, and speech. Imaging tests such as MRI or CT scans may also be used to identify any lesions or other abnormalities in the brain.\n\nTreatment for Achenbach's syndrome typically focuses on managing symptoms and improving function. Physical therapy and rehabilitation may be helpful in improving coordination and balance, while medications may be used to manage symptoms such as dizziness and headache. In some cases, surgery may be necessary to treat a specific underlying cause of the syndrome.",
    "llama-7b_fact_raw": "1. Achenbach's syndrome is characterized by hemiparesis, ataxia, and cerebellar signs like dysarthria and nystagmus.\n2. August Achenbach, a German neurologist, is credited with the first description of Achenbach's syndrome in 1881.\n3. The suspected cause of Achenbach's syndrome is a lesion or injury to the cerebellum.\n4. Achenbach's syndrome can manifest with varying severity and may include additional symptoms like dizziness, headache, and difficulties with speech and swallowing.\n5. Treatment for Achenbach's syndrome may involve physical therapy, medications, and potentially surgery to address an underlying cause.",
    "llama-7b_fact": [
      "Achenbach's syndrome is characterized by hemiparesis, ataxia, and cerebellar signs like dysarthria and nystagmus.",
      "August Achenbach, a German neurologist, is credited with the first description of Achenbach's syndrome in 1881.",
      "The suspected cause of Achenbach's syndrome is a lesion or injury to the cerebellum.",
      "Achenbach's syndrome can manifest with varying severity and may include additional symptoms like dizziness, headache, and difficulties with speech and swallowing.",
      "Treatment for Achenbach's syndrome may involve physical therapy, medications, and potentially surgery to address an underlying cause."
    ]
  },
  {
    "id": 2581,
    "user_query": "You MUST give a detailed answer to the following question: Which algorithm is used for detection of long repeat expansions?",
    "llama-7b_response": "There are several algorithms that can be used for the detection of long repeat expansions. One such algorithm is the \"sliding window\" approach.\n\nIn this approach, a window of DNA sequence is scanned for the presence of the repeat sequence. The window is moved along the DNA sequence one nucleotide at a time, and for each nucleotide, the repeat sequence is compared to the DNA sequence in the window. If the repeat sequence matches the DNA sequence in the window, the window is incremented by one nucleotide and the process is repeated. If the repeat sequence does not match the DNA sequence in the window, the window is not incremented and the process is repeated for the next nucleotide.\n\nOnce the entire DNA sequence has been scanned, the size of the repeat expansion can be determined by counting the number of nucleotides in the window that match the repeat sequence. If the repeat expansion is shorter than a certain threshold, it is considered to be normal. If the repeat expansion is longer than the threshold, it is considered to be pathological and may indicate a genetic disorder.\n\nAnother algorithm that can be used for the detection of long repeat expansions is the \"markov model\".\n\nIn this approach, a Markov model is constructed using the repeat sequence and the surrounding DNA sequence. The Markov model represents the probability of each nucleotide at each position in the repeat sequence and the surrounding DNA sequence. The Markov model is then used to scan the DNA sequence for the presence of the repeat sequence.\n\nFor each nucleotide in the DNA sequence, the probability of that nucleotide being present in the repeat sequence is calculated using the Markov model. If the probability of the nucleotide being present in the repeat sequence is greater than a certain threshold, it is considered to be part of the repeat expansion and the process is repeated for the next nucleotide. If the probability of the nucleotide being present in the repeat sequence is less than the threshold, it is considered to be part of the surrounding DNA sequence and the process is repeated for the next nucleotide.\n\nOnce the entire DNA sequence has been scanned, the size of the repeat expansion can be determined by counting the number of nucleotides in the DNA sequence that match the repeat sequence. If the repeat expansion is shorter than a certain threshold, it is considered to be normal. If the repeat expansion is longer than the threshold, it is considered",
    "llama-7b_fact_raw": "1. The \"sliding window\" approach is an algorithm used for the detection of long repeat expansions in DNA sequences.\n2. In the \"sliding window\" approach, a DNA sequence window is compared to a repeat sequence one nucleotide at a time.\n3. A Markov model can also be used to detect long repeat expansions by representing the probability of each nucleotide at each position in the repeat sequence and the surrounding DNA sequence.\n4. The size of a repeat expansion is considered pathological if it is longer than a certain threshold, indicating a possible genetic disorder.\n5. Both the \"sliding window\" approach and the Markov model involve scanning the entire DNA sequence to determine the size of the repeat expansion.",
    "llama-7b_fact": [
      "The \"sliding window\" approach is an algorithm used for the detection of long repeat expansions in DNA sequences.",
      "In the \"sliding window\" approach, a DNA sequence window is compared to a repeat sequence one nucleotide at a time.",
      "A Markov model can also be used to detect long repeat expansions by representing the probability of each nucleotide at each position in the repeat sequence and the surrounding DNA sequence.",
      "The size of a repeat expansion is considered pathological if it is longer than a certain threshold, indicating a possible genetic disorder.",
      "Both the \"sliding window\" approach and the Markov model involve scanning the entire DNA sequence to determine the size of the repeat expansion."
    ]
  },
  {
    "id": 2582,
    "user_query": "You MUST give a detailed answer to the following question: Which brain tumors does neuroligin-3 promote?",
    "llama-7b_response": "Neuroligin-3 is a protein that has been implicated in the development and progression of various types of brain tumors, including gliomas. Gliomas are a type of brain tumor that arise from glial cells, which are supportive cells in the brain that help to maintain its structure and function.\n\nNeuroligin-3 has been found to be overexpressed in a number of different types of gliomas, including astrocytomas, oligodendrogliomas, and ependymomas. These tumors are characterized by the abnormal proliferation of glial cells, and the overexpression of neuroligin-3 has been shown to promote the growth and survival of these cells.\n\nIn addition to promoting the growth of gliomas, neuroligin-3 has also been implicated in the development of other types of brain tumors, such as meningiomas and schwannomas. However, the role of neuroligin-3 in the development and progression of these tumors is not as well understood as it is in gliomas.\n\nOverall, the overexpression of neuroligin-3 has been implicated in the development and progression of a number of different types of brain tumors, including gliomas, meningiomas, and schwannomas. Further research is needed to fully understand the role of neuroligin-3 in the development and progression of these tumors, and to identify potential therapeutic targets for the treatment of brain tumors.",
    "llama-7b_fact_raw": "1. Neuroligin-3 is implicated in the development and progression of various types of brain tumors.\n2. Gliomas are brain tumors that arise from glial cells.\n3. Types of gliomas where neuroligin-3 is overexpressed include astrocytomas, oligodendrogliomas, and ependymomas.\n4. Overexpression of neuroligin-3 promotes the growth and survival of glial cells in gliomas.\n5. Neuroligin-3 has also been implicated in the development of brain tumors such as meningiomas and schwannomas.",
    "llama-7b_fact": [
      "Neuroligin-3 is implicated in the development and progression of various types of brain tumors.",
      "Gliomas are brain tumors that arise from glial cells.",
      "Types of gliomas where neuroligin-3 is overexpressed include astrocytomas, oligodendrogliomas, and ependymomas.",
      "Overexpression of neuroligin-3 promotes the growth and survival of glial cells in gliomas.",
      "Neuroligin-3 has also been implicated in the development of brain tumors such as meningiomas and schwannomas."
    ]
  },
  {
    "id": 2586,
    "user_query": "You MUST give a detailed answer to the following question: What is the approximate size of gas vesicles?",
    "llama-7b_response": "Gas vacuoles, also known as gas vesicles, are small, gas-filled organelles found in some bacteria and archaea. Their size can vary depending on the species of bacteria or archaea and can range from a few nanometers to several micrometers in diameter. In general, gas vacuoles are relatively small compared to the size of the bacterial cell, but they can still have a significant impact on the overall size and shape of the cell.",
    "llama-7b_fact_raw": "1. Gas vesicles are found in some bacteria and archaea.\n2. Gas vesicles can range from a few nanometers to several micrometers in diameter.\n3. The size of gas vesicles can vary depending on the species of bacteria or archaea.\n4. Gas vesicles are small compared to the size of the bacterial cell.\n5. Gas vesicles can have a significant impact on the overall size and shape of the cell.",
    "llama-7b_fact": [
      "Gas vesicles are found in some bacteria and archaea.",
      "Gas vesicles can range from a few nanometers to several micrometers in diameter.",
      "The size of gas vesicles can vary depending on the species of bacteria or archaea.",
      "Gas vesicles are small compared to the size of the bacterial cell.",
      "Gas vesicles can have a significant impact on the overall size and shape of the cell."
    ]
  },
  {
    "id": 2589,
    "user_query": "You MUST give a detailed answer to the following question: List BET proteins.",
    "llama-7b_response": "BET (Bromodomain and Extra-terminal domain) proteins are a family of epigenetic regulators that play a crucial role in the regulation of gene expression. They are characterized by the presence of two distinct domains: the bromodomain, which recognizes acetylated lysine residues on histone tails, and the extra-terminal (ET) domain, which is involved in protein-protein interactions and transcriptional regulation.\n\nThe BET protein family includes:\n\n1. BRD2 (Bromodomain and Extra-terminal domain 2)\n2. BRD3 (Bromodomain and Extra-terminal domain 3)\n3. BRD4 (Bromodomain and Extra-terminal domain 4)\n4. BAP1 (Bromodomain and Extra-terminal domain containing protein 1)\n5. BAP3 (Bromodomain and Extra-terminal domain containing protein 3)\n6. BAP2 (Bromodomain and Extra-terminal domain containing protein 2)\n7. BAP4 (Bromodomain and Extra-terminal domain containing protein 4)\n8. BAP5 (Bromodomain and Extra-terminal domain containing protein 5)\n9. BAP6 (Bromodomain and Extra-terminal domain containing protein 6)\n10. BAP7 (Bromodomain and Extra-terminal domain containing protein 7)\n11. BAP8 (Bromodomain and Extra-terminal domain containing protein 8)\n12. BAP9 (Bromodomain and Extra-terminal domain containing protein 9)\n13. BAP10 (Bromodomain and Extra-terminal domain containing protein 10)\n14. BAP11 (Bromodomain and Extra-terminal domain containing protein 11)\n15. BAP12 (Bromodomain and Extra-terminal domain containing protein 12)\n16. BAP13 (Bromodomain and Extra-terminal domain containing protein 13)\n17",
    "llama-7b_fact_raw": "1. BRD2, BRD3, and BRD4 are members of the BET protein family.\n2. BET proteins are epigenetic regulators involved in the regulation of gene expression.\n3. BET proteins are characterized by the presence of a bromodomain and an extra-terminal (ET) domain.\n4. The bromodomain of BET proteins recognizes acetylated lysine residues on histone tails.\n5. The extra-terminal (ET) domain of BET proteins is involved in protein-protein interactions and transcriptional regulation.",
    "llama-7b_fact": [
      "BRD2, BRD3, and BRD4 are members of the BET protein family.",
      "BET proteins are epigenetic regulators involved in the regulation of gene expression.",
      "BET proteins are characterized by the presence of a bromodomain and an extra-terminal (ET) domain.",
      "The bromodomain of BET proteins recognizes acetylated lysine residues on histone tails.",
      "The extra-terminal (ET) domain of BET proteins is involved in protein-protein interactions and transcriptional regulation."
    ]
  },
  {
    "id": 2610,
    "user_query": "You MUST give a detailed answer to the following question: Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-7b_response": "There are several algorithms that have been developed for the prediction of protein subcellular localization using deep learning. Some of the most popular ones include:\n\n1. DeepSubella: This is a deep learning-based algorithm that uses a convolutional neural network (CNN) to predict the subcellular localization of proteins. The algorithm was developed by Li et al. in 2017 and has been shown to be highly accurate in predicting the subcellular localization of proteins.\n2. DeepLocal: This is another deep learning-based algorithm that uses a CNN to predict the subcellular localization of proteins. The algorithm was developed by Li et al. in 2016 and has been shown to be highly accurate in predicting the subcellular localization of proteins.\n3. SMALLE: This is a deep learning-based algorithm that uses a recurrent neural network (RNN) to predict the subcellular localization of proteins. The algorithm was developed by Wang et al. in 2018 and has been shown to be highly accurate in predicting the subcellular localization of proteins.\n4. DeepSub: This is a deep learning-based algorithm that uses a CNN to predict the subcellular localization of proteins. The algorithm was developed by Li et al. in 2015 and has been shown to be highly accurate in predicting the subcellular localization of proteins.\n\nOverall, these algorithms have been shown to be highly accurate in predicting the subcellular localization of proteins and have the potential to revolutionize the field of protein subcellular localization prediction.",
    "llama-7b_fact_raw": "1. The DeepSubella algorithm utilizes a convolutional neural network (CNN) for predicting protein subcellular localization and was developed by Li et al. in 2017.\n2. DeepLocal is an algorithm that also uses a CNN for the prediction of protein subcellular localization; it was created by Li et al. in 2016.\n3. The SMALLE algorithm, developed by Wang et al. in 2018, employs a recurrent neural network (RNN) for predicting protein subcellular localization.\n4. DeepSub is a predictive algorithm using a CNN for protein subcellular localization, developed by Li et al. in 2015.\n5. These deep learning-based algorithms have been reported to have high accuracy in protein subcellular localization prediction.",
    "llama-7b_fact": [
      "The DeepSubella algorithm utilizes a convolutional neural network (CNN) for predicting protein subcellular localization and was developed by Li et al. in 2017.",
      "DeepLocal is an algorithm that also uses a CNN for the prediction of protein subcellular localization; it was created by Li et al. in 2016.",
      "The SMALLE algorithm, developed by Wang et al. in 2018, employs a recurrent neural network (RNN) for predicting protein subcellular localization.",
      "DeepSub is a predictive algorithm using a CNN for protein subcellular localization, developed by Li et al. in 2015.",
      "These deep learning-based algorithms have been reported to have high accuracy in protein subcellular localization prediction."
    ]
  },
  {
    "id": 2634,
    "user_query": "You MUST give a detailed answer to the following question: What is MULTOVL?",
    "llama-7b_response": "I'm sorry, but I am not familiar with the term \"MULTOVL.\" Can you provide more context or information about what you are asking?",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 2660,
    "user_query": "You MUST give a detailed answer to the following question: Can GDF15 be a biomarker for metformin treatment?",
    "llama-7b_response": "GDF15, also known as growth differentiation factor 15, is a protein that has been studied as a potential biomarker for various conditions, including diabetes. Metformin is a commonly used medication for treating type 2 diabetes, and it has been suggested that GDF15 may be a biomarker for the effectiveness of metformin treatment. However, the relationship between GDF15 and metformin treatment is complex and not yet fully understood.\n\nStudies have shown that metformin can reduce levels of GDF15 in the blood of people with type 2 diabetes. This suggests that metformin may be able to lower GDF15 levels by improving insulin sensitivity and glucose control. Lower levels of GDF15 have also been associated with improved insulin sensitivity and glucose control in people with type 2 diabetes, which further supports the idea that GDF15 may be a biomarker for the effectiveness of metformin treatment.\n\nHowever, the relationship between GDF15 and metformin treatment is not always consistent. Some studies have found no association between GDF15 levels and the effectiveness of metformin treatment, while others have found conflicting results. Additionally, the relationship between GDF15 and metformin treatment may vary depending on the individual and the stage of diabetes.\n\nOverall, while GDF15 has been studied as a potential biomarker for the effectiveness of metformin treatment, the relationship between the two is complex and not yet fully understood. Further research is needed to clarify the role of GDF15 as a biomarker for metformin treatment.",
    "llama-7b_fact_raw": "1. GDF15 stands for growth differentiation factor 15.\n2. Metformin is commonly used for treating type 2 diabetes.\n3. Studies have shown that metformin can reduce levels of GDF15 in the blood of people with type 2 diabetes.\n4. Lower levels of GDF15 have been associated with improved insulin sensitivity and glucose control in people with type 2 diabetes.\n5. The relationship between GDF15 and the effectiveness of metformin treatment is not consistently observed across studies.",
    "llama-7b_fact": [
      "GDF15 stands for growth differentiation factor 15.",
      "Metformin is commonly used for treating type 2 diabetes.",
      "Studies have shown that metformin can reduce levels of GDF15 in the blood of people with type 2 diabetes.",
      "Lower levels of GDF15 have been associated with improved insulin sensitivity and glucose control in people with type 2 diabetes.",
      "The relationship between GDF15 and the effectiveness of metformin treatment is not consistently observed across studies."
    ]
  },
  {
    "id": 2664,
    "user_query": "You MUST give a detailed answer to the following question: Is recursive splicing more common in short introns?",
    "llama-7b_response": "Recursive splicing is a process in which an intron is spliced out of an mRNA molecule and then spliced back into the same mRNA molecule, resulting in the creation of a new mRNA molecule with the intron removed. Recursive splicing can occur in both short and long introns, and the frequency of recursive splicing is not necessarily higher in short introns compared to long introns.\n\nThe frequency of recursive splicing is influenced by several factors, including the length of the intron, the presence of regulatory elements within the intron, and the presence of other splicing events in the vicinity of the intron. Short introns may be more prone to recursive splicing if they contain regulatory elements that promote splicing, or if they are located in close proximity to other splicing events that require the removal and reinsertion of the intron.\n\nHowever, the frequency of recursive splicing is also influenced by the overall splicing efficiency of the mRNA molecule, which can vary depending on factors such as the abundance of splicing machinery, the stability of the mRNA molecule, and the presence of alternative splicing events. In general, recursive splicing is more likely to occur in mRNA molecules with high splicing efficiency, regardless of the length of the intron.\n\nIn summary, while recursive splicing can occur in both short and long introns, the frequency of recursive splicing is not necessarily higher in short introns compared to long introns. The frequency of recursive splicing is influenced by several factors, including the length of the intron, the presence of regulatory elements, and the overall splicing efficiency of the mRNA molecule.",
    "llama-7b_fact_raw": "1. Recursive splicing is a process where an intron is spliced out of mRNA and then spliced back into the same mRNA molecule.\n2. The frequency of recursive splicing is not necessarily higher in short introns compared to long introns.\n3. Factors that influence recursive splicing include intron length, presence of regulatory elements within the intron, and nearby splicing events.\n4. Short introns may be more prone to recursive splicing if they contain regulatory elements that promote splicing or are close to other splicing events.\n5. The overall splicing efficiency of the mRNA molecule affects the likelihood of recursive splicing occurring.",
    "llama-7b_fact": [
      "Recursive splicing is a process where an intron is spliced out of mRNA and then spliced back into the same mRNA molecule.",
      "The frequency of recursive splicing is not necessarily higher in short introns compared to long introns.",
      "Factors that influence recursive splicing include intron length, presence of regulatory elements within the intron, and nearby splicing events.",
      "Short introns may be more prone to recursive splicing if they contain regulatory elements that promote splicing or are close to other splicing events.",
      "The overall splicing efficiency of the mRNA molecule affects the likelihood of recursive splicing occurring."
    ]
  },
  {
    "id": 2679,
    "user_query": "You MUST give a detailed answer to the following question: What is the TALE-iD method used for?",
    "llama-7b_response": "The TALE-iD (Transcription Activator-Like Effector (TALE) proteins for the Identification of Disease-associated Variants) method is used for the identification of disease-associated variants in the human genome.\n\nTALE proteins are engineered DNA-binding proteins that can recognize specific DNA sequences with high specificity and affinity. The TALE-iD method uses TALE proteins to selectively bind to regions of the genome that contain disease-associated variants, such as single nucleotide polymorphisms (SNPs) or copy number variations (CNVs).\n\nThe TALE-iD method involves the following steps:\n\n1. Design of TALE proteins: TALE proteins are designed to recognize specific DNA sequences, such as those found in disease-associated variants.\n2. Target enrichment: The genome is targeted for enrichment using the TALE-protein-bound probes. This allows for the selective capture of regions of the genome that contain disease-associated variants.\n3. Sequencing: The captured regions of the genome are then sequenced to identify the disease-associated variants.\n4. Variant calling: The sequencing data is analyzed to identify the disease-associated variants.\n\nThe TALE-iD method has several advantages over other methods for the identification of disease-associated variants. It allows for the targeted enrichment of specific regions of the genome, which reduces the amount of sequencing required and increases the sensitivity of the analysis. It also allows for the identification of rare variants, which can be difficult to detect using other methods.\n\nOverall, the TALE-iD method is a powerful tool for the identification of disease-associated variants in the human genome, and has the potential to improve our understanding of the genetic basis of complex diseases and enable the development of personalized medicine.",
    "llama-7b_fact_raw": "1. The TALE-iD method is used for the identification of disease-associated variants in the human genome.\n2. TALE-iD employs engineered Transcription Activator-Like Effector proteins that bind to specific DNA sequences.\n3. The TALE-iD method facilitates the targeted enrichment of regions containing disease-associated variants for sequencing.\n4. TALE proteins in TALE-iD are specifically designed to recognize sequences associated with disease variants, such as SNPs or CNVs.\n5. The TALE-iD method is designed to increase the sensitivity of analyzing genomic data and identify rare variants.",
    "llama-7b_fact": [
      "The TALE-iD method is used for the identification of disease-associated variants in the human genome.",
      "TALE-iD employs engineered Transcription Activator-Like Effector proteins that bind to specific DNA sequences.",
      "The TALE-iD method facilitates the targeted enrichment of regions containing disease-associated variants for sequencing.",
      "TALE proteins in TALE-iD are specifically designed to recognize sequences associated with disease variants, such as SNPs or CNVs.",
      "The TALE-iD method is designed to increase the sensitivity of analyzing genomic data and identify rare variants."
    ]
  },
  {
    "id": 2747,
    "user_query": "You MUST give a detailed answer to the following question: Which Lisp framework has been developed for image processing?",
    "llama-7b_response": "There are several Lisp frameworks that have been developed for image processing, including:\n\n1. Common Lisp Image Processing (CL-IP): CL-IP is a Common Lisp library for image processing and analysis. It provides a wide range of functions for tasks such as image manipulation, filtering, segmentation, and feature extraction.\n2. QuickDraw CL: QuickDraw CL is a Common Lisp library for image processing and computer vision. It provides a range of functions for tasks such as image manipulation, feature extraction, and object recognition.\n3. LispWorks Image Processing Library (LIP): LIP is a LispWorks library for image processing and analysis. It provides a range of functions for tasks such as image manipulation, filtering, segmentation, and feature extraction.\n4. SBCL Image Processing Library (SBCL-IP): SBCL-IP is a SBCL library for image processing and analysis. It provides a range of functions for tasks such as image manipulation, filtering, segmentation, and feature extraction.\n\nOverall, there are several Lisp frameworks available for image processing, and the choice of which one to use will depend on the specific requirements of the project.",
    "llama-7b_fact_raw": "1. Common Lisp Image Processing (CL-IP) is a library developed for image processing and analysis in Common Lisp.\n2. QuickDraw CL is an image processing and computer vision library developed for use with Common Lisp.\n3. LispWorks Image Processing Library (LIP) is an image processing library available in LispWorks.\n4. SBCL Image Processing Library (SBCL-IP) is an image processing library for the SBCL implementation of Lisp.",
    "llama-7b_fact": [
      "Common Lisp Image Processing (CL-IP) is a library developed for image processing and analysis in Common Lisp.",
      "QuickDraw CL is an image processing and computer vision library developed for use with Common Lisp.",
      "LispWorks Image Processing Library (LIP) is an image processing library available in LispWorks.",
      "SBCL Image Processing Library (SBCL-IP) is an image processing library for the SBCL implementation of Lisp."
    ]
  },
  {
    "id": 2759,
    "user_query": "You MUST give a detailed answer to the following question: How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-7b_response": "The question of how many genes in Saccharomyces cerevisiae (baker's yeast) are the result of an ancient whole genome duplication event is a complex one that has been the subject of much research.\n\nS. cerevisiae is a eukaryotic, single-celled fungus that is widely used as a model organism in genetics and molecular biology. The genome of S. cerevisiae consists of 12 megabases (Mb) of DNA and contains approximately 6,000 protein-coding genes.\n\nAncient whole genome duplications (WGDs) are a common feature of the evolution of eukaryotic genomes. WGDs result in the duplication of large portions of the genome, leading to the formation of duplicate genes and the evolution of new gene functions.\n\nThere have been several studies that have attempted to identify the number of genes in S. cerevisiae that are the result of an ancient WGD. These studies have used a variety of approaches, including comparative genomics, gene family analysis, and phylogenetic reconstruction.\n\nOne of the earliest studies to address this question was published in 2001 by Li and Durbin, who used a comparative genomics approach to identify duplicated blocks of genes in the S. cerevisiae genome. They identified several large blocks of duplicated genes that were likely the result of an ancient WGD, and estimated that approximately 25% of the S. cerevisiae genes were the result of this event.\n\nMore recent studies have used a variety of approaches to estimate the number of genes in S. cerevisiae that are the result of an ancient WGD. For example, a study published in 2014 used a combination of gene family analysis and phylogenetic reconstruction to estimate that approximately 30% of the S. cerevisiae genes were the result of an ancient WGD.\n\nOverall, the number of genes in S. cerevisiae that are the result of an ancient WGD is estimated to be between 1500 and 3000. However, the exact number is difficult to determine with certainty, and further research is likely to refine",
    "llama-7b_fact_raw": "1. Saccharomyces cerevisiae, commonly known as baker's yeast, is a eukaryotic, single-celled fungus used as a model organism in genetics and molecular biology.\n2. The genome of S. cerevisiae is composed of 12 megabases (Mb) of DNA.\n3. S. cerevisiae contains approximately 6,000 protein-coding genes.\n4. An ancient whole genome duplication event is responsible for the duplication of a significant portion of the S. cerevisiae genome.\n5. Studies estimate that between 25% and 30% of S. cerevisiae's genes, roughly 1500 to 3000 genes, are the result of an ancient whole genome duplication.",
    "llama-7b_fact": [
      "Saccharomyces cerevisiae, commonly known as baker's yeast, is a eukaryotic, single-celled fungus used as a model organism in genetics and molecular biology.",
      "The genome of S. cerevisiae is composed of 12 megabases (Mb) of DNA.",
      "S. cerevisiae contains approximately 6,000 protein-coding genes.",
      "An ancient whole genome duplication event is responsible for the duplication of a significant portion of the S. cerevisiae genome.",
      "Studies estimate that between 25% and 30% of S. cerevisiae's genes, roughly 1500 to 3000 genes, are the result of an ancient whole genome duplication."
    ]
  },
  {
    "id": 2763,
    "user_query": "You MUST give a detailed answer to the following question: Which complex is bound by estrogen-related receptor  (Esrrb)?",
    "llama-7b_response": "Estrogen-related receptor  (Esrrb) is a member of the nuclear receptor superfamily of transcription factors. It is a ligand-activated transcription factor that binds to DNA and regulates the expression of target genes involved in a variety of biological processes, including development, differentiation, and homeostasis.\n\nEsrrb is primarily expressed in the brain, where it plays a role in the regulation of neurotransmitter release, synaptic plasticity, and neuroprotection. It has also been shown to play a role in the regulation of bone metabolism, lipid metabolism, and immune function.\n\nEsrrb is known to be bound by a variety of ligands, including estrogens, androgens, and other steroid hormones. It has also been shown to be bound by non-steroidal ligands, such as thyroid hormones and retinoic acid.\n\nThere is limited information available on the specific complex that is bound by Esrrb. However, it is known that Esrrb can form heterodimers with other nuclear receptors, such as estrogen receptor  (Esr1) and glucocorticoid receptor (GR). These heterodimers can bind to DNA and regulate the expression of target genes involved in a variety of biological processes.\n\nIn summary, while there is limited information available on the specific complex that is bound by Esrrb, it is known to form heterodimers with other nuclear receptors and regulate the expression of target genes involved in a variety of biological processes.",
    "llama-7b_fact_raw": "1. Estrogen-related receptor  (Esrrb) is part of the nuclear receptor superfamily of transcription factors.\n2. Esrrb is a ligand-activated transcription factor that binds to DNA to regulate expression of target genes.\n3. Esrrb primarily has roles in development, differentiation, and homeostasis.\n4. Esrrb is predominantly expressed in the brain and is involved in the regulation of neurotransmitter release, synaptic plasticity, and neuroprotection.\n5. Esrrb can form heterodimers with other nuclear receptors such as estrogen receptor  (Esr1) and glucocorticoid receptor (GR).",
    "llama-7b_fact": [
      "Estrogen-related receptor  (Esrrb) is part of the nuclear receptor superfamily of transcription factors.",
      "Esrrb is a ligand-activated transcription factor that binds to DNA to regulate expression of target genes.",
      "Esrrb primarily has roles in development, differentiation, and homeostasis.",
      "Esrrb is predominantly expressed in the brain and is involved in the regulation of neurotransmitter release, synaptic plasticity, and neuroprotection.",
      "Esrrb can form heterodimers with other nuclear receptors such as estrogen receptor  (Esr1) and glucocorticoid receptor (GR)."
    ]
  },
  {
    "id": 2842,
    "user_query": "You MUST give a detailed answer to the following question: What is the role of ZCCHC17?",
    "llama-7b_response": "ZCCHC17 is a gene that encodes for a protein called zinc finger CCCH-type containing 17. This protein is a member of the CCCH-type zinc finger family, which is a class of transcription factors that bind to DNA and regulate gene expression.\n\nThe exact function of ZCCHC17 is not fully understood, but it is believed to play a role in regulating the expression of genes involved in a variety of biological processes, including cell growth, differentiation, and immune response.\n\nStudies have shown that ZCCHC17 is expressed in a variety of tissues and cells, including immune cells such as T cells and B cells. It has been suggested that ZCCHC17 may play a role in regulating the activation and proliferation of these immune cells.\n\nIn addition, ZCCHC17 has been implicated in the development of certain types of cancer, including leukemia and lymphoma. It has been shown that overexpression of ZCCHC17 can promote the growth and survival of cancer cells, suggesting that it may be a potential target for cancer therapy.\n\nOverall, while more research is needed to fully understand the role of ZCCHC17, it is clear that this protein plays an important role in regulating gene expression and may have implications for a variety of biological processes, including immune response and cancer development.",
    "llama-7b_fact_raw": "1. ZCCHC17 is a gene that encodes the protein zinc finger CCCH-type containing 17.\n2. The protein ZCCHC17 is a member of the CCCH-type zinc finger family, which consists of transcription factors regulating gene expression.\n3. ZCCHC17 is believed to be involved in regulating the expression of genes important in cell growth, differentiation, and immune response.\n4. ZCCHC17 is expressed in various tissues and cells, including immune cells like T cells and B cells.\n5. Overexpression of ZCCHC17 has been observed to promote growth and survival of cancer cells in certain types of cancer, such as leukemia and lymphoma.",
    "llama-7b_fact": [
      "ZCCHC17 is a gene that encodes the protein zinc finger CCCH-type containing 17.",
      "The protein ZCCHC17 is a member of the CCCH-type zinc finger family, which consists of transcription factors regulating gene expression.",
      "ZCCHC17 is believed to be involved in regulating the expression of genes important in cell growth, differentiation, and immune response.",
      "ZCCHC17 is expressed in various tissues and cells, including immune cells like T cells and B cells.",
      "Overexpression of ZCCHC17 has been observed to promote growth and survival of cancer cells in certain types of cancer, such as leukemia and lymphoma."
    ]
  },
  {
    "id": 2861,
    "user_query": "You MUST give a detailed answer to the following question: Which proteins form the nuclear pore basket in human cells?",
    "llama-7b_response": "The nuclear pore complex (NPC) is a large protein complex that forms a selective barrier between the nucleus and the cytoplasm of eukaryotic cells. The NPC consists of an outer ring of approximately 30 nucleoporins (Nups) and an inner ring of approximately 80 nucleoporins.\n\nThe proteins that form the nuclear pore basket are a group of nucleoporins that are involved in the formation of the inner ring of the NPC. These proteins include:\n\n1. Nup107-160\n2. Nup153\n3. Nup214\n4. Nup215\n5. Nup231\n6. Nup232\n7. Nup233\n8. Nup234\n9. Nup235\n10. Nup236\n11. Nup237\n12. Nup238\n13. Nup239\n14. Nup240\n15. Nup241\n16. Nup242\n17. Nup243\n18. Nup244\n19. Nup245\n20. Nup246\n21. Nup247\n22. Nup248\n23. Nup249\n24. Nup250\n25. Nup251\n26. Nup252\n27. Nup253\n28. Nup254\n29. Nup255\n30. Nup256\n31. Nup257\n32. Nup258\n33. Nup259\n34. Nup260\n35. Nup261\n36. Nup262\n37. Nup263\n38. Nup264\n39. Nup265\n40. Nup266\n41. Nup267\n42. Nup268\n43. Nup269\n44. Nup270\n45. Nup",
    "llama-7b_fact_raw": "1. The nuclear pore complex (NPC) forms a selective barrier between the nucleus and the cytoplasm of eukaryotic cells.\n2. The NPC is made up of an outer ring of approximately 30 nucleoporins and an inner ring of approximately 80 nucleoporins.\n3. Nucleoporins (Nups) are the proteins that constitute the nuclear pore complex.\n4. Nup107-160 and Nup153 are examples of nucleoporins that form the nuclear pore basket.\n5. The list of proteins provided as constituting the nuclear pore basket, ranging from Nup107-160 to Nup270, is likely incorrect or misrepresented, as there are typically fewer distinct nucleoporins in the NPC, and the naming convention does not usually employ a simple numerical sequence.\n\n(Note: The list of nucleoporins presented in the answer is either incorrect or misleading as there are not that many distinct nucleoporins known in the nuclear pore complex, and the numbers provided do not reflect the known nomenclature of nucleoporins. The factual statements have been generated based on conventional understanding and omit the long list of nucleoporins mentioned in the answer as this could not be independently verified.)",
    "llama-7b_fact": [
      "The nuclear pore complex (NPC) forms a selective barrier between the nucleus and the cytoplasm of eukaryotic cells.",
      "The NPC is made up of an outer ring of approximately 30 nucleoporins and an inner ring of approximately 80 nucleoporins.",
      "Nucleoporins (Nups) are the proteins that constitute the nuclear pore complex.",
      "Nup107-160 and Nup153 are examples of nucleoporins that form the nuclear pore basket.",
      "The list of proteins provided as constituting the nuclear pore basket, ranging from Nup107-160 to Nup270, is likely incorrect or misrepresented, as there are typically fewer distinct nucleoporins in the NPC, and the naming convention does not usually employ a simple numerical sequence.",
      "ote: The list of nucleoporins presented in the answer is either incorrect or misleading as there are not that many distinct nucleoporins known in the nuclear pore complex, and the numbers provided do not reflect the known nomenclature of nucleoporins. The factual statements have been generated based on conventional understanding and omit the long list of nucleoporins mentioned in the answer as this could not be independently verified.)"
    ]
  },
  {
    "id": 2919,
    "user_query": "You MUST give a detailed answer to the following question: What type of topoisomerase inhibitor is gepotidacin?",
    "llama-7b_response": "Gepotidacin is a topoisomerase I inhibitor.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 2943,
    "user_query": "You MUST give a detailed answer to the following question: Describe Canvas SPW",
    "llama-7b_response": "I'm sorry, but I'm not sure what you mean by \"Canvas SPW.\" Could you please provide more context or clarify your question?",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 2960,
    "user_query": "You MUST give a detailed answer to the following question: List STING agonists.",
    "llama-7b_response": "",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 2964,
    "user_query": "You MUST give a detailed answer to the following question: Describe SLIC-CAGE",
    "llama-7b_response": "SLIC-CAGE is a method used to classify and organize software systems based on their architecture. It stands for Software Layered Infrastructure Classification and Genetic Algorithm for Evolution.\n\nThe SLIC-CAGE method uses a genetic algorithm to evolve a classification of software systems based on their architecture. The classification is based on a layered infrastructure model, which divides software systems into layers based on their functionality and the interactions between them.\n\nThe genetic algorithm used in SLIC-CAGE starts with a set of initial classifications of software systems, which are then evolved over time through a process of mutation and selection. The goal of the algorithm is to find a set of classifications that accurately reflect the architecture of the software systems and are consistent with each other.\n\nThe SLIC-CAGE method can be used to classify a wide range of software systems, including operating systems, web applications, and embedded systems. It can also be used to compare the architecture of different software systems and to identify patterns and trends in their design.\n\nOverall, SLIC-CAGE is a powerful tool for classifying and organizing software systems based on their architecture, and it has a wide range of potential applications in software engineering and research.",
    "llama-7b_fact_raw": "1. SLIC-CAGE stands for Software Layered Infrastructure Classification and Genetic Algorithm for Evolution.\n2. SLIC-CAGE employs a genetic algorithm to evolve the classification of software systems based on their architecture.\n3. The classification system in SLIC-CAGE is based on a layered infrastructure model, which organizes software into layers by functionality and interaction.\n4. The process used in the SLIC-CAGE genetic algorithm involves mutation and selection to refine software system classifications.\n5. SLIC-CAGE can classify various types of software systems, including operating systems, web applications, and embedded systems.",
    "llama-7b_fact": [
      "SLIC-CAGE stands for Software Layered Infrastructure Classification and Genetic Algorithm for Evolution.",
      "SLIC-CAGE employs a genetic algorithm to evolve the classification of software systems based on their architecture.",
      "The classification system in SLIC-CAGE is based on a layered infrastructure model, which organizes software into layers by functionality and interaction.",
      "The process used in the SLIC-CAGE genetic algorithm involves mutation and selection to refine software system classifications.",
      "SLIC-CAGE can classify various types of software systems, including operating systems, web applications, and embedded systems."
    ]
  },
  {
    "id": 2978,
    "user_query": "You MUST give a detailed answer to the following question: What are the roles of LEM-3?",
    "llama-7b_response": "LEM-3, also known as Lymphoid Enhancer-Binding Factor 3, is a transcription factor that plays a crucial role in the development and function of the immune system. It is primarily expressed in lymphoid tissues, such as the thymus and bone marrow, and regulates the expression of genes involved in T cell development, B cell differentiation, and antibody production.\n\nOne of the key functions of LEM-3 is to regulate the differentiation of T cells, which are a type of white blood cell that play a central role in the immune response. LEM-3 regulates the expression of genes involved in the activation and proliferation of T cells, as well as the production of cytokines and chemokines that attract other immune cells to the site of an infection or inflammation.\n\nIn addition to its role in T cell development, LEM-3 is also involved in the differentiation of B cells, which are a type of white blood cell that produce antibodies to protect the body against infections. LEM-3 regulates the expression of genes involved in the activation and maturation of B cells, as well as the production of antibodies.\n\nOverall, LEM-3 plays a critical role in the development and function of the immune system, and its dysregulation has been implicated in a number of immune disorders, including autoimmune diseases and cancer.",
    "llama-7b_fact_raw": "1. LEM-3, known as Lymphoid Enhancer-Binding Factor 3, is a transcription factor important for the immune system.\n2. LEM-3 is primarily expressed in lymphoid tissues like the thymus and bone marrow.\n3. It has a role in regulating the expression of genes involved in T cell development.\n4. LEM-3 influences the differentiation of B cells involved in antibody production.\n5. Dysregulation of LEM-3 is associated with immune disorders, including autoimmune diseases and cancer.",
    "llama-7b_fact": [
      "LEM-3, known as Lymphoid Enhancer-Binding Factor 3, is a transcription factor important for the immune system.",
      "LEM-3 is primarily expressed in lymphoid tissues like the thymus and bone marrow.",
      "It has a role in regulating the expression of genes involved in T cell development.",
      "LEM-3 influences the differentiation of B cells involved in antibody production.",
      "Dysregulation of LEM-3 is associated with immune disorders, including autoimmune diseases and cancer."
    ]
  },
  {
    "id": 2992,
    "user_query": "You MUST give a detailed answer to the following question: List the releases of tmVar",
    "llama-7b_response": "I'm sorry, but I'm not sure what you mean by \"tmVar.\" Could you please provide more context or clarify your question?",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 3018,
    "user_query": "You MUST give a detailed answer to the following question: Which is the database of somatic mutations in normal cells?",
    "llama-7b_response": "The database of somatic mutations in normal cells is called the Cancer Genome Atlas (TCGA). TCGA is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) to characterize the genetic changes that occur in cancer cells.\n\nTCGA collects and analyzes DNA and RNA sequencing data from tumors and normal tissue samples from patients with a wide range of cancer types. The data is used to identify somatic mutations, which are changes in the DNA or RNA that occur in cancer cells but not in normal cells.\n\nTCGA has generated a vast amount of data on somatic mutations in normal cells, which is publicly available and can be accessed through the TCGA Data Portal. Researchers can use this data to study the genetic changes that occur in normal cells and how they may contribute to the development of cancer.\n\nOverall, TCGA is an important resource for the study of somatic mutations in normal cells and their role in cancer development.",
    "llama-7b_fact_raw": "1. The Cancer Genome Atlas (TCGA) is a database of somatic mutations in normal cells.\n2. TCGA is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI).\n3. TCGA collects and analyzes DNA and RNA sequencing data from tumors as well as normal tissue samples.\n4. The TCGA Data Portal provides public access to the data generated by TCGA.\n5. Researchers utilize TCGA data to study genetic changes in normal cells and their contribution to cancer development.",
    "llama-7b_fact": [
      "The Cancer Genome Atlas (TCGA) is a database of somatic mutations in normal cells.",
      "TCGA is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI).",
      "TCGA collects and analyzes DNA and RNA sequencing data from tumors as well as normal tissue samples.",
      "The TCGA Data Portal provides public access to the data generated by TCGA.",
      "Researchers utilize TCGA data to study genetic changes in normal cells and their contribution to cancer development."
    ]
  },
  {
    "id": 3037,
    "user_query": "You MUST give a detailed answer to the following question: Are there graph kernel libraries available implemented in JAVA?",
    "llama-7b_response": "",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": []
  },
  {
    "id": 3045,
    "user_query": "You MUST give a detailed answer to the following question: List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-7b_response": "The SHERLOCKv2 platform integrates four key advances:\n\n1. Real-time analytics: SHERLOCKv2 uses real-time analytics to process and analyze large amounts of data in real-time, allowing for faster and more accurate decision-making.\n2. Artificial intelligence and machine learning: SHERLOCKv2 incorporates artificial intelligence and machine learning algorithms to improve the accuracy and speed of threat detection and response.\n3. Automation and orchestration: SHERLOCKv2 includes automation and orchestration capabilities, allowing for more efficient and effective incident response and remediation.\n4. Open architecture and extensibility: SHERLOCKv2 has an open architecture and is extensible, allowing for easy integration with other systems and tools, as well as the ability to add new capabilities as needed.",
    "llama-7b_fact_raw": "1. SHERLOCKv2 incorporates real-time analytics for processing and analyzing data.\n2. SHERLOCKv2 includes artificial intelligence and machine learning algorithms for threat detection and response.\n3. SHERLOCKv2 features automation and orchestration capabilities for incident response and remediation.\n4. SHERLOCKv2 is designed with an open architecture that is extensible and allows integration with other systems.",
    "llama-7b_fact": [
      "SHERLOCKv2 incorporates real-time analytics for processing and analyzing data.",
      "SHERLOCKv2 includes artificial intelligence and machine learning algorithms for threat detection and response.",
      "SHERLOCKv2 features automation and orchestration capabilities for incident response and remediation.",
      "SHERLOCKv2 is designed with an open architecture that is extensible and allows integration with other systems."
    ]
  },
  {
    "id": 3078,
    "user_query": "You MUST give a detailed answer to the following question: Describe the bartender algorithm",
    "llama-7b_response": "The bartender algorithm, also known as the bartender problem, is a classic problem in computer science that involves scheduling a set of tasks to be executed on a set of processors. The problem is named after the bartender problem, which is a classic problem in artificial intelligence that involves a bartender trying to serve drinks to a group of customers as efficiently as possible.\n\nThe bartender algorithm is a scheduling algorithm that is used to determine the order in which tasks should be executed on a set of processors. The algorithm works by dividing the set of tasks into groups of tasks that can be executed concurrently, and then assigning each group of tasks to a separate processor. The algorithm then assigns the next task to be executed to the processor that has the least amount of work to do.\n\nThe bartender algorithm is a simple and efficient algorithm that can be used to schedule a large number of tasks on a set of processors. The algorithm works by dividing the set of tasks into groups of tasks that can be executed concurrently, and then assigning each group of tasks to a separate processor. The algorithm then assigns the next task to be executed to the processor that has the least amount of work to do.\n\nOne of the key advantages of the bartender algorithm is that it is simple to implement and does not require any complex data structures or algorithms. The algorithm is also highly efficient and can be used to schedule a large number of tasks on a set of processors.\n\nIn conclusion, the bartender algorithm is a classic problem in computer science that involves scheduling a set of tasks to be executed on a set of processors. The algorithm works by dividing the set of tasks into groups of tasks that can be executed concurrently, and then assigning each group of tasks to a separate processor. The algorithm then assigns the next task to be executed to the processor that has the least amount of work to do. The bartender algorithm is a simple and efficient algorithm that can be used to schedule a large number of tasks on a set of processors.",
    "llama-7b_fact_raw": "1. The bartender algorithm is a scheduling algorithm used in computing for executing tasks on processors.\n2. It involves grouping tasks that can be executed concurrently and assigning them to separate processors.\n3. The bartender algorithm assigns the next task to the processor with the least amount of work remaining.\n4. The algorithm is known for its simplicity and does not require complex data structures for implementation.\n5. The bartender algorithm is efficient for scheduling a large number of tasks on multiple processors.",
    "llama-7b_fact": [
      "The bartender algorithm is a scheduling algorithm used in computing for executing tasks on processors.",
      "It involves grouping tasks that can be executed concurrently and assigning them to separate processors.",
      "The bartender algorithm assigns the next task to the processor with the least amount of work remaining.",
      "The algorithm is known for its simplicity and does not require complex data structures for implementation.",
      "The bartender algorithm is efficient for scheduling a large number of tasks on multiple processors."
    ]
  },
  {
    "id": 3100,
    "user_query": "You MUST give a detailed answer to the following question: Which web-based pedigree editors are available?",
    "llama-7b_response": "There are several web-based pedigree editors available that can be used to create and edit family trees online. Some of the most popular options include:\n\n1. Geni: Geni is a free online genealogy and family history platform that allows users to create and manage their family trees. It offers a range of features, including the ability to collaborate with other users, add photos and documents, and track ancestors.\n2. WeRelate: WeRelate is a free, open-source genealogy website that allows users to create and edit family trees. It offers a range of features, including the ability to search for ancestors, add photos and documents, and collaborate with other users.\n3. FamilySearch: FamilySearch is a free online genealogy platform that allows users to create and manage their family trees. It offers a range of features, including the ability to collaborate with other users, add photos and documents, and search for ancestors.\n4. MyHeritage: MyHeritage is a paid genealogy platform that allows users to create and manage their family trees. It offers a range of features, including the ability to collaborate with other users, add photos and documents, and search for ancestors.\n5. Ancestry: Ancestry is a paid genealogy platform that allows users to create and manage their family trees. It offers a range of features, including the ability to collaborate with other users, add photos and documents, and search for ancestors.\n\nThese are just a few examples of the many web-based pedigree editors available. Each platform has its own unique features and benefits, so it's worth exploring a few options to find the one that best suits your needs.",
    "llama-7b_fact_raw": "1. Geni is a web-based genealogy platform where users can create, edit, and manage their family trees.\n2. WeRelate is an open-source genealogy website offering collaborative family tree editing features.\n3. FamilySearch is a free online genealogy platform that provides features for family tree management and ancestor searches.\n4. MyHeritage is a paid genealogy platform that includes collaborative features and allows adding photos and documents to family trees.\n5. Ancestry offers paid services for creating and managing family trees, including features for collaboration and document/photo adding.",
    "llama-7b_fact": [
      "Geni is a web-based genealogy platform where users can create, edit, and manage their family trees.",
      "WeRelate is an open-source genealogy website offering collaborative family tree editing features.",
      "FamilySearch is a free online genealogy platform that provides features for family tree management and ancestor searches.",
      "MyHeritage is a paid genealogy platform that includes collaborative features and allows adding photos and documents to family trees.",
      "Ancestry offers paid services for creating and managing family trees, including features for collaboration and document/photo adding."
    ]
  },
  {
    "id": 3107,
    "user_query": "You MUST give a detailed answer to the following question: Which curated databases exist for spider-venom toxins?",
    "llama-7b_response": "There are several curated databases that exist for spider venom toxins. Here are some of the most notable ones:\n\n1. SpiderTox: SpiderTox is a database of spider venom toxins that was developed by researchers at the University of Melbourne in Australia. It contains information on the biochemical and biological properties of spider venom toxins, as well as their potential therapeutic applications. The database includes information on toxins from a wide range of spider species, including both venomous and non-venomous spiders.\n2. Arachnovibes: Arachnovibes is a database of spider venom toxins that was developed by researchers at the University of California, Riverside. It contains information on the biochemical and biological properties of spider venom toxins, as well as their potential therapeutic applications. The database includes information on toxins from a wide range of spider species, including both venomous and non-venomous spiders.\n3. SpiderGen: SpiderGen is a database of spider venom toxins that was developed by researchers at the University of California, Los Angeles. It contains information on the biochemical and biological properties of spider venom toxins, as well as their potential therapeutic applications. The database includes information on toxins from a wide range of spider species, including both venomous and non-venomous spiders.\n4. SpiderTech: SpiderTech is a database of spider venom toxins that was developed by researchers at the University of California, Irvine. It contains information on the biochemical and biological properties of spider venom toxins, as well as their potential therapeutic applications. The database includes information on toxins from a wide range of spider species, including both venomous and non-venomous spiders.\n\nThese databases are valuable resources for researchers studying spider venom toxins, as they provide a wealth of information on the biochemical and biological properties of these toxins, as well as their potential therapeutic applications.",
    "llama-7b_fact_raw": "1. SpiderTox is a database for spider venom toxins developed by researchers at the University of Melbourne in Australia.\n2. Arachnovibes is a database for spider venom toxins developed by researchers at the University of California, Riverside.\n3. SpiderGen is a database for spider venom toxins developed by researchers at the University of California, Los Angeles.\n4. SpiderTech is a database for spider venom toxins developed by researchers at the University of California, Irvine.",
    "llama-7b_fact": [
      "SpiderTox is a database for spider venom toxins developed by researchers at the University of Melbourne in Australia.",
      "Arachnovibes is a database for spider venom toxins developed by researchers at the University of California, Riverside.",
      "SpiderGen is a database for spider venom toxins developed by researchers at the University of California, Los Angeles.",
      "SpiderTech is a database for spider venom toxins developed by researchers at the University of California, Irvine."
    ]
  },
  {
    "id": 3111,
    "user_query": "You MUST give a detailed answer to the following question: Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-7b_response": "Axitinib is a medication that is used to treat certain types of cancer, including pancreatic cancer. While there is some evidence to suggest that axitinib may be effective at prolonging survival in some patients with pancreatic cancer, the evidence is not definitive and more research is needed to fully understand its effects on survival in this population.\n\nOne study published in the journal Cancer Research in 2015 found that axitinib may be effective at prolonging survival in patients with advanced pancreatic cancer. In this study, patients who received axitinib had a median survival time of 6.1 months, compared to 4.7 months in patients who did not receive the medication. However, it is worth noting that this study was small and further research is needed to confirm these findings.\n\nAnother study published in the journal Clinical Cancer Research in 2018 found that axitinib may be effective at prolonging survival in patients with advanced pancreatic cancer who have already received chemotherapy. In this study, patients who received axitinib had a median survival time of 6.9 months, compared to 4.4 months in patients who did not receive the medication.\n\nOverall, while there is some evidence to suggest that axitinib may be effective at prolonging survival in patients with pancreatic cancer, more research is needed to fully understand its effects on survival in this population. It is important for patients to discuss the potential benefits and risks of axitinib with their healthcare provider, and to consider all available treatment options before making a decision about their care.",
    "llama-7b_fact_raw": "1. Axitinib is a medication used to treat certain types of cancer, including pancreatic cancer.\n2. A study published in Cancer Research in 2015 indicated that axitinib may prolong survival in patients with advanced pancreatic cancer, showing a median survival time of 6.1 months with the medication.\n3. The median survival time for patients who did not receive axitinib in the 2015 study was 4.7 months.\n4. Research published in Clinical Cancer Research in 2018 suggested that axitinib might prolong survival in patients with advanced pancreatic cancer who have received chemotherapy, reporting a median survival time of 6.9 months with the medication.\n5. The median survival time for patients who did not receive axitinib in the 2018 study was 4.4 months.",
    "llama-7b_fact": [
      "Axitinib is a medication used to treat certain types of cancer, including pancreatic cancer.",
      "A study published in Cancer Research in 2015 indicated that axitinib may prolong survival in patients with advanced pancreatic cancer, showing a median survival time of 6.1 months with the medication.",
      "The median survival time for patients who did not receive axitinib in the 2015 study was 4.7 months.",
      "Research published in Clinical Cancer Research in 2018 suggested that axitinib might prolong survival in patients with advanced pancreatic cancer who have received chemotherapy, reporting a median survival time of 6.9 months with the medication.",
      "The median survival time for patients who did not receive axitinib in the 2018 study was 4.4 months."
    ]
  }
]